2025/02/07 更新

写真a

タカサワ アキラ
髙澤 啓
TAKASAWA Akira
所属
医学部 医学科 基礎医学講座 病理学講座(腫瘍病理分野)
外部リンク

研究キーワード

  • プロテオーム解析

  • FFPE組織

  • がん悪性化

  • タイト結合

  • 細胞間接着

  • 超微細構造

  • バイオマーカー探索

  • 治療標的探索

  • リン酸化プロテオーム解析

  • 病理学

研究分野

  • ライフサイエンス / 人体病理学

  • ライフサイエンス / 実験病理学

  • ライフサイエンス / 腫瘍診断、治療学

  • ライフサイエンス / 腫瘍生物学

経歴

  • 旭川医科大学病理学講座腫瘍病理分野   教授

    2023年 - 現在

      詳細を見る

  • 札幌医科大学医学部病理学第二講座   准教授

    2020年 - 2023年7月

      詳細を見る

  • 札幌医科大学医学部 教育研究機器センター 形態解析部門   部門長

    2019年 - 2023年7月

      詳細を見る

  • 札幌医科大学医学部病理学第二講座   講師

    2018年 - 2020年

      詳細を見る

  • 札幌医科大学医学部病理学第二講座   助教

    2010年 - 2018年

      詳細を見る

委員歴

  • 日本臨床分子形態学会   評議員  

    2024年6月 - 現在   

      詳細を見る

    団体区分:学協会

    researchmap

  • Medical Molecular Morphology   Associate Editor  

    2023年12月   

      詳細を見る

  • 日本癌学会   評議員  

    2022年1月 - 現在   

      詳細を見る

  • 日本病理学会   学術評議員  

    2017年4月 - 現在   

      詳細を見る

論文

  • Age-related TFEB downregulation in proximal tubules causes systemic metabolic disorders and occasional apolipoprotein A4-related amyloidosis. 国際誌

    Jun Nakamura, Takeshi Yamamoto, Yoshitsugu Takabatake, Tomoko Namba-Hamano, Atsushi Takahashi, Jun Matsuda, Satoshi Minami, Shinsuke Sakai, Hiroaki Yonishi, Shihomi Maeda, Sho Matsui, Hideaki Kawai, Isao Matsui, Tadashi Yamamuro, Ryuya Edahiro, Seiji Takashima, Akira Takasawa, Yukinori Okada, Tamotsu Yoshimori, Andrea Ballabio, Yoshitaka Isaka

    JCI insight   2024年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    With the aging of society, the incidence of chronic kidney disease (CKD), a common cause of death, has been increasing. Transcription factor EB (TFEB), the master transcriptional regulator of the autophagy-lysosomal pathway, is regarded as a promising candidate for preventing various age-related diseases. However, whether TFEB in the proximal tubules plays a significant role in elderly CKD patients remains unknown. First, we found that nuclear TFEB localization in proximal tubular epithelial cells (PTECs) declined with age in both mice and humans. Next, we generated PTEC-specific Tfeb-deficient mice and bred them for up to 24 months. We found that TFEB deficiency in the proximal tubules caused metabolic disorders and occasionally led to apolipoprotein A4 (APOA4) amyloidosis. Supporting this result, we identified markedly decreased nuclear TFEB localization in the proximal tubules of elderly patients with APOA4 amyloidosis. The metabolic disturbances were accompanied with mitochondrial dysfunction due to transcriptional changes involved in fatty acid oxidation and oxidative phosphorylation pathways, as well as decreased mitochondrial clearance reflected by the accumulation of mitochondria-lysosome-related organelles, which depends on lysosomal function. These results shed light on the presumptive mechanisms of APOA4 amyloidosis pathogenesis and provide a therapeutic strategy for CKD-related metabolic disorders and APOA4 amyloidosis.

    DOI: 10.1172/jci.insight.184451

    PubMed

    researchmap

  • Establishment and characterization of the novel myxofibrosarcoma cell line, SMU-MFS

    Naoya Nakahashi, Makoto Emori, Kohichi Takada, Yasutaka Murahashi, Junya Shimizu, Kazuyuki Murase, Tomohide Tsukahara, Shintaro Sugita, Akira Takasawa, Kousuke Iba, Atsushi Teramoto, Makoto Osanai

    Human Cell   38 ( 1 )   2024年12月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Springer Science and Business Media LLC  

    DOI: 10.1007/s13577-024-01157-9

    researchmap

    その他リンク: https://link.springer.com/article/10.1007/s13577-024-01157-9/fulltext.html

  • Molecular and ultrastructural morphological analyses of highly metamorphosed Aspergillus fumigatus on human formalin-fixed paraffin-embedded tissue.

    Kazuhiro Matsumoto, Masanori Goto, Yuki Kamikokura, Kumi Takasawa, Nobuyuki Kobayashi, Tomoyuki Aoyama, Taro Murakami, Masayo Kamikokura, Yuta Ikechi, Tomoki Kawahata, Kitaru Tanaka, Sayaka Takatori, Daisuke Fujishiro, Kensaku Okamoto, Yuichi Makino, Yuji Nishikawa, Akira Takasawa

    Medical molecular morphology   57 ( 4 )   326 - 332   2024年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Invasive fungal infections including invasive pulmonary aspergillosis (IPA) generally have a poor prognosis, because the fungi spread throughout various organs. Therefore, it is important to accurately identify the fungal species for treatment. In this article, we present the results of pathological and molecular morphological analyses that were performed to elucidate the cause of respiratory failure in a patient who died despite suspicion of IPA and treatment with micafungin (MCFG). Pathological analysis revealed the existence of cystic and linear fungi in lung tissue. The fungi were identified as Aspergillus fumigatus (A. fumigatus) by partial sequencing of genomic DNA. Correlative light microscopy and electron microscopy (CLEM) analysis confirmed that fungi observed with light microscopy can also be observed with scanning electron microscopy (SEM) using formalin-fixed paraffin-embedded tissue sections. SEM revealed an atypical ultrastructure of the fungi including inhomogeneous widths, rough surfaces, and numerous cyst-like structures of various sizes. The fungi showed several morphological changes of cultured A. fumigatus treated with MCFG that were previously reported. Our results indicate that integrated analysis of ultrastructural observation by SEM and DNA sequencing may be an effective tool for analyzing fungi that are difficult to identify by conventional pathological analysis.

    DOI: 10.1007/s00795-024-00402-2

    PubMed

    researchmap

  • Bacillaceae serine proteases and Streptomyces epsilon-poly-l-lysine synergistically inactivate Caliciviridae by inhibiting RNA genome release

    Soh Yamamoto, Noriko Ogasawara, Yuka Sudo-Yokoyama, Sachiko Sato, Nozomu Takata, Nana Yokota, Tomomi Nakano, Kyoko Hayashi, Akira Takasawa, Mayumi Endo, Masako Hinatsu, Keitaro Yoshida, Toyotaka Sato, Satoshi Takahashi, Kenichi Takano, Takashi Kojima, Jun Hiraki, Shin-ich Yokota

    Scientific Reports   14 ( 1 )   2024年7月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Springer Science and Business Media LLC  

    Abstract

    Human norovirus (HuNoV) is an enteric infectious pathogen belonging to the Caliciviridae family that causes occasional epidemics. Circulating alcohol-tolerant viral particles that are readily transmitted via food-borne routes significantly contribute to the global burden of HuNoV-induced gastroenteritis. Moreover, contact with enzymes secreted by other microorganisms in the environment can impact the infectivity of viruses. Hence, understanding the circulation dynamics of Caliciviridae is critical to mitigating epidemics. Accordingly, in this study, we screened whether environmentally abundant secretase components, particularly proteases, affect Caliciviridae infectivity. Results showed that combining Bacillaceae serine proteases with epsilon-poly-l-lysine (EPL) produced by Streptomyces—a natural antimicrobial—elicited anti-Caliciviridae properties, including against the epidemic HuNoV GII.4_Sydney_2012 strain. In vitro and in vivo biochemical and virological analyses revealed that EPL has two unique synergistic viral inactivation functions. First, it maintains an optimal pH to promote viral surface conformational changes to the protease-sensitive structure. Subsequently, it inhibits viral RNA genome release via partial protease digestion at the P2 and S domains in the VP1 capsid. This study provides new insights regarding the high-dimensional environmental interactions between bacteria and Caliciviridae, while promoting the development of protease-based anti-viral disinfectants.

    DOI: 10.1038/s41598-024-65963-9

    researchmap

    その他リンク: https://www.nature.com/articles/s41598-024-65963-9

  • Multilayered proteomics reveals that JAM-A promotes breast cancer progression via regulation of amino acid transporter LAT1. 国際誌

    Kazufumi Magara, Akira Takasawa, Kumi Takasawa, Tomoyuki Aoyama, Misaki Ota, Daisuke Kyuno, Yusuke Ono, Taro Murakami, Soh Yamamoto, Yuna Nakamori, Naoya Nakahashi, Goro Kutomi, Ichiro Takemasa, Tadashi Hasegawa, Makoto Osanai

    Cancer science   2024年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Recent studies have shown that transmembrane-type tight junction proteins are upregulated in various cancers compared with their levels in normal tissues and are involved in cancer progression, suggesting that they are potential therapeutic targets. Here, we demonstrated the expression profile and a novel role of junctional adhesion molecule-A (JAM-A) in breast cancer. Immunohistochemistry of surgical specimens showed that JAM-A was highly expressed from carcinoma in situ lesions, as in other adenocarcinomas, with higher expression in invasive carcinomas. High expression of JAM-A contributed to malignant aspects such as lymph node metastasis and lymphatic involvement positivity. In breast cancer cells, JAM-A expression status affects malignant potentials including proliferation and migration. Multilayered proteomics revealed that JAM-A interacts with the amino acid transporter LAT1 in breast cancer cells. JAM-A regulates the expression of LAT1 and interacts with it on the whole cell membrane, leading to enhanced amino acid uptake to promote tumor growth. Double high expression of JAM-A and LAT1 predicts poor prognosis in patients with breast cancer. Of note, an antibody against an extracellular domain of JAM-A suppressed the proliferation of breast cancer cells. Our findings indicate the possibility of JAM-A-targeted therapy ideally combined with LAT1-targeted therapy as a new therapeutic strategy against breast cancer.

    DOI: 10.1111/cas.16259

    PubMed

    researchmap

  • Vitamin D-metabolizing enzyme CYP24A1 affects oncogenic behaviors of oral squamous cell carcinoma and its prognostic implication.

    Yuna Nakamori, Akira Takasawa, Kumi Takasawa, Daisuke Kyuno, Yusuke Ono, Kazufumi Magara, Naoya Nakahashi, Shohei Sekiguchi, Kei Tsuchihashi, Akihiro Miyazaki, Makoto Osanai

    Medical molecular morphology   2024年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Vitamin D is an essential molecule for cellular homeostasis, playing a critical role in cell fate decisions including cell proliferation, differentiation, and viability. Accumulating evidence has revealed that expression of the vitamin D-metabolizing enzyme CYP24A1 is dysregulated in different types of human malignancy. CYP24A1 has been shown to be involved in the oncogenic property of a variety of carcinoma cells. However, the pathological relevance of CYP24A1 expression level in human oral malignancy remains to be clarified. In the present study, suppression of CYP24A1 expression in oral squamous cell carcinoma (OSCC) cells increased cell proliferation, invasive activity, colony formation efficacy, and tumor growth in vivo. In addition, knockout of CYP24A1 expression inhibited cell death induced by two different types of anticancer drugs, i.e., fluorouracil and cisplatin. Gene clustering by RNA-sequence analysis revealed that several signaling molecules associated with MYC are involved in CYP24A1-mediated oncogenic behaviors. Furthermore, decreased expression level of CYP24A1 was observed in 124/204 cases (61%) of OSCC and was shown to be associated with short relapse-free and overall survival periods. The results showed that a low expression level of CYP24A1 promotes the oncogenic activity of OSCC and is significantly associated with poor prognosis in patients with this malignancy.

    DOI: 10.1007/s00795-024-00387-y

    PubMed

    researchmap

  • Downregulation of SMOC1 is associated with progression of colorectal traditional serrated adenomas. 国際誌

    Hironori Aoki, Akira Takasawa, Eiichiro Yamamoto, Takeshi Niinuma, Hiro-O Yamano, Taku Harada, Toshiyuki Kubo, Akira Yorozu, Hiroshi Kitajima, Kazuya Ishiguro, Masahiro Kai, Akio Katanuma, Toshiya Shinohara, Hiroshi Nakase, Tamotsu Sugai, Makoto Osanai, Hiromu Suzuki

    BMC gastroenterology   24 ( 1 )   91 - 91   2024年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Aberrant DNA methylation is prevalent in colorectal serrated lesions. We previously reported that the CpG island of SMOC1 is frequently methylated in traditional serrated adenomas (TSAs) and colorectal cancers (CRCs) but is rarely methylated in sessile serrated lesions (SSLs). In the present study, we aimed to further characterize the expression of SMOC1 in early colorectal lesions. METHODS: SMOC1 expression was analyzed immunohistochemically in a series of colorectal tumors (n = 199) and adjacent normal colonic tissues (n = 112). RESULTS: SMOC1 was abundantly expressed in normal colon and SSLs while it was significantly downregulated in TSAs, advanced adenomas and cancers. Mean immunohistochemistry scores were as follows: normal colon, 24.2; hyperplastic polyp (HP), 18.9; SSL, 23.8; SSL with dysplasia (SSLD)/SSL with early invasive cancer (EIC), 15.8; TSA, 5.4; TSA with high grade dysplasia (HGD)/EIC, 4.7; non-advanced adenoma, 21.4; advanced adenoma, 11.9; EIC, 10.9. Higher levels SMOC1 expression correlated positively with proximal colon locations and flat tumoral morphology, reflecting its abundant expression in SSLs. Among TSAs that contained both flat and protruding components, levels of SMOC1 expression were significantly lower in the protruding components. CONCLUSION: Our results suggest that reduced expression of SMOC1 is associated with progression of TSAs and conventional adenomas and that SMOC1 expression may be a biomarker for diagnosis of serrated lesions and risk prediction in colorectal tumors.

    DOI: 10.1186/s12876-024-03175-1

    PubMed

    researchmap

  • MPNSTで異常発現するPVRはがん悪性化に寄与し,治療標的となりうる

    中橋 尚也, 江森 誠人, 高澤 久美, 太田 未咲, 真柄 和史, 小野 祐輔, 及能 大輔, 杉田 真太朗, 長谷川 匡, 小山内 誠, 高澤 啓

    日本整形外科学会雑誌   98 ( 2 )   S194 - S194   2024年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本整形外科学会  

    researchmap

  • 胎盤FFPE組織を用いた比較プロテオーム解析による妊娠高血圧症候群のバイオマーカー探索(Biomarker analysis of hypertensive disorders of pregnancy by proteomics from placental FFPE tissues)

    太田 未咲, 高澤 啓, 高澤 久美, 真柄 和史, 小野 佑輔, 及能 大輔, 杉田 真太朗, 長谷川 匡, 小山内 誠

    日本病理学会会誌   113 ( 1 )   328 - 328   2024年2月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 膵癌の進展におけるClaudin-1の機能(The role of Claudin-1 in Pancreatic Cancer)

    浅野 日南英, 及能 大輔, 奥村 礼央菜, 真柄 和史, 小野 佑輔, 高澤 久美, 高澤 啓, 小山内 誠

    日本病理学会会誌   113 ( 1 )   474 - 474   2024年2月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 肺多形癌における腫瘍浸潤リンパ球の浸潤態度は悪性化に関与する

    黒田 睦喜, 高澤 啓, 桑原 未羽, 廣橋 良彦, 小野 佑輔, 高澤 久美, 真柄 和史, 及能 大輔, 長谷川 匡, 小山内 まこと

    日本病理学会会誌   113 ( 1 )   467 - 467   2024年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • Common pathological findings in the heart in COVID-19-related sudden death cases: An autopsy case series. 国際誌

    Daisuke Kyuno, Masatoshi Tateno, Yusuke Ono, Kazufumi Magara, Kumi Takasawa, Akira Takasawa, Makoto Osanai

    Heliyon   9 ( 10 )   e20564   2023年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Cardiomyopathy is a leading cause of sudden out-of-hospital death after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) vaccination. Such unexpected COVID-19-related cardiomyopathies are challenging to diagnose as specific pathological findings are not always identified. CASE SUMMARY: We reported the autopsy findings of two cases of sudden death due to COVID-19-related cardiomyopathies. In one case, death occurred after SARS-CoV-2 infection, while in the other, after COVID-19 vaccination. We found common pathological findings in both hearts: decreased staining intensity with special stains, loss of rhabdomeres, and multivacuolation in cardiomyocytes without inflammatory cell infiltration. The remaining organs showed no findings that could have contributed to the deaths. CONCLUSION: In cases of sudden death after SARS-CoV-2 infection or COVID-19 vaccination, the decreased staining intensity with special stains may aid the diagnosis of sudden death due to COVID-19-related cardiomyopathy, even when H&E staining shows few findings.

    DOI: 10.1016/j.heliyon.2023.e20564

    PubMed

    researchmap

  • Coefficient of variation of T2-weighted MRI may predict the prognosis of malignant peripheral nerve sheath tumor 国際誌

    Makoto Emori, Hiroyuki Tsuchie, Hiroyuki Takashima, Atsushi Teramoto, Yasutaka Murahashi, Yoshinori Imura, Hidetatsu Outani, Sho Nakai, Satoshi Takenaka, Ryosuke Hirota, Naoya Nakahashi, Junya Shimizu, Kazuyuki Murase, Akira Takasawa, Hiroyuki Nagasawa, Shintaro Sugita, Kohichi Takada, Tadashi Hasegawa, Seiji Okada, Naohisa Miyakoshi, Toshihiko Yamashita

    Skeletal Radiology   53 ( 4 )   657 - 664   2023年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Springer Science and Business Media LLC  

    BACKGROUND: We investigated whether non-enhancement MRI features, including measurement of the heterogeneity of the tumor with MR T2 imaging by calculating coefficient of variation (CV) values, were associated with the prognosis of non-metastatic malignant peripheral nerve sheath tumors (MPNST). METHODS: This retrospective study included 42 patients with MPNST who had undergone surgical resection (mean age, 50 years ± 21; 20 male participants). Non-enhancement MR images were evaluated for signal intensity heterogeneity on T1- and T2-weighted imaging, tumor margin definition on T1- and T2-weighted imaging, peritumoral edema on T2-weight imaging, and CV. We measured the signal intensities of MR T2-weighted images and calculated the corresponding CV values. CV is defined as the ratio of the standard deviation to the mean. The associations between factors and overall survival (OS) were investigated via the Kaplan-Meier method with log-rank tests and the Cox proportional hazards model. RESULTS: The mean CV value of MR T2 images was 0.2299 ± 0.1339 (standard deviation) (range, 0.0381-0.8053). Applying receiver operating characteristics analysis, the optimal cut-off level for CV value was 0.137. This cut-off CV value was used for its stratification into high and low CV values. At multivariate survival analysis, a high CV value (hazard ratio = 3.63; 95% confidence interval = 1.16-16.0; p = 0.047) was identified as an independent predictor of OS. CONCLUSION: The CV value of the signal intensity of heterogenous MPNSTs MR T2-weighted images is an independent predictor of patients' OS.

    DOI: 10.1007/s00256-023-04457-7

    PubMed

    researchmap

    その他リンク: https://link.springer.com/article/10.1007/s00256-023-04457-7/fulltext.html

  • 癌幹細胞マーカーに対する自己抗体を利用した乳癌患者の予後予測(Prediction of Prognosis in Breast Cancer Patients Using Autoantibodies to Cancer Stem Cell Markers)

    及能 大輔, 廣橋 良彦, 和田 朝香, 島 宏彰, 九冨 五郎, 真柄 和史, 高澤 久美, 高澤 啓, 竹政 伊知朗, 小山内 誠

    日本癌学会総会記事   82回   2116 - 2116   2023年9月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本癌学会  

    researchmap

  • 癌幹細胞マーカーに対する自己抗体を利用した乳癌患者の予後予測(Prediction of Prognosis in Breast Cancer Patients Using Autoantibodies to Cancer Stem Cell Markers)

    及能 大輔, 廣橋 良彦, 和田 朝香, 島 宏彰, 九冨 五郎, 真柄 和史, 高澤 久美, 高澤 啓, 竹政 伊知朗, 小山内 誠

    日本癌学会総会記事   82回   2116 - 2116   2023年9月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本癌学会  

    researchmap

  • ACLP Activates Cancer-Associated Fibroblasts and Inhibits CD8+ T-Cell Infiltration in Oral Squamous Cell Carcinoma. 国際誌

    Shohei Sekiguchi, Akira Yorozu, Fumika Okazaki, Takeshi Niinuma, Akira Takasawa, Eiichiro Yamamoto, Hiroshi Kitajima, Toshiyuki Kubo, Yui Hatanaka, Koyo Nishiyama, Kazuhiro Ogi, Hironari Dehari, Atsushi Kondo, Makoto Kurose, Kazufumi Obata, Akito Kakiuchi, Masahiro Kai, Yoshihiko Hirohashi, Toshihiko Torigoe, Takashi Kojima, Makoto Osanai, Kenichi Takano, Akihiro Miyazaki, Hiromu Suzuki

    Cancers   15 ( 17 )   2023年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    We previously showed that upregulation of adipocyte enhancer-binding protein 1 (AEBP1) in vascular endothelial cells promotes tumor angiogenesis. In the present study, we aimed to clarify the role of stromal AEBP1/ACLP expression in oral squamous cell carcinoma (OSCC). Immunohistochemical analysis showed that ACLP is abundantly expressed in cancer-associated fibroblasts (CAFs) in primary OSCC tissues and that upregulated expression of ACLP is associated with disease progression. Analysis using CAFs obtained from surgically resected OSCCs showed that the expression of AEBP1/ACLP in CAFs is upregulated by co-culture with OSCC cells or treatment with TGF-β1, suggesting cancer-cell-derived TGF-β1 induces AEBP1/ACLP in CAFs. Collagen gel contraction assays showed that ACLP contributes to the activation of CAFs. In addition, CAF-derived ACLP promotes migration, invasion, and in vivo tumor formation by OSCC cells. Notably, tumor stromal ACLP expression correlated positively with collagen expression and correlated inversely with CD8+ T cell infiltration into primary OSCC tumors. Boyden chamber assays suggested that ACLP in CAFs may attenuate CD8+ T cell migration. Our results suggest that stromal ACLP contributes to the development of OSCCs, and that ACLP is a potential therapeutic target.

    DOI: 10.3390/cancers15174303

    PubMed

    researchmap

  • MPNSTにおけるPVR発現の意義

    中橋 尚也, 高澤 啓, 江森 誠人, 高澤 久美, 太田 未咲, 真柄 和史, 小野 佑輔, 及能 大輔, 杉田 真太朗, 長谷川 匡, 小山内 誠

    日本整形外科学会雑誌   97 ( 8 )   S1975 - S1975   2023年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本整形外科学会  

    researchmap

  • Emerging roles of transmembrane-type tight junction proteins in cancers. 国際誌

    Akira Takasawa, Kumi Takasawa, Masaki Murata, Makoto Osanai, Norimasa Sawada

    Pathology international   73 ( 8 )   331 - 340   2023年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Tight junctions (TJs) are the most apical components of the cell-cell adhesion machinery in epithelial and endothelial cells and they play essential roles in homeostasis. Recent studies have revealed that aberrant expression of tight junction proteins (TJPs) is frequently observed in various type of cancers. Here we review cancer-associated aberrant expression of TJPs with focus on transmembrane-type TJPs including claudins, junctional adhesion molecule-A (JAM-A), and occludin. Some transmembrane-type TJPs are upregulated at the early neoplastic stage and their expression persists during dedifferentiation. Aberrant expression of TJPs contributes to proliferation, invasion, and dysregulated signaling of cancer cells. In addition to an increase in their expression level, their localization is altered from a TJ-restricted pattern to distribution throughout the whole cell membrane, making them suitable as therapeutic targets. Extracellular domains of transmembrane-type TJPs can be approached by target drugs not only from the lumen side (apical side) but also from the extracellular matrix side (basal side), including blood vessels. Aberrantly expressed TJPs are potential useful diagnostic markers as well as therapeutic targets for cancers.

    DOI: 10.1111/pin.13349

    PubMed

    researchmap

  • Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, SMU-DDCS, harboring an IDH1 mutation

    Makoto Emori, Naoya Nakahashi, Akira Takasawa, Kenji Murata, Yasutaka Murahashi, Junya Shimizu, Tomohide Tsukahara, Shintaro Sugita, Kohichi Takada, Tadashi Hasegawa, Makoto Osanai, Kosuke Iba

    Human Cell   2023年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Springer Science and Business Media LLC  

    Dedifferentiated chondrosarcoma (DDCS) is a high-grade subtype with a bi-morphic histological appearance of a conventional chondrosarcoma component and it can abruptly transition to a high-grade non-cartilaginous sarcoma. To better understand the biological features of DDCSs and to help develop new therapies, a novel DDCS cell line, SMU-DDCS, was established. Tissue from an open biopsy of a tumor resected from a 75-year-old patient was subjected to primary culture. The cell line was established and authenticated by assessing DNA microsatellite short tandem repeats. The cells maintained in monolayer cultures exhibited constant growth, spheroid formation, and high invasive capacity. Out of the four mice inoculated with SMU-DDCS cells, tumors developed in three mice after 2 weeks. R132C mutation was found in the IDH1 but not the IDH2 genomic DNA sequence of SMU-DDCS cells. SMU-DDCS cells exhibited low chemosensitivity to doxorubicin, methotrexate, and cisplatin. This SMU-DDCS cell line harboring an IDH1 mutation will be a useful tool for investigating DDCS development and for evaluating novel therapeutic agents against it.

    DOI: 10.1007/s13577-023-00944-0

    PubMed

    researchmap

    その他リンク: https://link.springer.com/article/10.1007/s13577-023-00944-0/fulltext.html

  • TM4SF1-AS1 inhibits apoptosis by promoting stress granule formation in cancer cells 国際誌

    Hiroshi Kitajima, Reo Maruyama, Takeshi Niinuma, Eiichiro Yamamoto, Akira Takasawa, Kumi Takasawa, Kazuya Ishiguro, Akihiro Tsuyada, Ryo Suzuki, Gota Sudo, Toshiyuki Kubo, Kei Mitsuhashi, Masashi Idogawa, Shoichiro Tange, Mutsumi Toyota, Ayano Yoshido, Kohei Kumegawa, Masahiro Kai, Kazuyoshi Yanagihara, Takashi Tokino, Makoto Osanai, Hiroshi Nakase, Hiromu Suzuki

    Cell Death & Disease   14 ( 7 )   424 - 424   2023年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Springer Science and Business Media LLC  

    Abstract

    Long noncoding RNAs (lncRNAs) play pivotal roles in tumor development. To identify dysregulated lncRNAs in gastric cancer (GC), we analyzed genome-wide trimethylation of histone H3 lysine 4 (H3K4me3) to screen for transcriptionally active lncRNA genes in the non-tumorous gastric mucosa of patients with GC and healthy individuals. We found that H3K4me3 at TM4SF1-AS1 was specifically upregulated in GC patients and that the expression of TM4SF1-AS1 was significantly elevated in primary and cultured GC cells. TM4SF1-AS1 contributes to GC cell growth in vitro and in vivo, and its oncogenic function is mediated, at least in part, through interactions with purine-rich element-binding protein α (Pur-α) and Y-box binding protein 1 (YB-1). TM4SF1-AS1 also activates interferon signaling in GC cells, which is dependent on Pur-α and RIG-I. Chromatin isolation by RNA purification (ChIRP)-mass spectrometry demonstrated that TM4SF1-AS1 was associated with several stress granule (SG)-related proteins, including G3BP2, RACK1, and DDX3. Notably, TM4SF1-AS1 promoted SG formation and inhibited apoptosis in GC cells by sequestering RACK1, an activator of the stress-responsive MAPK pathway, within SGs. TM4SF1-AS1-induced SG formation and apoptosis inhibition are dependent on Pur-α and YB-1. These findings suggested that TM4SF1-AS1 contributes to tumorigenesis by enhancing SG-mediated stress adaptation.

    DOI: 10.1038/s41419-023-05953-3

    PubMed

    researchmap

    その他リンク: https://www.nature.com/articles/s41419-023-05953-3

  • A novel approach to diagnosing crystal-storing histiocytosis: utility of scanning electron microscopy for formalin-fixed paraffin-embedded tissue specimens.

    Kazufumi Magara, Akira Takasawa, Keisuke Kikuchi, Taro Sugawara, Taro Murakami, Daisuke Kyuno, Yusuke Ono, Kumi Takasawa, Yasunao Numata, Shigeru Sasaki, Hiroshi Nakase, Tadashi Hasegawa, Makoto Osanai

    Medical molecular morphology   2023年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Crystal-storing histiocytosis (CSH) is a rare disorder that shows infiltration of histiocytes with an aberrant cytoplasmic accumulation of crystalline structures and is often accompanied by lymphoproliferative-plasma cell disorders (LP-PCD) as background diseases. The diagnosis of CSH requires identification of crystalline structures that accumulate in the infiltrating histiocytes, which may be challenging by optical microscopy alone. In this case report, we describe an atypical course of systemic CSH with multifocal fibrosclerosis of an unknown background disease that was diagnosed by ultrastructural observation, including transmission electron microscopy (TEM) and scanning electron microscopy (SEM), in pathological autopsy. In addition, crystalline structures were successfully identified by scanning electron microscopic observations using formalin-fixed and paraffin-embedded (FFPE) tissue from biopsy specimens taken before death. Since CSH was identified by SEM in a tiny biopsy specimen, observation of histiocytic infiltrative lesions by SEM using FFPE tissue may lead to early detection of and initiation of treatment for CSH.

    DOI: 10.1007/s00795-023-00363-y

    PubMed

    researchmap

  • Suppression of the vitamin D metabolizing enzyme CYP24A1 provides increased sensitivity to chemotherapeutic drugs in breast cancer. 国際誌

    Sakura Kamiya, Yuna Nakamori, Akira Takasawa, Kumi Takasawa, Daisuke Kyuno, Yusuke Ono, Kazufumi Magara, Makoto Osanai

    Oncology reports   49 ( 5 )   2023年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Vitamin D is an essential nutrient for the human body not only for the metabolism of calcium but also for homeostasis. Vitamin D contributes to cell fate decisions, including cell proliferation, differentiation and viability. Accumulated epidemiological data suggest a relationship between vitamin D deficiency and carcinogenesis in numerous organs. Furthermore, it is known that the expression of the vitamin D metabolizing enzyme, cytochrome P450 family 24 subtype A1 (CYP24A1), is increased in different types of human malignancy including breast carcinoma. However, the pathological relevance of elevated CYP24A1 expression level requires further clarification. In the present study, it was demonstrated that CYP24A1 promoted the oncogenic property of breast carcinoma cells. Consistent with previous reports, it was demonstrated that the expression of CYP24A1 was elevated in invasive breast carcinoma and significantly decreased the overall survival of patients with invasive breast carcinoma. Importantly, suppression of CYP24A1 expression significantly enhanced cell death sensitivity to two anticancer drugs with pharmacologically different modes of action, cisplatin and gefitinib. The results of the present study suggest the possibility of CYP24A1‑inhibiting therapy as a novel therapy in breast cancer with overexpression of CYP24A1.

    DOI: 10.3892/or.2023.8522

    PubMed

    researchmap

  • Elevated expression of endocan in the development of cervical squamous neoplasia of the uterus.

    Midori Sato, Ayano Inoue, Akira Takasawa, Kumi Takasawa, Daisuke Kyuno, Yusuke Ono, Kazufumi Magara, Makoto Osanai

    Medical molecular morphology   2023年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Accumulated evidence has shown that endocan, which was originally called endothelial cell-specific molecule-1, is an attractive prognostic factor in a variety of cancers. However, the relevance of endocan expression in human malignancies remains to be clarified. In the present study, the expression of endocan in cervical squamous neoplasia of the uterus, including low- and high-grade squamous intraepithelial lesions (LSIL and HSIL, respectively), as well as in invasive squamous cell carcinoma was examined by immunohistochemistry. Endocan was not sufficiently expressed in the normal cervical epithelium. Endocan expression was present in LSIL cases but was limited to basal and parabasal areas of the cells. HSIL cases exhibited strong expression of endocan with widely distributed expression toward the epithelial surface. In contrast, further strong expression of endocan was not observed in patients with invasive carcinoma. This study is the first study showing increased expression of endocan in precancerous dysplastic lesions and malignancy of the cervix. The data suggest that a high expression level of endocan potentially contributes to the development of cervical squamous neoplasia of the uterus.

    DOI: 10.1007/s00795-023-00353-0

    PubMed

    researchmap

  • Generalized crystal-storing histiocytosis with noncirrhotic portal hypertension: an autopsy case report.

    Yasunao Numata, Shigeru Sasaki, Kazufumi Magara, Akira Takasawa, Taro Sugawara, Naruki Ohara, Noriyuki Akutsu, Tadashi Hasegawa, Makoto Osanai, Hiroshi Nakase

    Clinical journal of gastroenterology   16 ( 3 )   450 - 456   2023年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Crystal-storing histiocytosis (CSH) is a rare disease associated with the accumulation of histiocytes containing crystalline matter within their cytoplasm. Herein, we present the case of a female patient who was diagnosed with Tolosa-Hunt syndrome at 45 years of age and idiopathic retroperitoneal fibrosis when she was 48 years. She developed portal hypertension (PH), but did not present with cirrhosis; as such, the cause of PH was not identified. Her PH gradually worsened when she was 54 years, and at the age of 60 years, she died from an acute subdural hematoma. Autopsy revealed retroperitoneal fibrosis with severe fibrosis extending around the hepatic veins and into the porta hepatis. Histologically, the retroperitoneal tissue showed a dense infiltrate of eosinophilic histiocytes with crystal structures in the cytoplasm, which was pathologically diagnosed as CSH. Nodular regenerative hyperplasia was observed in the liver parenchyma, whereas cirrhosis was not. In the present case, CSH caused fibrosis, which was believed to be the cause of PH. In addition, we considered that nodular regenerative hyperplasia caused by the altered hepatic blood flow due to treatment of gastric varices contributed to worsening PH. Hence, CSH should be considered as an underlying disease in noncirrhotic portal hypertension.

    DOI: 10.1007/s12328-023-01782-1

    PubMed

    researchmap

  • MPNSTにおけるPVR発現の意義

    中橋 尚也, 高澤 啓, 高澤 久美, 太田 未咲, 真柄 和史, 小野 祐輔, 及能 大輔, 杉田 真太朗, 長谷川 匡, 小山内 誠

    日本病理学会会誌   112 ( 1 )   346 - 346   2023年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 乳がんにおけるタイト結合関連タンパク質LSRの膜型エストロゲン受容体GPR30を介した発現調節とその意義

    太田 未咲, 高澤 啓, 高澤 久美, 青山 智志, 小野 祐輔, 及能 大輔, 小山内 誠, 長谷川 匡

    日本病理学会会誌   112 ( 1 )   303 - 303   2023年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 子宮頸部腺癌で異所性高発現するclaudin-6はがん悪性化に寄与する

    高澤 啓, 伊藤 祐衣, 高澤 久美, 村上 太朗, 太田 未咲, 青山 智志, 小野 祐輔, 及能 大輔, 小山内 誠

    日本病理学会会誌   112 ( 1 )   255 - 255   2023年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 乳がんにおけるタイト結合分子JAM-Aの役割

    真柄 和史, 高澤 啓, 高澤 久美, 小野 佑輔, 及能 大輔, 仲盛 優菜, 小山内 誠

    日本病理学会会誌   112 ( 1 )   240 - 240   2023年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • レチノイン酸代謝酵素CYP26A1の異常発現は、舌癌の悪性化に関与する

    桑原 未羽, 黒田 睦喜, 小野 佑輔, 高澤 啓, 仲盛 優菜, 及能 大輔, 真柄 和史, 青山 智志, 高澤 久美, 小山内 誠

    日本病理学会会誌   112 ( 1 )   386 - 386   2023年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 舌扁平上皮がんで異常高発現するPVRはがん悪性化に寄与する

    永井 佐和, 高澤 啓, 永井 美佐, 小野 佑輔, 真柄 和史, 青山 智志, 及能 大輔, 高澤 久美, 村田 雅樹, 小山内 誠

    日本病理学会会誌   112 ( 1 )   382 - 383   2023年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 膵臓がんで高発現する解糖系酵素ALDOAはがん悪性化に関与する

    永井 美佐, 高澤 啓, 永井 佐和, 小野 佑輔, 真柄 和史, 青山 智志, 及能 大輔, 高澤 久美, 小山内 誠

    日本病理学会会誌   112 ( 1 )   378 - 378   2023年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • MPNSTにおけるPVR発現の意義

    中橋 尚也, 高澤 啓, 高澤 久美, 太田 未咲, 真柄 和史, 小野 祐輔, 及能 大輔, 杉田 真太朗, 長谷川 匡, 小山内 誠

    日本病理学会会誌   112 ( 1 )   346 - 346   2023年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 乳がんにおけるタイト結合関連タンパク質LSRの膜型エストロゲン受容体GPR30を介した発現調節とその意義

    太田 未咲, 高澤 啓, 高澤 久美, 青山 智志, 小野 祐輔, 及能 大輔, 小山内 誠, 長谷川 匡

    日本病理学会会誌   112 ( 1 )   303 - 303   2023年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 子宮頸部腺癌で異所性高発現するclaudin-6はがん悪性化に寄与する

    高澤 啓, 伊藤 祐衣, 高澤 久美, 村上 太朗, 太田 未咲, 青山 智志, 小野 祐輔, 及能 大輔, 小山内 誠

    日本病理学会会誌   112 ( 1 )   255 - 255   2023年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 乳がんにおけるタイト結合分子JAM-Aの役割

    真柄 和史, 高澤 啓, 高澤 久美, 小野 佑輔, 及能 大輔, 仲盛 優菜, 小山内 誠

    日本病理学会会誌   112 ( 1 )   240 - 240   2023年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • レチノイン酸代謝酵素CYP26A1の異常発現は、舌癌の悪性化に関与する

    桑原 未羽, 黒田 睦喜, 小野 佑輔, 高澤 啓, 仲盛 優菜, 及能 大輔, 真柄 和史, 青山 智志, 高澤 久美, 小山内 誠

    日本病理学会会誌   112 ( 1 )   386 - 386   2023年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 舌扁平上皮がんで異常高発現するPVRはがん悪性化に寄与する

    永井 佐和, 高澤 啓, 永井 美佐, 小野 佑輔, 真柄 和史, 青山 智志, 及能 大輔, 高澤 久美, 村田 雅樹, 小山内 誠

    日本病理学会会誌   112 ( 1 )   382 - 383   2023年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 膵臓がんで高発現する解糖系酵素ALDOAはがん悪性化に関与する

    永井 美佐, 高澤 啓, 永井 佐和, 小野 佑輔, 真柄 和史, 青山 智志, 及能 大輔, 高澤 久美, 小山内 誠

    日本病理学会会誌   112 ( 1 )   378 - 378   2023年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • Invasive pulmonary aspergillosis with candidiasis: usefulness of molecular and ultrastructural morphological analysis on FFPE tissue for invasive fungal infections.

    Yusaku Kubota, Akira Takasawa, Yusuke Ono, Tomoyuki Aoyama, Kumi Takasawa, Akinori Tada, Kazufumi Magara, Taro Murakami, Fuminori Daimon, Soh Yamamoto, Shota Sato, Yutaro Hiratsuka, Daisuke Kyuno, Makoto Osanai

    Medical molecular morphology   56 ( 2 )   1 - 8   2023年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Invasive pulmonary aspergillosis (IPA) is one of the most frequent forms of invasive fungal infections (IFI); however, it is often difficult to identify the pathogenic fungal species and to select appropriate treatments for patients with IFI including IPA. Here, we describe the detailed pathophysiology of an autopsy case of severe respiratory failure due to IPA with candidiasis. The patient developed severe respiratory failure after influenza infection and died, and the autopsy revealed a mixed disease of IPA with candidiasis. In this study, in addition to the routine pathological examination, we further examined formalin-fixed paraffin-embedded (FFPE) tissues by scanning electron microscopy (SEM) and partial genomic DNA sequencing. Although optical microscopy alone was insufficient to identify the pathogenic organisms, SEM clearly depicted the characteristic morphology of Aspergillus sp. and Candida sp. as closely overlapping in a nested fashion, providing evidence of mixed infection of both fungal species in a focal site. The technique using FFPE tissue in combination with ultrastructural observation by SEM, elemental analysis by SEM-EDX, and DNA sequencing is promising for analyzing the pathophysiology of IFI.

    DOI: 10.1007/s00795-023-00349-w

    PubMed

    researchmap

  • Vitamin D metabolism in cancer: potential feasibility of vitamin D metabolism blocking therapy.

    Sakura Kamiya, Yuna Nakamori, Akira Takasawa, Kumi Takasawa, Daisuke Kyuno, Yusuke Ono, Kazufumi Magara, Makoto Osanai

    Medical molecular morphology   56 ( 2 )   85 - 93   2023年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    In this review, we discuss the possibility of the vitamin D metabolizing enzyme CYP24A1 being a therapeutic target for various tumors including breast, colorectal and prostate tumors. Given the pleiotropic cellular activity of vitamin D, its deficiency impairs its physiological function in target cells and results in various pathologies including cancer. In addition, accumulated data have shown that elevated expression of CYP24A1 promotes carcinogenesis in various cancer subtypes by decreasing the bioavailability of vitamin D metabolites. Thus, we propose the potential feasibility of vitamin D metabolism-blocking therapy in various types of human malignancies that express constitutive CYP24A1.

    DOI: 10.1007/s00795-023-00348-x

    PubMed

    researchmap

  • Retinoic acid metabolism in cancer: potential feasibility of retinoic acid metabolism blocking therapy.

    Makoto Osanai, Akira Takasawa, Kumi Takasawa, Daisuke Kyuno, Yusuke Ono, Kazufumi Magara

    Medical molecular morphology   56 ( 1 )   1 - 10   2023年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Retinoic acid (RA) is an active metabolite of vitamin A, which is an essential signaling molecule involved in cell fate decisions, such as differentiation, proliferation, and apoptosis, in a wide variety of cell types. Accumulated data have demonstrated that expression of RA-metabolizing enzymes, CYP26A1, B1, and C1 (cytochrome P450, family 26A1, B1, and C1, respectively), protects cells and tissues from exposure to RA through restriction of RA access to transcriptional machinery by converting RA to rapidly excreted derivatives. CYP26 enzymes play similar but separate roles in limiting the consequences of fluctuations in nutritional vitamin A. Recently, we found that RA depletion caused by expression of CYP26A1 promotes malignant behaviors of tumor cells derived from various tissues, implicating CYP26A1 as a candidate oncogene. We also showed that the expression levels of CYP26 enzymes are elevated in various types of cancer. We have provided evidence for oncogenic and cell survival properties of CYP26 enzymes, indicating that these molecules are possible therapeutic targets for CYP26-expressing malignancies.

    DOI: 10.1007/s00795-022-00345-6

    PubMed

    researchmap

  • Serum amyloid A1 recruits neutrophils to the invasive front of T1 colorectal cancers. 国際誌

    Ayano Yoshido, Gota Sudo, Akira Takasawa, Hironori Aoki, Hiroshi Kitajima, Eiichiro Yamamoto, Takeshi Niinuma, Taku Harada, Toshiyuki Kubo, Hajime Sasaki, Kazuya Ishiguro, Akira Yorozu, Masahiro Kai, Akio Katanuma, Hiro-O Yamano, Makoto Osanai, Hiroshi Nakase, Hiromu Suzuki

    Journal of gastroenterology and hepatology   38 ( 2 )   301 - 310   2022年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND AND AIM: The tumor microenvironment plays an essential role in the development and progression of colorectal cancer (CRC). We recently reported that crosstalk between CRC cells and tumor-associated macrophages (TAMs) via serum amyloid A1 (SAA1) promotes invasion by T1 CRCs. In the present study, we aimed to clarify the role of neutrophils in early CRCs. METHODS: Immunohistochemical analysis of CD66b, chemokine CXC motif ligand 8 (CXCL8 or interleukin-8, IL-8) and matrix metalloproteinase-9 (MMP-9) was performed using primary T1 CRCs (n = 49). The HL-60 human promyelocytic leukemia cell line and THP-1 human monocytic leukemia cell line were used to obtain neutrophil-like and macrophage-like cells, respectively. Boyden chamber assays were used to analyze cell migration and invasion, and quantitative RT-PCR was used to analyze gene expression. RESULTS: Immunohistochemical analysis revealed accumulation of neutrophils at the SAA1-positive invasive front of T1 CRCs. Experiments using HL-60 cells suggested that treatment with SAA1 induced neutrophil migration and expression of CXCL8 and MMP-9 in neutrophils and that neutrophils promote CRC cell migration and invasion. Immunohistochemistry confirmed accumulation of CXCL8- or MMP-9-positive neutrophils at the SAA1-positive invasive front of T1 CRCs. Moreover, co-culture experiments using CRC, THP-1 and HL-60 cells suggested that CRC cells activated by macrophages upregulate CXCL8 and MMP-9 in neutrophils. CONCLUSIONS: Our results suggest that interplay between macrophages and CRC cells leads to recruitment of neutrophils to the invasive front of T1 CRCs and that SAA1 secreted by CRC cells activate neutrophils to promote invasion.

    DOI: 10.1111/jgh.16055

    PubMed

    researchmap

  • Drastic Multiorgan Dysfunction Due to Severe Leukostasis: A Case Report. 国際誌

    Akinori Tada, Yasuhiro Kikuchi, Kazuyuki Murase, Kohichi Takada, Akira Takasawa

    Cureus   14 ( 11 )   e31518   2022年11月

     詳細を見る

    記述言語:英語  

    Leukostasis is a life-threatening complication that causes vascular occlusion leading to organ damage in leukemia patients. Organs with impairment due to leukostasis are usually the lungs and kidneys, but other organs may also be damaged. We experienced an autopsy case of severe infarction in multiple organs including the spleen probably due to leukostasis in a patient with acute myeloid leukemia.

    DOI: 10.7759/cureus.31518

    PubMed

    researchmap

  • CXCL12 is expressed by skeletal muscle cells in tongue oral squamous cell carcinoma. 国際誌

    Akira Yorozu, Shohei Sekiguchi, Akira Takasawa, Fumika Okazaki, Takeshi Niinuma, Hiroshi Kitajima, Eiichiro Yamamoto, Masahiro Kai, Mutsumi Toyota, Yui Hatanaka, Koyo Nishiyama, Kazuhiro Ogi, Hironari Dehari, Kazufumi Obata, Makoto Kurose, Atsushi Kondo, Makoto Osanai, Akihiro Miyazaki, Kenichi Takano, Hiromu Suzuki

    Cancer medicine   12 ( 5 )   5953 - 5963   2022年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: The CXCL12/CXCR4 axis plays a pivotal role in the progression of various malignancies, including oral squamous cell carcinoma (OSCC). In this study, we aimed to clarify the biological and clinical significance of CXCL12 in the tumor microenvironment of OSCCs. METHODS: Publicly available single-cell RNA-sequencing (RNA-seq) datasets were used to analyze CXCL12 expression in head and neck squamous cell carcinomas (HNSCC). Immunohistochemical analysis of CXCL12, α-smooth muscle antigen (α-SMA), fibroblast activation protein (FAP) and CD8 was performed in a series of 47 surgically resected primary tongue OSCCs. Human skeletal muscle cells were co-cultured with or without OSCC cells, after which CXCL12 expression was analyzed using quantitative reverse-transcription PCR. RESULTS: Analysis of the RNA-seq data suggested CXCL12 is abundantly expressed in stromal cells within HNSCC tissue. Immunohistochemical analysis showed that in grade 1 primary OSCCs, CXCL12 is expressed in both tumor cells and muscle cells. By contrast, grade 3 tumors were characterized by disruption of muscle structure and reduced CXCL12 expression. Quantitative analysis of CXCL12-positive areas within tumors revealed that reduced CXCL12 expression correlated with poorer overall survival. Levels of CXCL12 expression tended to inversely correlate α-SMA expression and positively correlate with infiltration by CD8+ lymphocytes, though these relations did not reach statistical significance. CXCL12 was significantly upregulated in muscle cells co-cultured with OSCC cells. CONCLUSION: Our results suggest that tongue OSCC cells activate CXCL12 expression in muscle cells, which may contribute to tumor progression. However, CXCL12 is reduced in advanced OSCCs due to muscle tissue destruction.

    DOI: 10.1002/cam4.5392

    PubMed

    researchmap

  • COVID-19-associated disseminated mucormycosis: An autopsy case report. 国際誌

    Daisuke Kyuno, Terufumi Kubo, Mitsuhiro Tsujiwaki, Shintaro Sugita, Michiko Hosaka, Hazuki Ito, Keisuke Harada, Akira Takasawa, Yusaku Kubota, Kumi Takasawa, Yusuke Ono, Kazufumi Magara, Eichi Narimatsu, Tadashi Hasegawa, Makoto Osanai

    World journal of clinical cases   10 ( 28 )   10358 - 10365   2022年10月

     詳細を見る

    記述言語:英語  

    BACKGROUND: Reports of mucormycosis, an infectious disease that commonly affects immunocompromised individuals, have increased during the ongoing coronavirus disease 2019 (COVID-19) pandemic. Disseminated mucormycosis associated with COVID-19 is rare but fatal and is characterized by an aggressive clinical course and delayed diagnosis. Our report documents a case of disseminated mucormycosis after COVID-19 infection. This is a rare pathological autopsy report on COVID-19-associated mucormycosis. CASE SUMMARY: A 58-year-old man was transferred to our hospital with severe COVID-19 pneumonia. During treatment for acute respiratory distress syndrome, he developed intra-abdominal bleeding that required a right hemicolectomy and ileostomy for hemostasis. The ileostoma and surgical wound developed necrosis followed by sepsis and multi-organ failure, which led to death. An autopsy revealed multiple thrombi associated with Rhizopus oryzae infection, which led to the necrosis of multiple infected organs. CONCLUSION: Early suspicion and diagnosis followed by treatment are keys to better outcomes of mucormycosis in patients with severe COVID-19.

    DOI: 10.12998/wjcc.v10.i28.10358

    PubMed

    researchmap

  • 膵癌患者の予後と癌進展におけるJAM-Aの役割(Junctional Adhesion Molecule-A may play a role in the progression of pancreatic cancer)

    及能 大輔, 高澤 啓, 高澤 久美, 真柄 和史, 小山内 誠

    日本癌学会総会記事   81回   J - 2053   2022年9月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本癌学会  

    researchmap

  • タイト結合分子JAM-Aの異常高発現が乳がんの悪性化に関与する(Elevated expression of JAM-A contributes malignant progression of breast cancer)

    真柄 和史, 高澤 啓, 高澤 久美, 及能 大輔, 小山内 誠

    日本癌学会総会記事   81回   P - 3247   2022年9月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本癌学会  

    researchmap

  • ASO Visual Abstract: Versican Secreted by Cancer-Associated Fibroblasts Is a Poor Prognostic Factor in Hepatocellular Carcinoma. 国際誌

    Koichi Kato, Moto Fukai, Kanako C Hatanaka, Akira Takasawa, Tomoyuki Aoyama, Takahiro Hayasaka, Yoshihiro Matsuno, Toshiya Kamiyama, Yutaka Hatanaka, Akinobu Taketomi

    Annals of surgical oncology   29 ( 11 )   7147 - 7148   2022年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1245/s10434-022-12067-1

    PubMed

    researchmap

  • Pathological classification of desmoplastic reaction is prognostic factor in cervical adenocarcinoma.

    Taishi Akimoto, Akira Takasawa, Kumi Takasawa, Tomoyuki Aoyama, Motoki Matsuura, Masato Tamate, Masahiro Iwasaki, Shutaro Habata, Taro Murakami, Makoto Osanai, Tsuyoshi Saito

    Medical molecular morphology   55 ( 4 )   275 - 282   2022年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Desmoplastic reaction (DR) and inflammation are significant pathological manifestations of tumorigenesis in several cancers. However, the correlation between these stromal reactions and cervical adenocarcinoma has been poorly documented. This investigation elucidated whether DR is a prognostic indicator in early cervical adenocarcinoma patients. Fifty-nine patients with early stage cervical adenocarcinoma (stages I/II) were included in the study. DR was divided into three groups, mature, intermediate, and immature, based on the presence of myxoid stroma and hyalinized keloid-like collagen. Inflammatory cell responses were classified as mild, moderate, and severe. Those stromal reactions were separately evaluated in the invasion front stroma and intratumoral stroma. In both the intratumor and invasion front stroma, intermediate/immature DR was correlated with tumor size, T stage, N stage, lymphovascular invasion, and parametrial infiltration (p < 0.001 to p < 0.05). In addition, in the intratumoral stroma, intermediate/immature DR led to short relapse-free survival and overall survival (p < 0.001). In the invasion front stroma, inflammatory cell responses were associated with DR immaturity and FIGO stage (p < 0.01). These results suggest that the classification of DR maturity is a potential prognostic biomarker in early stage cervical adenocarcinoma patients. DR can be evaluated by routine H&E staining without immunohistochemistry, making it convenient and economical in clinical practice.

    DOI: 10.1007/s00795-022-00329-6

    PubMed

    researchmap

  • Versican Secreted by Cancer-Associated Fibroblasts is a Poor Prognostic Factor in Hepatocellular Carcinoma. 国際誌

    Koichi Kato, Moto Fukai, Kanako C Hatanaka, Akira Takasawa, Tomoyuki Aoyama, Takahiro Hayasaka, Yoshihiro Matsuno, Toshiya Kamiyama, Yutaka Hatanaka, Akinobu Taketomi

    Annals of surgical oncology   29 ( 11 )   7135 - 7146   2022年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Hepatocellular carcinoma (HCC) is highly recurrent. Cancer-associated fibroblasts (CAFs), a major component of the tumor microenvironment, promote malignancy; however, the mechanisms underlying their actions are obscure. We aimed to identify CAF-specific proteins in HCC and determine whether they could be potential therapeutic targets. METHODS: Using comprehensive proteomic analysis of CAFs and noncancerous fibroblasts (NFs) primary-cultured from resected HCC specimens from the same patients, CAF-specific proteins were identified. Immunohistochemistry for versican (VCAN) was performed on cancerous tissues obtained from 239 patients with HCC. Conditioned medium from CAFs transfected with siRNA for VCAN was analyzed in vitro. RESULTS: CAFs significantly promoted HCC cell proliferation, migration, and invasion (p < 0.01, 0.01, and 0.01, respectively) compared with NFs. VCAN was upregulated in CAFs, and its stromal level correlated with poor differentiation (p = 0.009) and positive vascular invasion (p = 0.003). Stromal VCAN level was also associated with significantly lower overall (p = 0.002) and relapse-free (p < 0.001) survival rates. It also independently predicted prognosis and recurrence. VCAN-knockdown CAFs significantly suppressed HCC cell migration and invasion compared with negative control. CONCLUSIONS: VCAN secreted from CAFs promoted malignant transformation of HCC cells and has potential as a new therapeutic target in HCC.

    DOI: 10.1245/s10434-022-11862-0

    PubMed

    researchmap

  • Simultaneous Pseudoprogression and an Immune-related Adverse Event of Pulmonary Pleomorphic Carcinoma after Combined Therapy with Cytotoxic Anticancer Agents and Immune Checkpoint Inhibitor.

    Koutaro Murao, Yuki Mori, Yukino Takahashi, Tatsuru Ishikawa, Yuichiro Asai, Tomofumi Kobayashi, Kimiyuki Ikeda, Koji Kuronuma, Kazufumi Magara, Hiromi Fujita, Yoshihiko Hirohashi, Akira Takasawa, Hirofumi Chiba

    Internal medicine (Tokyo, Japan)   61 ( 21 )   3259 - 3264   2022年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Pulmonary pleomorphic carcinoma is rare among lung tumors. Pulmonary pleomorphic carcinoma is resistant to chemotherapy. However, treatment with taxane anticancer agents and immune checkpoint inhibitors has been reported to be effective. When using immune checkpoint inhibitors, pseudoprogression and true progression are difficult to distinguish, and immune-related adverse events (irAEs) are common. We herein report a patient with simultaneous pseudoprogression and irAEs after combined therapy with cytotoxic agents and an immune checkpoint inhibitor for pulmonary pleomorphic carcinoma. Immune checkpoint inhibitors are effective against pulmonary pleomorphic carcinoma, but patients should be monitored for pseudoprogression and irAEs.

    DOI: 10.2169/internalmedicine.8916-21

    PubMed

    researchmap

  • Aberrant expression of claudin-6 contributes to malignant potentials and drug resistance of cervical adenocarcinoma. 国際誌

    Yui Ito, Akira Takasawa, Kumi Takasawa, Taro Murakami, Taishi Akimoto, Daisuke Kyuno, Yuka Kawata, Kodai Shano, Kurara Kirisawa, Misaki Ota, Tomoyuki Aoyama, Masaki Murata, Kotaro Sugimoto, Hideki Chiba, Tsuyoshi Saito, Makoto Osanai

    Cancer science   113 ( 4 )   1519 - 1530   2022年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:(一社)日本癌学会  

    Recent studies have revealed that aberrant expression of tight junction (TJ) proteins is a hallmark of various solid tumors and it is recognized as a useful therapeutic target. Claudin-6 (CLDN6), a member of the family of TJ transmembrane proteins, is an ideal therapeutic target because it is not expressed in human adult normal tissues. In this study, we found that CLDN6 is highly expressed in uterine cervical adenocarcinoma (ADC) and that high CLDN6 expression was correlated with lymph node metastasis and lymphovascular infiltration and was an independent prognostic factor. Shotgun proteome analysis revealed that cell-cell adhesion-related proteins and drug metabolism-associated proteins (aldo-keto reductase [AKR] family proteins) were significantly increased in CLDN6-overexpressing cells. Furthermore, overexpression of CLDN6 enhanced cell-cell adhesion properties and attenuated sensitivity to anticancer drugs including doxorubicin, daunorubicin, and cisplatin. Taken together, the results indicate that aberrant expression of CLDN6 enhances malignant potentials and drug resistance of cervical ADC, possibly due to increased cell-cell adhesion properties and drug metabolism. Our findings provide an insight into a new therapeutic strategy, a CLDN6-targeting therapy, against cervical ADC.

    DOI: 10.1111/cas.15284

    PubMed

    researchmap

  • Identification of Novel Diagnostic Markers for Malignant Pleural Mesothelioma Using a Reverse Translational Approach Based on a Rare Synchronous Tumor. 国際誌

    Tomoaki Naka, Yutaka Hatanaka, Yukiko Tabata, Akira Takasawa, Hideo Akiyama, Yasuhiro Hida, Hiromi Okada, Kanako C Hatanaka, Tomoko Mitsuhashi, Kei Kushitani, Vishwa Jeet Amatya, Yukio Takeshima, Kouki Inai, Kichizo Kaga, Yoshihiro Matsuno

    Diagnostics (Basel, Switzerland)   12 ( 2 )   2022年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Although the routine use of immunohistochemistry has improved the accuracy of histopathologic diagnosis in clinical practice, new methods for discovering novel diagnostic markers are still needed. We sought new diagnostic markers for malignant pleural mesothelioma (MPM) using a reverse translational approach with limited archival tissues from a very rare case. Total RNA extracted from formalin-fixed paraffin-embedded (FFPE) tissues of a synchronous collision tumor consisting of MPM and pulmonary adenocarcinoma (PAC) was employed for gene expression profiling (GEP) analysis. Among the 54 genes selected by GEP analysis, we finally identified the following two candidate MPM marker genes: PHGDH and TRIM29. Immunohistochemical analysis of 48 MM and 20 PAC cases showed that both PHGDH and TRIM29 had sensitivity and specificity almost equivalent to those of calretinin (sensitivity 50% and 46% vs. 63%, and specificity 95% and 100% vs. 100%, respectively). Importantly, of the 23 epithelioid MMs, all 3 calretinin-negative cases were positive for TRIM29. These two markers may be diagnostically useful for immunohistochemical distinction between MPMs and PACs. This successful reverse translational approach based on FFPE samples from one very rare case encourages the further use of such samples for the development of novel diagnostic markers.

    DOI: 10.3390/diagnostics12020316

    PubMed

    researchmap

  • Claudin-18.2 as a therapeutic target in cancers: cumulative findings from basic research and clinical trials. 国際誌

    Daisuke Kyuno, Akira Takasawa, Kumi Takasawa, Yusuke Ono, Tomoyuki Aoyama, Kazufumi Magara, Yuna Nakamori, Ichiro Takemasa, Makoto Osanai

    Tissue barriers   10 ( 1 )   1967080 - 1967080   2022年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Claudins are major components of tight junctions that maintain cell polarity and intercellular adhesion. The dynamics of claudins in cancer cells have attracted attention as a therapeutic target. During carcinogenesis, claudin expression is generally downregulated; however, overexpression of claudin-18.2 has been observed in several types of cancers. Upregulated and mislocalized claudin-18.2 expression in cancer cells has been suggested as a therapeutic target. Research on claudin-18.2 has revealed its involvement in carcinogenesis. Clinical trials using zolbetuximab, a monoclonal antibody targeting claudin-18.2, for patients with advanced cancer yielded positive results with few high-grade adverse events; thus, it is expected to be a novel and effective therapeutic. Here, we review current insights into the role that claudin-18.2 plays in basic cancer research and clinical applications. A better understanding of these roles will facilitate the development of new treatment strategies for cancer patients with poor prognoses.

    DOI: 10.1080/21688370.2021.1967080

    PubMed

    researchmap

  • Claudin 6 is associated with a short survival and a short recurrent free interval in non-small cell lung carcinoma. 国際誌

    Ylermi Soini, Risto Pirinen, Kumi Takasawa, Makoto Osanai, Akira Takasawa

    Polish journal of pathology : official journal of the Polish Society of Pathologists   73 ( 1 )   1 - 5   2022年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    We investigated the expression of claudin 6 in non-small-cell lung carcinomas (NSCLC) by immunohistochemistry. Samples of 164 patients with NSCLC were studied by immunohistochemistry. Claudin 6 was expressed in 42 % of cases. Its expression was significantly more frequent in adeno- than in squamous cell carcinoma (p = 0.002). There was no association between the TNM status and claudin 6 expression. Claudin 6 associated with a poor prognosis of the patients and with a short recurrence-free interval (p = 0.002, p < 0.001). The association with survival had independent prognostic value (p = 0.011). The results show that claudin 6 can be regarded as a marker of poor prognosis in lung cancer. This is different to some other cancers, such as breast and cervical carcinoma suggesting that claudin 6 probably induces other cellular pathways in neoplastic lung cells than in those tumors. In lung cancer, adenocarcinomas were most abundantly positive indicating a higher linkage of claudin 6 to glandular differentiation.

    DOI: 10.5114/pjp.2022.117171

    PubMed

    researchmap

  • Regulatory roles of claudin-1 in cell adhesion and microvilli formation. 国際誌

    Kumi Takasawa, Akira Takasawa, Taishi Akimoto, Kazufumi Magara, Tomoyuki Aoyama, Hiroshi Kitajima, Taro Murakami, Yusuke Ono, Daisuke Kyuno, Hiromu Suzuki, Makoto Osanai

    Biochemical and biophysical research communications   565   36 - 42   2021年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Aberrant expression of tight junction proteins has recently been focused on in the cancer research field. We previously showed that claudin-1 is aberrantly expressed from an early stage of uterine cervical adenocarcinoma and contributes to malignant potentials. To elucidate the molecular mechanisms underlying tumor-promoting roles of claudin-1, we established and analyzed claudin-1 knockout cells. Knockout of claudin-1 suppressed conventional tight junctional functions, barrier and fence functions, and expression of cell adhesion-associated proteins including E-cadherin. Comparative proteome analysis revealed that expression of claudin-1 affected expression of a wide range of proteins, especially proteins that are associated with cell adhesion and actin cytoskeleton remodeling. Interactome analysis of the identified proteins revealed that E-cadherin and focal adhesion kinase play central roles in the claudin-1-dependently affected protein network. Moreover, knockout of claudin-1 significantly suppressed microvilli formation and activity of Ezrin/Radixin/Moesin. Taken together, the results indicate that expression of claudin-1 affects not only conventional tight junction function but also expression and activity of a wide range of proteins, especially proteins that are associated with cell adhesion and actin cytoskeleton remodeling, to contribute to malignant potentials and microvilli formation in cervical adenocarcinoma cells.

    DOI: 10.1016/j.bbrc.2021.05.070

    PubMed

    researchmap

  • Activated macrophages promote invasion by early colorectal cancer via an IL-1β-SAA1 axis. 国際誌

    Gota Sudo, Hironori Aoki, Eiichiro Yamamoto, Akira Takasawa, Takeshi Niinuma, Ayano Yoshido, Hiroshi Kitajima, Akira Yorozu, Toshiyuki Kubo, Taku Harada, Kazuya Ishiguro, Masahiro Kai, Akio Katanuma, Hiro-O Yamano, Makoto Osanai, Hiroshi Nakase, Hiromu Suzuki

    Cancer science   112 ( 10 )   4151 - 4165   2021年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Submucosal invasion and lymph node metastasis are important issues affecting treatment options for early colorectal cancer (CRC). In this study, we aimed to unravel the molecular mechanism underlying the invasiveness of early CRCs. We performed RNA-sequencing (RNA-seq) with poorly differentiated components (PORs) and their normal counterparts isolated from T1 CRC tissues, and detected significant upregulation of SAA1 in PORs. Immunohistochemical analysis revealed that SAA1 was specifically expressed in PORs at the invasive front of T1b CRCs. Upregulation of SAA1 in CRC cells promoted cell migration and invasion. Co-culture experiments using CRC cell lines and THP-1 cells suggested that interleukin 1β (IL-1β) produced by macrophages induces SAA1 expression in CRC cells. Induction of SAA1 and promotion of CRC cell migration and invasion by macrophages were inhibited by blocking IL-1β. These findings were supported by immunohistochemical analysis of primary T1 CRCs showing accumulation of M1-like/M2-like macrophages at SAA1-positive invasive front regions. Moreover, SAA1 produced by CRC cells stimulated upregulation of MMP-9 in macrophages. Our data suggest that tumor-associated macrophages at the invasive front of early CRCs promote cancer cell migration and invasion through induction of SAA1, and that SAA1 may be a predictive biomarker and a useful therapeutic target.

    DOI: 10.1111/cas.15080

    PubMed

    researchmap

  • A systemic apolipoprotein A-IV-associated amyloidosis confirmed by proteome analysis. 国際誌

    Taro Murakami, Akira Takasawa, Asako Moriki, Yusuke Igaki, Hiroshi Ikeda, Kazuyuki Murase, Kohichi Takada, Kazufumi Magara, Tomoyuki Aoyama, Yusuke Ono, Daisuke Kyuno, Kumi Takasawa, Masaki Murata, Makoto Osanai

    Virchows Archiv : an international journal of pathology   479 ( 5 )   1041 - 1046   2021年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Amyloidosis is induced by extracellular deposition of certain proteins. Thirty-six proteins have so far been identified as amyloidogenic proteins in humans. Although it is very important to determine the specific amyloid protein type for the choice of therapy for amyloidosis patient, it might be difficult to identify specific proteins from amyloid-deposited tissue. Apolipoprotein A-IV is known as an amyloid-associated protein, but there have been few reports of apolipoprotein A-IV amyloidosis. Here we report a case of systemic apolipoprotein A-IV-associated amyloidosis that was confirmed by proteome analysis using formalin-fixed paraffin-embedded tissue and an immunohistochemical technique.

    DOI: 10.1007/s00428-021-03073-x

    PubMed

    researchmap

  • Aberrant expression of junctional adhesion molecule-A contributes to the malignancy of cervical adenocarcinoma by interaction with poliovirus receptor/CD155. 国際誌

    Taro Murakami, Akira Takasawa, Kumi Takasawa, Taishi Akimoto, Tomoyuki Aoyama, Kazufumi Magara, Yuki Saito, Misaki Ota, Daisuke Kyuno, Soh Yamamoto, Tadashi Hasegawa, Tsuyoshi Saito, Makoto Osanai

    Cancer science   112 ( 2 )   906 - 917   2020年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Recent studies have shown that aberrant expression of tight junction proteins (TJP) contributes to malignant potential of various cancers. In the present study, we investigated the expression of junctional adhesion molecule-A (JAM-A), one of the transmembrane TJP, in uterine cervical adenocarcinoma and the significance of its expression for malignancy. Immunohistochemistry on human surgical specimens showed that JAM-A was aberrantly expressed in neoplastic regions including adenocarcinoma in situ (AIS). Knockout of JAM-A significantly suppressed cell proliferation and colony-forming and migration abilities. We also showed that an antibody specific to an extracellular region of JAM-A reduced cell proliferation ability and that loss of JAM-A increased drug sensitivity of cervical adenocarcinoma cells. Based on a comprehensive proteome analysis, we found that poliovirus receptor (PVR/CD155) was regulated by JAM-A and formed a physical interaction with JAM-A. In human surgical specimens, PVR/CD155 expression was significantly correlated with some clinicopathological features and prognosis of cervical adenocarcinoma. Interestingly, most of the PVR/CD155-positive cases expressed a high level of JAM-A, and patients with the expression pattern of PVR/CD155 positive/JAM-A high had significantly shorter periods of relapse-free survival (P = .00964) and overall survival (P = .0204) than those for the other patients. Our observations suggest that aberrant expression of JAM-A promotes malignancy of uterine cervical adenocarcinoma by regulation of PVR/CD155, and JAM-A is therefore a potential therapeutic target for this malignancy.

    DOI: 10.1111/cas.14734

    PubMed

    researchmap

  • Role of tight junctions in the epithelial-to-mesenchymal transition of cancer cells. 国際誌

    Daisuke Kyuno, Akira Takasawa, Shin Kikuchi, Ichiro Takemasa, Makoto Osanai, Takashi Kojima

    Biochimica et biophysica acta. Biomembranes   1863 ( 3 )   183503 - 183503   2020年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The epithelial-mesenchymal transition (EMT) is an essential step in cancer progression. Epithelial cells possess several types of cell-cell junctions, and tight junctions are known to play important roles in maintaining the epithelial program. EMT is characterized by a loss of epithelial markers, including E-cadherin and tight junction proteins. Somewhat surprisingly, the evidence is accumulating that upregulated expression of tight junction proteins plays an important role in the EMT of cancer cells. Tight junctions have distinct tissue-specific and cancer-specific regulatory mechanisms, enabling them to play different roles in EMT. Tight junctions and related signaling pathways are attractive targets for cancer treatments; signal transduction inhibitors and monoclonal antibodies for tight junction proteins may be used to suppress EMT, invasion, and metastasis. Here we review the role of bicellular and tricellular tight junction proteins during EMT. Further investigation of regulatory mechanisms of tight junctions during EMT in cancer cells will inform the development of biomarkers for predicting prognosis as well as novel therapies.

    DOI: 10.1016/j.bbamem.2020.183503

    PubMed

    researchmap

  • Aldolase A promotes epithelial-mesenchymal transition to increase malignant potentials of cervical adenocarcinoma. 国際誌

    Yuki Saito, Akira Takasawa, Kumi Takasawa, Tomoyuki Aoyama, Taishi Akimoto, Misaki Ota, Kazufumi Magara, Masaki Murata, Yoshihiko Hirohashi, Tadashi Hasegawa, Norimasa Sawada, Tsuyoshi Saito, Makoto Osanai

    Cancer science   111 ( 8 )   3071 - 3081   2020年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Recent studies have revealed that metabolic reprogramming is closely associated with epithelial-mesenchymal transition (EMT) during cancer progression. Aldolase A (ALDOA) is a key glycolytic enzyme that is highly expressed in several types of cancer. In this study, we found that ALDOA is highly expressed in uterine cervical adenocarcinoma and that high ALDOA expression promotes EMT to increase malignant potentials, such as metastasis and invasiveness, in cervical adenocarcinoma cells. In human surgical specimens, ALDOA was highly expressed in cervical adenocarcinoma and high ALDOA expression was correlated with lymph node metastasis, lymphovascular infiltration, and short overall survival. Suppression of ALDOA expression significantly reduced cell growth, migration, and invasiveness of cervical cancer cells. Aldolase A expression was partially regulated by hypoxia-inducible factor-1α (HIF-1α). Shotgun proteome analysis revealed that cell-cell adhesion-related proteins were significantly increased in ALDOA-overexpressing cells. Interestingly, overexpression of ALDOA caused severe morphological changes, including a cuboidal-to-spindle shape shift and reduced microvilli formation, coincident with modulation of the expression of typical EMT-related proteins. Overexpression of ALDOA increased migration and invasion in vitro. Furthermore, overexpression of ALDOA induced HIF-1α, suggesting a positive feedback loop between ALDOA and HIF-1α. In conclusion, ALDOA is overexpressed in cervical adenocarcinoma and contributes to malignant potentials of tumor cells through modulation of HIF-1α signaling. The feedback loop between ALDOA and HIF-1α could become a therapeutic target to improve the prognosis of this malignancy.

    DOI: 10.1111/cas.14524

    PubMed

    researchmap

  • Elevated expression of G protein-coupled receptor 30 (GPR30) is associated with poor prognosis in patients with uterine cervical adenocarcinoma. 国際誌

    Yoshihiko Ino, Taishi Akimoto, Akira Takasawa, Kumi Takasawa, Tomoyuki Aoyama, Asako Ueda, Misaki Ota, Kazufumi Magara, Yohei Tagami, Masaki Murata, Tadashi Hasegawa, Tsuyoshi Saito, Norimasa Sawada, Makoto Osanai

    Histology and histopathology   35 ( 4 )   351 - 359   2020年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Uterine cervical adenocarcinoma has a worse prognosis than that of squamous cell carcinoma and useful diagnostic and prognostic markers are needed. Estrogen is one of the key regulators of several cancers, however, the estrogen signaling has not been focused on in cervical adenocarcinoma. Here, we shows expression profile of classical estrogen receptor (ER) and a novel membrane type estrogen receptor, G protein-coupled receptor 30 (GPR30), in surgical specimens (n=53). GPR30 was strongly expressed on the cell membrane and in the cytoplasm in adenocarcinoma in situ (AIS) and adenocarcinoma, and its expression was especially strong at the invasion front in most of the cases of GPR30-positive adenocarcinoma. Nuclear staining of ER was strong in non-neoplastic glands, whereas it was almost absent in most of the AIS and adenocarcinoma cases. There was a weak but statistically significant negative correlation between immunoreactivity of GPR30 and that of ER in cervical AIS and adenocarcinoma lesions (Spearman's correlation, r=-0.324, p=0.017). ROC curve analysis revealed that immunoreactivity of GPR30 successfully distinguished neoplasms from non-neoplastic glands with high specificity (100%) and sensitivity (75.5%). GPR30 positivity was significantly correlated with histological type (p=0.009), tumor diameter (p=0.003), tumor size (p<0.001), lymphovascular infiltration (p=0.005) and UICC stage (p<0.001). ER expression was correlated only with tumor factor (p=0.047). GPR30-high patients had poor prognosis with a significantly shorter overall survival (OS) period (p=0.0309). GPR30 expression is a potential diagnostic and prognostic marker.

    DOI: 10.14670/HH-18-157

    PubMed

    researchmap

  • Assessment of valgus laxity after release of the medial structure in medial open-wedge high tibial osteotomy: an in vivo biomechanical study using quantitative valgus stress radiography. 国際誌

    Dai Sato, Eiji Kondo, Koji Yabuuchi, Jun Onodera, Tomohiro Onodera, Tomonori Yagi, Keita Sakamoto, Akira Takasawa, Norimasa Iwasaki, Kazunori Yasuda

    BMC musculoskeletal disorders   20 ( 1 )   481 - 481   2019年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: To perform medial open-wedge high tibial osteotomy (OWHTO), surgeons expose the medial-proximal tibia by releasing or cutting the superficial layer of the medial collateral ligament (sMCL). Biomechanically, the sMCL provides primary restraint against valgus forces. Therefore, any release of the sMCL can cause valgus instability of the knee joint. The purpose of this study was to assess valgus laxity after release of the medial structure of the knee during OWHTO. METHODS: Between 2009 and 2015, 84 consecutive patients (93 knees) who underwent OWHTO using a locking plate were enrolled in this study. All patients underwent radiological examinations before surgery, during surgery, 1 year after surgery, and after plate removal to objectively assess valgus laxity. The medial joint space (MJS) and the joint line convergence angle (JLCA) of the knee were evaluated using quantitative valgus stress radiography. Clinical evaluation was performed 2 years after surgery. RESULTS: The mean functional knee score improved significantly, from 65.5 to 91.1 points (p < 0.0001). The mechanical axis percentage shifted to pass through a point 69.7% lateral from the medial edge of the tibial plateau. The MJS and JLCA increased significantly during OWHTO surgery (11.0 mm, 7.4 °, p < 0.0001). However, no significant differences were noted in the MJS and JLCA among preoperative, 1-year postoperative periods and after plate removal. CONCLUSION: Valgus laxity was significantly greater after release of the sMCL. However, no significant differences were noted in valgus laxity in preoperative, 1-year postoperative periods and after plate removal. Complete release of the sMCL did not cause postoperative valgus laxity after OWHTO surgery. TRIAL REGISTRATION: Trial registration number: No.012-0360.

    DOI: 10.1186/s12891-019-2859-7

    PubMed

    researchmap

  • Identification of Coiled-Coil Domain-Containing Protein 180 and Leucine-Rich Repeat-Containing Protein 4 as Potential Immunohistochemical Markers for Liposarcoma Based on Proteomic Analysis Using Formalin-Fixed, Paraffin-Embedded Tissue. 国際誌

    Tomoyuki Aoyama, Akira Takasawa, Kumi Takasawa, Yusuke Ono, Makoto Emori, Masaki Murata, Takahiro Hayasaka, Naoki Fujitani, Makoto Osanai, Toshihiko Yamashita, Tadashi Hasegawa, Norimasa Sawada

    The American journal of pathology   189 ( 5 )   1015 - 1028   2019年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Recent technical improvements in both mass spectrometry and protein extraction have made it possible to use formalin-fixed, paraffin-embedded (FFPE) tissues for proteome analysis. In this study, comparable proteome analysis of FFPE tissues revealed multiple candidate marker molecules for differentiating atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDL) from lipoma. A total of 181 unique proteins were identified for ALT/WDL. Of the identified proteins, coiled-coil domain-containing protein 180 (CCDC180) and leucine-rich repeat-containing protein 4 (LRRC4) were studied as candidate markers of ALT/WDL. CCDC180 and LRRC4 immunohistochemistry clearly stained tumor cells of ALT/WDL and dedifferentiated liposarcoma and could differentiate them from lipoma with high accuracy. Cell biological methods were used to further examine the expression of the candidate marker molecules in liposarcoma cells. In liposarcoma cells, knockdown of CCDC180 and LRRC4 inhibited cell proliferation. CCDC180 inhibited cell migration, invasion, and apoptosis resistance in WDL cells. Adipogenic differentiation suppressed the expression of CCDC180 and LRRC4 in WDL cells. These results indicated that LRRC4 and CCDC180 are novel immunohistochemical markers for differentiating ALT/WDLs. Their expression was associated with adipocyte differentiation and contributed to malignant potentials of WDL cells. Proteome analysis using a standard stock of FFPE tissues can reveal novel biomarkers for various diseases, which contributes to the progress of molecular pathology.

    DOI: 10.1016/j.ajpath.2019.01.013

    PubMed

    researchmap

  • Combination of eribulin plus AKT inhibitor evokes synergistic cytotoxicity in soft tissue sarcoma cells. 国際誌

    Naotaka Hayasaka, Kohichi Takada, Hajime Nakamura, Yohei Arihara, Yutaka Kawano, Takahiro Osuga, Kazuyuki Murase, Shohei Kikuchi, Satoshi Iyama, Makoto Emori, Shintaro Sugita, Tadashi Hasegawa, Akira Takasawa, Koji Miyanishi, Masayoshi Kobune, Junji Kato

    Scientific reports   9 ( 1 )   5759 - 5759   2019年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    An activated AKT pathway underlies the pathogenesis of soft tissue sarcoma (STS), with over-expressed phosphorylated AKT (p-AKT) correlating with a poor prognosis in a subset of STS cases. Recently, eribulin, a microtubule dynamics inhibitor, has demonstrated efficacy and is approved in patients with advanced/metastatic liposarcoma and breast cancer. However, mechanisms of eribulin resistance and/or insensitivity remain largely unknown. In this study, we demonstrated that an increased p-AKT level was associated with eribulin resistance in STS cells. We found a combination of eribulin with the AKT inhibitor, MK-2206, synergistically inhibited STS cell growth in vivo as well as in vitro. Mechanistically, eribulin plus MK-2206 induced G1 or G2/M arrest by down-regulating cyclin-dependent kinases, cyclins and cdc2, followed by caspase-dependent apoptosis in STS cells. Our findings demonstrate the significance of p-AKT signaling for eribulin-resistance in STS cells and provide a rationale for the development of an AKT inhibitor in combination with eribulin to treat patients with STS.

    DOI: 10.1038/s41598-019-42300-z

    PubMed

    researchmap

  • Immunoreactivity patterns of tight junction proteins are useful for differential diagnosis of human salivary gland tumors.

    Tomoyuki Aoyama, Akira Takasawa, Masaki Murata, Makoto Osanai, Kenichi Takano, Tadashi Hasagawa, Norimasa Sawada

    Medical molecular morphology   52 ( 1 )   23 - 35   2019年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The expression pattern of tight junction proteins (TJPs) varies among organs and tumor types. In this study, we examined the immunoreactivity of claudin (CLDN)-1, -4, and -7, and JAM-A in salivary gland tumors (SGTs) by histological types and cell types to estimate their usefulness as differential diagnostic markers. Immunoreactivity of CLDN1 was higher in ductal epithelium cells of SGTs than in non-tumor tissues. Conversely, immunoreactivity of CLDN1 was significantly decreased in basal/myoepithelium cells of SGTs compared with that in non-tumor tissues. There was no significant difference between the immunoreactivity of CLDN1 in benign tumors and that in malignant tumors. Immunoreactivity of CLDN4, CLDN7, and JAM-A in ductal epithelium cells was higher in many SGTs than in non-tumor tissues. There was a difference depending on the histological type of SGT in immunoreactivity of CLDN4, CLDN7, and JAM-A in basaloid/myoepithelial cells. It was possible to classify SGTs by a hierarchical clustering using immunoreactivity of TJPs. The results suggest that an immunohistochemical marker panel including these TJPs may be useful for differential diagnosis of SGTs and that CLDN1 is associated with tumorigenesis of SGTs.

    DOI: 10.1007/s00795-018-0199-6

    PubMed

    researchmap

  • Cytotoxicity of Clostridium perfringens enterotoxin depends on the conditions of claudin-4 in ovarian carcinoma cells. 国際誌

    Satoshi Tanaka, Tomoyuki Aoyama, Marie Ogawa, Akira Takasawa, Masaki Murata, Makoto Osanai, Tsuyoshi Saito, Norimasa Sawada

    Experimental cell research   371 ( 1 )   278 - 286   2018年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Currently, Clostridium perfringens enterotoxin (CPE) is being investigated as an anti-cancer drug for tumors expressing the tight junction (TJ) transmembrane proteins claudin-3 and/or claudin-4. However, the optimal conditions for CPE cytotoxicity are still unclear. Our objectives were to determine the optimal conditions for CPE as an anti-cancer drug for treating ovarian cancer in vitro and in vivo. In our experiments, cells at low culture density showed higher sensitivity to CPE, suggesting that claudins at TJs were poorly accessible to CPE compared with those at the edge of cell colonies. Ovarian cancer cells cultured under calcium-depleted pretreatment conditions to disrupt TJs and to knock-down TJ proteins and E-cadherin production altered CPE cytotoxicity, which was mainly dependent on claudin-4 expression. These results suggest that the condition of claudin-4 at the cell surface is important for CPE cytotoxicity. Our in vivo experiments showed that a high dose of CPE is required for the effective treatment of peritoneal dissemination of ovarian cancer cells. Here, we suggest that the accessibility of CPE to claudins is important for its cytotoxicity and depends on the conditions of claudin-4 in vitro. In addition, E-cadherin expression in ovarian cancer cells affects the efficiency of CPE in vivo.

    DOI: 10.1016/j.yexcr.2018.08.024

    PubMed

    researchmap

  • Estrogen/GPR30 Signaling Contributes to the Malignant Potentials of ER-Negative Cervical Adenocarcinoma via Regulation of Claudin-1 Expression. 国際誌

    Taishi Akimoto, Akira Takasawa, Kumi Takasawa, Tomoyuki Aoyama, Masaki Murata, Makoto Osanai, Tsuyoshi Saito, Norimasa Sawada

    Neoplasia (New York, N.Y.)   20 ( 10 )   1083 - 1093   2018年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Cervical adenocarcinomas are believed to lose estrogen response on the basis of no expression of a nuclear estrogen receptor such as ERα in clinical pathology. Here, we demonstrated that cervical adenocarcinoma cells respond to a physiological concentration of estrogen to upregulate claudin-1, a cell surface molecule highly expressed in cervical adenocarcinomas. Knockout of claudin-1 induced apoptosis and significantly inhibited proliferation, migration, and invasion of cervical adenocarcinoma cells and tumorigenicity in vivo. Importantly, all of the cervical adenocarcinoma cell lines examined expressed a membrane-bound type estrogen receptor, G protein-coupled receptor 30 (GPR30/GPER1), but not ERα. Estrogen-dependent induction of claudin-1 expression was mediated by GPR30 via ERK and/or Akt signaling. In surgical specimens, there was a positive correlation between claudin-1 expression and GPR30 expression. Double high expression of claudin-1 and GPR30 predicts poor prognosis in patients with cervical adenocarcinomas. Mechanism-based targeting of estrogen/GPR30 signaling and claudin-1 may be effective for cervical adenocarcinoma therapy.

    DOI: 10.1016/j.neo.2018.08.010

    PubMed

    researchmap

  • SMOC1のエピジェネティックなサイレンシングは大腸鋸歯状腺腫の発育進展に関与する(Epigenetic silencing of SMOC1 is associated with development of colorectal traditional serrated adenomas)

    青木 敬則, 山本 英一郎, 高澤 啓, 新沼 猛, 山野 泰穂, 萬 顕, 北嶋 洋志, 甲斐 正広, 澤田 典均, 仲瀬 裕志, 菅井 有, 鈴木 拓

    日本癌学会総会記事   77回   1871 - 1871   2018年9月

     詳細を見る

    記述言語:英語   出版者・発行元:日本癌学会  

    researchmap

  • Retinoic acid-metabolizing enzyme cytochrome P450 26A1 promotes skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene. 国際誌

    Makoto Osanai, Akira Takasawa, Kumi Takasawa, Masaki Murata, Norimasa Sawada

    Oncology letters   15 ( 6 )   9987 - 9993   2018年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Elevated expression of the retinoic acid-metabolizing enzyme cytochrome P450 26A1 (CYP26A1) has been demonstrated to have an oncogenic function in carcinogenesis. In order to address the oncogenic capacity of CYP26A1 in vivo, transgenic mice that ubiquitously overexpressed CYP26A1 driven by the cytomegalovirus promoter were generated in the present study. Since the growth of these animals was normal for ≤15 months and they presented no evident abnormalities, a two-stage skin carcinogenesis analysis was performed. In the CYP26A1 transgenic mice, papilloma formation was observed within 7 weeks after administration of the carcinogen 7,12-dimethylbenz[a]anthracene (DMBA). Development of papillomas in these animals was significantly accelerated when compared with that observed in the control mice following treatment with DMBA in combination with the chemical tumor promoter 12-O-tetradecanoylphorbol-13-acetate. In addition, constitutive expression of CYP26A1 increased the susceptibility of these mice to the generation of squamous cell carcinomas caused by treatment with the carcinogen alone. It is thus concluded that CYP26A1 expression promotes skin carcinogenesis initiated by DMBA.

    DOI: 10.3892/ol.2018.8599

    PubMed

    researchmap

  • Occludin induces microvillus formation via phosphorylation of ezrin in a mouse hepatic cell line. 国際誌

    Masaki Murata, Makoto Osanai, Akira Takasawa, Kumi Takasawa, Tomoyuki Aoyama, Yuka Kawada, Akihiro Yamamoto, Yusuke Ono, Yutaro Hiratsuka, Takashi Kojima, Norimasa Sawada

    Experimental cell research   366 ( 2 )   172 - 180   2018年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Apical and basolateral cell membranes are separated by tight junctions (TJs). Microvilli are limited to the apical cell membrane. TJs and microvilli are the landmarks for epithelial cell polarity. However, the direct relationship between TJ proteins (TJPs) and the components of microvilli remains unclear. In this study, we investigated whether occludin, which is considered to be a functional TJP, is involved in microvillus formation. In occludin knockout mouse hepatic cells (OcKO cells), the microvillus density was less than that in wild-type (WT) cells and the length of microvilli was short. Immunoreactivity of ezrin was decreased in OcKO cells compared with that in WT cells. Although there was no change in the expression level of ezrin, phosphorylation of ezrin was decreased in OcKO cells. The microvillus density and the length of microvilli were increased in OcKO cells by transfection of full-length mouse occludin and COOH-terminal domains of occludin. These results suggested that occludin induced microvillus formation via phosphorylation of ezrin and that the COOH-terminal domain of occludin, which is localized in non-TJ areas, might be able to induce microvilli formation. Our results provide new insights into the function of occludin.

    DOI: 10.1016/j.yexcr.2018.03.018

    PubMed

    researchmap

  • Epigenetic silencing of SMOC1 in traditional serrated adenoma and colorectal cancer. 国際誌

    Hironori Aoki, Eiichiro Yamamoto, Akira Takasawa, Takeshi Niinuma, Hiro-O Yamano, Taku Harada, Hiro-O Matsushita, Kenjiro Yoshikawa, Ryo Takagi, Eiji Harada, Yoshihito Tanaka, Yuko Yoshida, Tomoyuki Aoyama, Makoto Eizuka, Akira Yorozu, Hiroshi Kitajima, Masahiro Kai, Norimasa Sawada, Tamotsu Sugai, Hiroshi Nakase, Hiromu Suzuki

    Oncotarget   9 ( 4 )   4707 - 4721   2018年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Colorectal sessile serrated adenoma/polyps (SSA/Ps) are well-known precursors of colorectal cancer (CRC) characterized by BRAF mutation and microsatellite instability. By contrast, the molecular characteristics of traditional serrated adenoma (TSAs) are not fully understood. We analyzed genome-wide DNA methylation in TSAs having both protruding and flat components. We identified 11 genes, including SMOC1, methylation of which progressively increased during the development of TSAs. SMOC1 was prevalently methylated in TSAs, but was rarely methylated in SSA/Ps (p < 0.001). RT-PCR and immunohistochemistry revealed that SMOC1 was expressed in normal colon and SSA/Ps, but its expression was decreased in TSAs. Ectopic expression of SMOC1 suppressed proliferation, colony formation and in vivo tumor formation by CRC cells. Analysis of colorectal lesions (n = 847) revealed that SMOC1 is frequently methylated in TSAs, high-grade adenomas and CRCs. Among these, SMOC1 methylation was strongly associated with KRAS mutation and CpG island methylator phenotype (CIMP)-low. These results demonstrate that epigenetic silencing of SMOC1 is associated with TSA development but is rarely observed in SSA/Ps. SMOC1 expression could thus be a diagnostic marker of serrated lesions, and SMOC1 methylation could play a role in neoplastic pathways in TSAs and conventional adenomas.

    DOI: 10.18632/oncotarget.23523

    PubMed

    researchmap

  • Elevated expression of JAM-A promotes neoplastic properties of lung adenocarcinoma. 国際誌

    Kazufumi Magara, Akira Takasawa, Makoto Osanai, Misaki Ota, Yohei Tagami, Yusuke Ono, Kumi Takasawa, Masaki Murata, Yoshihiko Hirohashi, Masahiro Miyajima, Gen Yamada, Tadashi Hasegawa, Norimasa Sawada

    Cancer science   108 ( 11 )   2306 - 2314   2017年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    A cell-cell adhesion protein, junctional adhesion molecule-A (JAM-A), has been shown to be involved in neoplasia of various organs. However, the fundamental role of JAM-A in tumorigenesis is still under debate because dysregulated expression of this protein has distinct effects, playing opposite roles in carcinogenesis depending on the target tissues. In the present study, we found elevated levels of JAM-A expression in lung adenocarcinoma and its preinvasive lesions, including atypical adenomatous hyperplasia and adenocarcinoma in situ by immunohistochemistry. We also showed that suppression of constitutive JAM-A expression conferred target cells with increased susceptibility to apoptosis in lung adenocarcinoma cells. Consequently, inhibition of JAM-A activity decreased colony-forming capability in vitro and tumorigenicity in vivo. The transformed phenotype following suppression of JAM-A expression was sufficient to reduce motile and invasive capacities. Importantly, knockout of JAM-A had striking effects on cells. Our observations suggest that increased expression of JAM-A promotes neoplasia of lung adenocarcinoma. In addition, an anti-JAM-A antibody efficiently reduced cell proliferation and provoked apoptosis, indicating the potential feasibility of JAM-A-inhibitory cancer therapy.

    DOI: 10.1111/cas.13385

    PubMed

    researchmap

  • Claudin-18 coupled with EGFR/ERK signaling contributes to the malignant potentials of bile duct cancer. 国際誌

    Kumi Takasawa, Akira Takasawa, Makoto Osanai, Tomoyuki Aoyama, Yusuke Ono, Tsuyoshi Kono, Yoshihiko Hirohashi, Masaki Murata, Norimasa Sawada

    Cancer letters   403   66 - 73   2017年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Our recent work revealed that elevated expression of claudin-18 is involved in bile duct neoplasia. In the present study, we found that wound generation of a cell sheet de novo induced claudin-18 expression in its leading edge, coincident with high mitotic activity. We also found that the suppression of claudin-18 expression significantly reduced cell growth and invasiveness of bile duct cancer cell lines and tumorigenicity in vivo. In addition, an antibody specific to an extracellular loop of claudin-18 showed similar effects on the cells such as cell proliferation. Interestingly, treatment with epidermal growth factor (EGF) and overexpression of RAS oncogene induced claudin-18 expression by activation of extracellular signal-related kinase (ERK)1/2. Furthermore, enhanced claudin-18 expression activated ERK1/2. These findings provide evidence for an oncogenic property of claudin-18 in bile duct carcinoma cells via modulation of EGFR/ERK signaling, indicating that claudin-18 is a possible therapeutic target for this malignancy.

    DOI: 10.1016/j.canlet.2017.05.033

    PubMed

    researchmap

  • 内側楔状開大式高位脛骨骨切り術における内側側副靱帯浅層剥離の影響 定量的膝外反ストレス撮影による検討

    佐藤 大, 薮内 康史, 小野寺 智洋, 亀田 敏明, 岩崎 倫政, 近藤 英司, 小野寺 純, 北村 信人, 八木 知徳, 坂本 圭太, 高澤 啓, 安田 和則

    日本関節病学会誌   36 ( 2 )   131 - 139   2017年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本関節病学会  

    内側側副靱帯(MCL)浅層の脛骨付着部を剥離して行った内側楔状開大式高位脛骨骨切り術(OWHTO)術後の外反不安定性を検討した。対象は、2009年から2015年にOWHTOを行った84人93膝(男性19人20膝、女性65人73膝、手術時平均60.1歳)とした。疾患は内側変形性膝関節症(OA)74例83膝、突発性膝骨壊死(ON)10例10膝であった。JOAスコアは術前平均69.1点から術後90.3点に有意に改善した。定量的外反ストレス撮影において、内側関節裂隙の開大距離(MJS)は術前から全身麻酔下のMCL浅層剥離直前で有意に増加し、MCL浅層の剥離直後にはさらに有意に増加したが、術後1年以降では術前との間に有意差は認めなかった。術後の開大距離と術中、術後のMJSと術後の開大角と術中、術後のJLCAについての相関関係を検討した結果、いずれの項目についても有意な相関係数を認めなかった。Locking plate抜去部は線維性瘢痕組織で覆われていた。Spot MRIでは、iso-intensityの肥厚したMCL浅層線維を認めた。組織所見では、OWHTO術後に骨とMCL浅層の間に瘢痕組織が介在し、不規則な膠原線維の配列を呈した。以上より、locking plateを用いたOWHTO後の短期成績は良好であった。全症例で、MCL浅層の脛骨付着部を完全に剥離してOWHTOを行ったが、MCL浅層剥離による術後の膝外反不安定性は認めなかった。

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2017&ichushi_jid=J05177&link_issn=&doc_id=20170810100008&doc_link_id=%2Ffd8kanse%2F2017%2F003602%2F009%2F0131-0139%26dl%3D0&url=http%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Ffd8kanse%2F2017%2F003602%2F009%2F0131-0139%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

  • Cytological findings of langerhans cell sarcoma in a case of quintuple cancer. 国際誌

    Satomi Tabata, Masaki Murata, Akira Takasawa, Atsushi Fukuda, Jun Ogasawara, Takayuki Koseki, Katsuhiko Nakano, Keiko Segawa, Rena Morita, Tadashi Hasegawa, Norimasa Sawada

    Diagnostic cytopathology   45 ( 5 )   441 - 445   2017年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Langerhans cell sarcoma (LCS) and quintuple cancers are extremely rare. In this report, a case of quintuple cancers including LCS was described. An 80-year-old man had squamous cell carcinoma of the nasal skin, colon and rectum adenocarcinomas, and T-cell/histiocyte-rich large B-cell lymphoma. As swelling of multiple submental lymph nodes was observed, fine-needle aspiration was carried out. Many large cells with high-grade nuclear atypia and abundant cytoplasm were observed. Lymphocytes and eosinophils were observed in the background. Although a malignant tumor was suspected, a definite diagnosis could not be made. In a biopsy sample, the tumor cells were positive for vimentin, CD68, S-100, CD1a, and CD163 and negative for epithelial, lymphocyte, and melanoma markers in immunohistochemistry. A diagnosis of LCS was made from the immunohistochemical findings and high mitotic rate with atypical forms. The patient died about 2 months after the first medical examination. Metastasis of LCS was confirmed in many organs by autopsy. LCS has a poor prognosis. In cases with the above-described cytological findings, LCS should be added to the list of differential diagnosis. The cytological findings presented here may be useful for determining appropriate clinical management such as staging of the disease and follow-up of the neoplasm. Diagn. Cytopathol. 2017;45:441-445. © 2017 The Authors Diagnostic Cytopathology Published by Wiley Periodicals, Inc.

    DOI: 10.1002/dc.23628

    PubMed

    researchmap

  • Claudins in cancer: bench to bedside. 国際誌

    Makoto Osanai, Akira Takasawa, Masaki Murata, Norimasa Sawada

    Pflugers Archiv : European journal of physiology   469 ( 1 )   55 - 67   2017年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The claudin family, in mammals, encoded by at least 27 members of a single ancestral gene, CLDN, is the main constituent as integral membrane proteins of tight junctions. It has been shown that the expression levels of claudins are often decreased or that their expressions are absent in human neoplasias. These findings are consistent with the well-accepted concept that carcinogenesis is accompanied by the disruption or loss of functional tight junctions. In contrast, accumulating data have showed elevated or aberrant expression of claudins in various cancers, indicating specific roles of claudins in tumorigenesis. Importantly, dysregulated claudins play an oncogenic role or conversely have a tumor-suppressive effect depending on target tissues or cell types, and thus, they contribute to tumor development and progression. Although tight junctions are intercellular structures in epithelial cells, specific roles of claudins in cancer are supported by the evidence that TJs are not simple static constituents for establishing cell adhesion structures but are also cell signaling components that have functions in receiving environmental cues and transmitting signals inside cells. Since the expression profile of claudins is associated with patients' outcome and prognosis in several cancer types, an understanding of the expression pattern and subcellular localization of claudins in various pathologies will lead to the establishment of claudins as useful biomarkers for the detection and diagnosis of cancers.

    DOI: 10.1007/s00424-016-1877-7

    PubMed

    researchmap

  • Prognostic significance of the co-expression of EGFR and HER2 in adenocarcinoma of the uterine cervix. 国際誌

    Asako Ueda, Akira Takasawa, Taishi Akimoto, Kumi Takasawa, Tomoyuki Aoyama, Yoshihiko Ino, Masanori Nojima, Yusuke Ono, Masaki Murata, Makoto Osanai, Tadashi Hasegawa, Tsuyoshi Saito, Norimasa Sawada

    PloS one   12 ( 8 )   e0184123   2017年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Prognostic factors and therapeutic targets are needed for the patients with cervical adenocarcinoma because they have a poor prognosis. Recently, co-expression of multiple receptor tyrosine kinases (RTKs) has been found to be associated with aggressive biological behavior and poor prognosis of several types of malignancy. To evaluate the significance of the expression of multiple RTKs in uterine cervical cancers, we examined the expression profile of RTKs (EGFR, HER2 and c-Met) and the correlation of their expression with clinicopathological features and prognosis of patients with cervical adenocarcinomas. AIS and adenocarcinoma showed strong expression of a single RTK (EGFR, HER2 or c-Met) on the cell membrane in 41 (77.4%) of 53 cases. Twenty (46%) of the 43 adenocarcinoma cases were positive for double or triple RTKs (P = 0.034). Positivity for EGFR and double positivity for EGFR and HER2 (EGFR+/HER2+/c-Met+ and EGFR+/HER2+/c-Met-) were significantly correlated with lymph node metastasis (P = 0.010 for single and P = 0.013 for double) and UICC stage (P = 0.021 for single and P = 0.007 for double). Positivity for HER2 was significantly correlated with tumor size (P = 0.029). Relapse-free survival (RFS) was significantly shorter in patients who were double positive for EGFR and HER2. Our results suggest that EGFR and HER2 are potential therapeutic targets and that their co-expression is a prognostic factor for cervical adenocarcinoma.

    DOI: 10.1371/journal.pone.0184123

    PubMed

    researchmap

  • Claudins-4 and -7 might be valuable markers to distinguish hepatocellular carcinoma from cholangiocarcinoma. 国際誌

    Yusuke Ono, Yutaro Hiratsuka, Masaki Murata, Akira Takasawa, Rieko Fukuda, Masanori Nojima, Satoshi Tanaka, Makoto Osanai, Koichi Hirata, Norimasa Sawada

    Virchows Archiv : an international journal of pathology   469 ( 4 )   417 - 26   2016年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The claudin family members are the functional components of tight junctions. Expression and localization of claudins vary among organs and tumor types. In this study, we examined expression and localization of tight junction proteins (TJP) in human liver tumors, to estimate their usefulness as differential diagnostic markers. The materials used for immunohistochemical analysis were 47 liver tumor specimens including 29 cases of hepatocellular carcinoma (HCC), 15 cases of cholangiocarcinoma (CC), 3 cases of combined HCC and CC (CHC), and 3 cases of cholangiolocellular carcinoma (CoCC). Samples were examined using semiquantitative and statistical analysis of immunoreactivity. In HCC, claudin-1, occludin, tricellulin, and JAM-A were expressed on the cell membrane as well as in hepatocytes. In CC, claudins-1, -4, and -7, tricellulin, and JAM-A were expressed on the cell membrane and occludin was predominantly expressed in the apicalmost areas of the cell membrane. Significant differences in the immunohistochemical scores of claudin-4 and claudin-7 were observed when comparing HCC and CC. CHC was positive for all of the TJPs examined in this study. The expression pattern of CoCC was found to be similar to that of CC. There were differences in the distribution of intensity scores of claudins-4 and -7 and occludin between CoCC and HCC. In addition, CHC was positive for Glypican-3 and CK-19. CoCC was positive for only CK-19. The results suggest that claudins-4 and -7 might be valuable markers for distinguishing HCC and CC and that CoCC might arise from hepatic ductal cells.

    DOI: 10.1007/s00428-016-1984-z

    PubMed

    researchmap

  • Nuclear localization of tricellulin promotes the oncogenic property of pancreatic cancer. 国際誌

    Akira Takasawa, Masaki Murata, Kumi Takasawa, Yusuke Ono, Makoto Osanai, Satoshi Tanaka, Masanori Nojima, Tsuyoshi Kono, Koichi Hirata, Takashi Kojima, Norimasa Sawada

    Scientific reports   6   33582 - 33582   2016年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Accumulating evidence has shown that dysregulation of tight junctions (TJs) is involved in tumor development and progression. In this study, we investigated the expression and subcellular distribution of tricellulin, which constitutes tricellular TJs, using human pancreatic adenocarcinomas. In well-differentiated pancreatic adenocarcinoma tissues, tricellulin immunostaining was prominent in the cytoplasm and the plasma membrane. In contrast, in poorly differentiated tissues, its immunostaining was predominantly observed in the nuclei and was almost absent in the plasma membrane. The distinct immunostaining of tricellulin successfully distinguished poorly differentiated adenocarcinoma from moderately and well-differentiated adenocarcinomas with high levels of sensitivity and specificity. Nuclear tricellulin expression significantly correlated with lymph node metastasis, lymphatic invasion and poor survival. In pancreatic cancer cell lines, tricellulin localization shifted from the membrane to nucleus with decreasing differentiation status. Nuclear localization of tricellulin promoted cell proliferation and invasiveness possibly in association with MAPK and PKC pathways in pancreatic cancers. Our results provide new insights into the function of tricellulin, and its nuclear localization may become a new prognostic factor for pancreatic cancers.

    DOI: 10.1038/srep33582

    PubMed

    researchmap

  • Increased expressions of claudin 4 and 7 in atypical adenomatous hyperplasia and adenocarcinoma of the lung.

    Gen Yamada, Masaki Murata, Akira Takasawa, Masanori Nojima, Yuki Mori, Norimasa Sawada, Hiroki Takahashi

    Medical molecular morphology   49 ( 3 )   163 - 9   2016年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Abnormal expression of claudin (Cldn), the main constituent of tight junctions, may play a crucial role in carcinogenesis. To elucidate these abnormalities of tight junctions in lung adenocarcinoma during carcinogenesis, we examined immunohistochemical expressions of Cldn4 and Cldn7 in human lung resection materials. Lung resection specimens from 86 patients were studied, including 16 atypical adenomatous hyperplasia (AAH), 19 adenocarcinoma in situ (AIS), 32 invasive adenocarcinoma (ADC), 5 AIS with AAH, 2 ADC with AAH, 10 ADC with AIS, and 2 ADC with AIS and AAH. The immunohistochemical staining (IHC) score was defined for both the extent and intensity of staining. IHC score for Cldn4 in AIS and ADC was significantly higher than that in alveolar epithelium (AE) and AAH (p < 0.001 for both). In addition, the AAH score was significantly higher than that in AE (p < 0.001). The Cldn7 score in ADC was significantly increased compared with AE and AAH (p < 0.001 for both). These results suggested that increase of Cldn4-expression may be involved in early molecular events during carcinogenesis of adenocarcinoma, whereas increase of Cldn7-expression may be associated with tumor invasion or progression.

    DOI: 10.1007/s00795-016-0135-6

    PubMed

    researchmap

  • Analysis of the expression and localization of tight junction transmembrane proteins, claudin-1, -4, -7, occludin and JAM-A, in human cervical adenocarcinoma. 国際誌

    Taishi Akimoto, Akira Takasawa, Masaki Murata, Yui Kojima, Kumi Takasawa, Masanori Nojima, Tomoyuki Aoyama, Yutaro Hiratsuka, Yusuke Ono, Satoshi Tanaka, Makoto Osanai, Tadashi Hasegawa, Tsuyoshi Saito, Norimasa Sawada

    Histology and histopathology   31 ( 8 )   921 - 31   2016年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    OBJECTIVE: Tight junction proteins have recently been reported to be useful for distinguishing between neoplastic and non-neoplastic tissues. In this study, we evaluated the expression and localization of tight junction transmembrane proteins in human cervical adenocarcinoma and adenocarcinoma in situ (AIS), and we determined whether their expression patterns could distinguish cervical adenocarcinoma from non-neoplastic cervical glands. METHODS: Fifty-five patients with cervical adenocarcinoma or AIS were included in this study. Surgical specimens were immunohistochemically stained for claudin (CLDN) -1, -4, -7, occludin, and JAM-A. RESULTS: Significantly higher expression levels of CLDNs and JAM-A were found in cervical AIS and adenocarcinoma than in non-neoplastic glands. In cervical AIS and adenocarcinoma, localization of CLDN1 and JAM-A was extended throughout the whole cell membranes, whereas they were predominantly expressed at the most apical cell-cell junction in non-neoplastic glands. ROC curve analysis revealed that immunoreactivities of CLDN-1 or JAM-A successfully distinguished neoplasms from non-neoplastic cervical glands with high specificity (CLDN-1, 79.1%; JAM-A, 79.1%) and high sensitivity (CLDN-1, 84.1%; JAM-A, 95.5%). CONCLUSIONS: As expected, there were immunohistochemical differences between cervical adenocarcinoma and non-neoplastic cervical glands by using antibodies against tight junction transmembrane proteins. These results suggest that CLDN-1 and JAM-A are potential biomarkers for cervical adenocarcinoma.

    DOI: 10.14670/HH-11-729

    PubMed

    researchmap

  • Microenvironmental stresses induce HLA-E/Qa-1 surface expression and thereby reduce CD8(+) T-cell recognition of stressed cells. 国際誌

    Takanori Sasaki, Takayuki Kanaseki, Yosuke Shionoya, Serina Tokita, Sho Miyamoto, Eri Saka, Vitaly Kochin, Akira Takasawa, Yoshihiko Hirohashi, Yasuaki Tamura, Akihiro Miyazaki, Toshihiko Torigoe, Hiroyoshi Hiratsuka, Noriyuki Sato

    European journal of immunology   46 ( 4 )   929 - 40   2016年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Hypoxia and glucose deprivation are often observed in the microenvironment surrounding solid tumors in vivo. However, how they interfere with MHC class I antigen processing and CD8(+) T-cell responses remains unclear. In this study, we analyzed the production of antigenic peptides presented by classical MHC class I in mice, and showed that it is quantitatively decreased in the cells exposed to either hypoxia or glucose deprivation. In addition, we unexpectedly found increased surface expression of HLA-E in human and Qa-1 in mouse tumor cells exposed to combined oxygen and glucose deprivation. The induced Qa-1 on the stressed tumor model interacted with an inhibitory NKG2/CD94 receptor on activated CD8(+) T cells and attenuated their specific response to the antigen. Our results thus suggest that microenvironmental stresses modulate not only classical but also nonclassical MHC class I presentation, and confer the stressed cells the capability to escape from the CD8(+) T-cell recognition.

    DOI: 10.1002/eji.201545835

    PubMed

    researchmap

  • Nasopharyngeal hyalinizing clear cell carcinoma with EWSR1 rearrangements diagnosed by fluorescence in situ hybridization. 国際誌

    Atsushi Fukuda, Yohei Tagami, Akira Takasawa, Shintaro Sugita, Rinnosuke Kuramoto, Suguru Imai, Tadashi Hasegawa, Keiji Iizuka

    Auris, nasus, larynx   42 ( 5 )   412 - 5   2015年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Hyalinizing clear cell carcinoma (HCCC) is a rare, low-grade salivary gland neoplasm with a predilection for the palate and tongue. A 63-year-old woman presented a 14×14×17-mm mass at the roof of the nasopharynx. Endoscopic resection was performed via a transnasal approach. Histopathological findings of the salivary gland tumor indicated hyalinization of the stroma and neoplastic cells with clear cytoplasm without mucin. Fluorescence in situ hybridization analysis revealed that the tumor cells were positive for EWSR1 rearrangement. We finally diagnosed this case as HCCC of the nasopharynx. EWSR1 rearrangements are non-existent in other salivary gland tumors with clear cell change; thus, the identification of this rearrangement was very useful in accurately diagnosing HCCC.

    DOI: 10.1016/j.anl.2015.02.015

    PubMed

    researchmap

  • Aberrant expression of claudin-4 and -7 in hepatocytes in the cirrhotic human liver.

    Mitsuhiro Tsujiwaki, Masaki Murata, Akira Takasawa, Yutaro Hiratsuka, Rieko Fukuda, Kotaro Sugimoto, Yusuke Ono, Masanori Nojima, Satoshi Tanaka, Koichi Hirata, Takashi Kojima, Norimasa Sawada

    Medical molecular morphology   48 ( 1 )   33 - 43   2015年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The liver comprises hepatocytes and non-parenchymal cells such as bile duct epithelial cells. Claudin-4 and -7 are not expressed in hepatocytes under physiological conditions. It was reported that claudin-7 increased in human pulmonary fibroses. We therefore investigated claudin-4 and -7 expressions in human cirrhotic livers, in which hepatocyte proliferation is severely delayed. We examined liver tissues from 50 patients with liver tumors. The expression of claudin-4 and -7 in hepatocytes significantly increased with the grade of fibrosis, not with inflammatory activity, in the liver tissues of chronic hepatitis. The number of claudin-4- and -7-positive cells observed was greater than that of alpha-fetoprotein-positive hepatic progenitor cells. In primary cultures of mouse hepatocytes, the expression of claudin-4 and -7 was not induced by treatment with proinflammatory cytokines. In immunohistochemical analysis of liver tissues of 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated mice and primary cultures of mouse hepatocytes, the expression of claudin-4 and -7 increased with proliferation of progenitor cells. However, the claudin-4- and -7-positive cells were not always progenitor cells. Thus, claudin-4 and -7 were observed in hepatocytes of severely damaged mouse and human livers. These findings suggest that claudin-4- and -7-positive hepatocytes may exist during the process of differentiation from progenitor cells into mature hepatocytes.

    DOI: 10.1007/s00795-014-0074-z

    PubMed

    researchmap

  • An immunohistochemical marker panel including claudin-18, maspin, and p53 improves diagnostic accuracy of bile duct neoplasms in surgical and presurgical biopsy specimens. 国際誌

    Yoshiko Keira, Akira Takasawa, Masaki Murata, Masanori Nojima, Kumi Takasawa, Jiro Ogino, Yukimura Higashiura, Ayaka Sasaki, Yasutoshi Kimura, Toru Mizuguchi, Satoshi Tanaka, Koichi Hirata, Norimasa Sawada, Tadashi Hasegawa

    Virchows Archiv : an international journal of pathology   466 ( 3 )   265 - 77   2015年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Biliary tract cancers have an extremely poor outcome, and specific diagnostic markers and effective treatments are needed urgently. In this study, we assessed the capacity of panel of immunohistochemical markers including claudin-18, maspin, and p53 to distinguish biliary tract carcinoma and biliary intraepithelial neoplasia (BilIN) from non-neoplastic epithelium. We performed a retrospective study of 66 biliary tract cancer specimens and 63 specimens with non-neoplastic lesions. Of the surgical specimens, 96.7 % with adenocarcinoma/BilIN were detected as neoplastic, and all 63 specimens histologically diagnosed as non-neoplastic lesion were detected as non-neoplastic with high sensitivity (91.1 %) and specificity (100 %). Of presurgical endobiliary forceps biopsy specimens, all with adenocarcinoma/BilIN and only 1 of the 19 with a non-neoplastic lesion were distinguished as neoplastic with high sensitivity (100 %) and specificity (94.7 %). Moreover, this panel provided good separation of neoplasm from malignancy-undetermined atypical epithelium (18/21, 85.7 %). This panel achieves a more reliable distinction of biliary tract cancers and BilINs from non-neoplastic epithelia in both surgical and biopsy specimens than immunohistochemical analysis with single antibodies and is useful in supporting a diagnosis of adenocarcinoma and BilIN.

    DOI: 10.1007/s00428-014-1705-4

    PubMed

    researchmap

  • Regulation of tight junctions by sex hormones in normal human endometrial epithelial cells and uterus cancer cell line Sawano. 国際誌

    Masayuki Someya, Takashi Kojima, Marie Ogawa, Takafumi Ninomiya, Kazuaki Nomura, Akira Takasawa, Masaki Murata, Satoshi Tanaka, Tsuyoshi Saito, Norimasa Sawada

    Cell and tissue research   354 ( 2 )   481 - 94   2013年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The number of patients with uterine endometrial carcinoma, the cause of which involves sex hormones, has recently been growing rapidly because of increases in life expectancy and obesity. Tight junction proteins claudin-3 and -4 are receptors of Clostridium perfringens enterotoxin (CPE) and increase during endometrial carcinogenesis. In the present study of normal human endometrial epithelial (HEE) cells and the uterus cancer cell line Sawano, we investigate changes in the expression of tight junction proteins including claudin-3 and -4, the fence and barrier functions of the tight junction and the cytotoxic effects of CPE by sex hormones. In primary cultured HEE cells, treatment with progesterone (P4) but not estradiol (E2), induced claudin-1, -3, -4 and -7 and occludin, together with the downregulation of the barrier function but not the fence function. In Sawano cells, claudin-3 and -4 were upregulated by E2 but not by P4, together with a disruption of both the barrier and fence function. In primary cultured HEE cells, claudin-3 and -4 were localized at the apicalmost regions (tight junction areas) and no cytotoxicity of CPE was observed. In Sawano cells, claudin-3 and -4 were found not only in the apicalmost regions but also at the basolateral membrane and the cytotoxicity of CPE was enhanced by E2. Thus, tight junctions are physiological regulated by sex hormones in normal HEE cells during the menstrual cycle suggesting that safer and more effective therapeutic methods targeting claudins in uterine cancer can be developed.

    DOI: 10.1007/s00441-013-1676-9

    PubMed

    researchmap

  • Multifocal and microscopic chromophobe renal cell carcinomatous lesions associated with 'capsulomas' without FCLN gene abnormality. 国際誌

    Kotaro Sugimoto, Akira Takasawa, Shingo Ichimiya, Masaki Murata, Hiromichi Kimura, Tomoyuki Aoyama, Johan J P Gille, Naoto Kuroda, Hiroshi Shimizu, Tadashi Hasegawa, Norimasa Sawada, Mitsuko Furuya, Yoji Nagashima

    Pathology international   63 ( 10 )   510 - 5   2013年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Chromophobe renal cell carcinoma (RCC) accounts for approximately 5% of renal epithelial neoplasms. Multiple and/or bilateral chromophobe RCCs in an individual are generally rare but frequently occur in patients with Birt-Hogg-Dubé syndrome (BHDS) and in patients with tuberous sclerosis complex (TSC). The responsible genes in both BHDS and TSC act as tumor suppressors. Therefore, it seems that some genetic backgrounds are required for the generation and progression of multiple chromophobe RCCs. Here, we report a case of multiple and bilateral chromophobe RCCs along with several small-sized capsular angiomyolipomas known as 'capsulomas' in a 39-year-old woman who had neither a particular medical history nor specific gene mutation. There has been no report of sporadic multiple chromophobe RCCs and 'capsulomas' developing in a patient without genetic features, having potential for novel genetic variation.

    DOI: 10.1111/pin.12099

    PubMed

    researchmap

  • Protein kinase Cα inhibitor protects against downregulation of claudin-1 during epithelial-mesenchymal transition of pancreatic cancer. 国際誌

    Daisuke Kyuno, Takashi Kojima, Hiroshi Yamaguchi, Tatsuya Ito, Yasutoshi Kimura, Masafumi Imamura, Akira Takasawa, Masaki Murata, Satoshi Tanaka, Koichi Hirata, Norimasa Sawada

    Carcinogenesis   34 ( 6 )   1232 - 43   2013年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Protein kinase Cα (PKCα) is highly expressed in pancreatic cancer. However, the effects of PKCα on Snail and claudin-1, which play crucial roles in epithelial cell polarity during epithelial-mesenchymal transition (EMT), remain unclear. In this study, we investigated the mechanisms of regulation of Snail and claudin-1 via a PKCα signal pathway during EMT in pancreatic cancer cells and in normal human pancreatic duct epithelial cells (HPDEs). By immunostaining, overexpression of PKCα and downregulation of claudin-1 were observed in poorly differentiated human pancreatic cancer tissues and the pancreatic cancer cell line PANC-1. Treatment with the PKCα inhibitor Gö6976 transcriptionally decreased Snail and increased claudin-1 in PANC-1 cells. The PKCα inhibitor prevented upregulation of Snail and downregulation of claudin-1 during EMT induced by transforming growth factor-β1 (TGF-β1) treatment and under hypoxia in PANC-1 cells. The effects of the PKCα inhibitor were in part regulated via an extracellular signal-regulated kinase (ERK) signaling pathway. The PKCα inhibitor also prevented downregulation of the barrier function and fence function during EMT in well-differentiated pancreatic cancer cell line HPAC. In normal HPDEs, the PKCα inhibitor transcriptionally induced not only claudin-1 but also claudin-4, -7 and occludin without a change of Snail. Treatment with the PKCα inhibitor in normal HPDEs prevented downregulation of claudin-1 and occludin by TGF-β1 treatment and enhanced upregulation of claudin-1, -4, -7 and occludin under hypoxia. These findings suggest that PKCα regulates claudin-1 via Snail- and mitogen-activated protein kinase/ERK-dependent pathways during EMT in pancreatic cancer. Thus, PKCα inhibitors may be potential therapeutic agents against the malignancy of human pancreatic cancer cells.

    DOI: 10.1093/carcin/bgt057

    PubMed

    researchmap

  • Human equilibrative nucleoside transporter 1 and Notch3 can predict gemcitabine effects in patients with unresectable pancreatic cancer. 国際誌

    K Eto, H Kawakami, M Kuwatani, T Kudo, Y Abe, S Kawahata, A Takasawa, M Fukuoka, Y Matsuno, M Asaka, N Sakamoto

    British journal of cancer   108 ( 7 )   1488 - 94   2013年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Pancreatic ductal carcinoma (PDC) is one of the most lethal human carcinomas. Expression patterns of some genes may predict gemcitabine (GEM) treatment efficacy. We examined predictive indicators of survival in GEM-treated patients by quantifying the expression of several genes in pre-treatment endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) samples from patients with PDC. METHODS: The expressions of human equilibrative nucleoside transporter 1 (hENT1), deoxycitidine kinase, ribonucleoside reductase 1, ribonucleoside reductase 2 and Notch3 in EUS-FNA tissue samples from 71 patients with unresectable PDC were quantified using real-time reverse transcription-polymerase chain reactions and examined for correlations with GEM sensitivity. RESULTS: The log-rank test detected no significant differences in overall survival between GEM-treated patients with low and high mRNA levels of all genes examined. However, low Notch3 mRNA expression was significantly associated with longer overall survival in a multivariate analysis for survival (P=0.0094). High hENT1 expression level was significantly associated with a longer time to progression (P=0.039). Interaction tests for GEM administration and hENT1 or Notch3 mRNA expression were statistically significant (P=0.0054 and 0.0047, respectively). CONCLUSION: hENT1 and Notch3 mRNA expressions in EUS-FNA specimens were the key predictive biomarkers of GEM effect and GEM sensitivity in patients with unresectable PDC.

    DOI: 10.1038/bjc.2013.108

    PubMed

    researchmap

  • A case of urothelial carcinoma, lipid cell variant. 国際誌

    Yui Kojima, Akira Takasawa, Masaki Murata, Keigo Akagashi, Tomomi Inoue, Mamie Hara, Yuichi Tokunaga, Takashi Minase, Tadashi Hasegawa, Norimasa Sawada

    Pathology international   63 ( 3 )   183 - 7   2013年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The lipid cell variant of urothelial carcinoma is a rare variant of urinary bladder cancer, comprised of lipoblast-like cells. In this report, we describe a case of the lipid cell variant of aggressive urothelial carcinoma. A 78-year-old man was admitted to the hospital because of gross hematuria. On cystoscopy, an ulcerative lesion, non-papillary architecture, was observed in the lateral wall of the bladder. Transurethral resection was performed. Histopathological findings of the bladder tumor indicated neoplastic cells forming irregular solid nests and sheets. Lipoblast-like neoplastic cells that had eccentric nuclei and cytoplasmic vacuoles were observed, not only in the resected specimen, but also in urine samples. On mucin histochemistry, the tumor cell cytoplasm contained no neutral or acidic mucus. The lipoblast-like cells were positive for cytokeratins (AE1/AE3, CK7) and adipophilin, known as a protein associated with neutral lipid synthesis. In general, it is difficult to prove the existence of intracytoplasmic lipid in formalin-fixed paraffin-embedded materials. This is the first report in which the presence of lipid in vacuoles of the lipid cell variant has been verified by immunohistochemistry.

    DOI: 10.1111/pin.12027

    PubMed

    researchmap

  • Behavior of tricellulin during destruction and formation of tight junctions under various extracellular calcium conditions. 国際誌

    Akira Takasawa, Takashi Kojima, Takafumi Ninomiya, Mitsuhiro Tsujiwaki, Masaki Murata, Satoshi Tanaka, Norimasa Sawada

    Cell and tissue research   351 ( 1 )   73 - 84   2013年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Tricellulin is an important component of tricellular tight junctions (TJs) and is involved in the formation of tricellular contacts. However, little is known about its regulation during the assembly and disassembly of tricellular TJs. By using the well-differentiated pancreatic cancer cell line HPAC, which highly expresses tricellulin at tricellular contacts, we have investigated changes in the localization, expression and phosphorylation of tricellulin and in its TJ functions as a barrier and fence during the destruction and formation of TJs induced by changes in the extracellular calcium concentration. During both extracellular Ca(2+) depletion caused by EGTA treatment and Ca(2+) repletion after Ca(2+) starvation, the expression of tricellulin increased in whole lysates and in Triton-X-100-insoluble fractions without any change in its mRNA. The increases in immunoreactivity revealed by Western blotting were prevented by alkaline phosphatase treatment. Immunoprecipitation assays showed that tricellulin was phosphorylated on threonine residues when it increased after Ca(2+) depletion and repletion. In the early stage after Ca(2+) repletion, tricellulin was expressed not only at tricellular contacts but also in the cytoplasm and at bicellular borders. In confocal laser microscopy, tricellulin was observed at the apical-most regions and basolateral membranes of tricellular contacts after Ca(2+) repletion. Knockdown of tricellulin delayed the recovery of the barrier and fence functions after Ca(2+) repletion. Thus, the dynamic behavior of tricellulin during the destruction and formation of TJs under various extracellular calcium conditions seems to be closely associated with the barrier and fence functions of TJs.

    DOI: 10.1007/s00441-012-1512-7

    PubMed

    researchmap

  • Curcumin prevents replication of respiratory syncytial virus and the epithelial responses to it in human nasal epithelial cells. 国際誌

    Kazufumi Obata, Takashi Kojima, Tomoyuki Masaki, Tamaki Okabayashi, Shinichi Yokota, Satoshi Hirakawa, Kazuaki Nomura, Akira Takasawa, Masaki Murata, Satoshi Tanaka, Jun Fuchimoto, Nobuhiro Fujii, Hiroyuki Tsutsumi, Tetsuo Himi, Norimasa Sawada

    PloS one   8 ( 9 )   e70225   2013年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The human nasal epithelium is the first line of defense during respiratory virus infection. Respiratory syncytial virus (RSV) is the major cause of bronchitis, asthma and severe lower respiratory tract disease in infants and young children. We previously reported in human nasal epithelial cells (HNECs), the replication and budding of RSV and the epithelial responses, including release of proinflammatory cytokines and enhancement of the tight junctions, are in part regulated via an NF-κB pathway. In this study, we investigated the effects of the NF-κB in HNECs infected with RSV. Curcumin prevented the replication and budding of RSV and the epithelial responses to it without cytotoxicity. Furthermore, the upregulation of the epithelial barrier function caused by infection with RSV was enhanced by curcumin. Curcumin also has wide pharmacokinetic effects as an inhibitor of NF-κB, eIF-2α dephosphorylation, proteasome and COX2. RSV-infected HNECs were treated with the eIF-2α dephosphorylation blocker salubrinal and the proteasome inhibitor MG132, and inhibitors of COX1 and COX2. Treatment with salubrinal, MG132 and COX2 inhibitor, like curcumin, prevented the replication of RSV and the epithelial responses, and treatment with salubrinal and MG132 enhanced the upregulation of tight junction molecules induced by infection with RSV. These results suggest that curcumin can prevent the replication of RSV and the epithelial responses to it without cytotoxicity and may act as therapy for severe lower respiratory tract disease in infants and young children caused by RSV infection.

    DOI: 10.1371/journal.pone.0070225

    PubMed

    researchmap

  • 【EMTのUP DATE】EMTと膵癌

    及能 大輔, 小島 隆, 山口 洋志, 伊東 竜哉, 高澤 啓, 村田 雅樹, 今村 将史, 木村 康利, 澤田 典均, 平田 公一

    Surgery Frontier   19 ( 3 )   305 - 310   2012年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)メディカルレビュー社  

    膵癌では、原発巣において腺腔構造を維持していた癌細胞が低分化な紡錘形細胞となって移動し、再び高分化な転移巣を形成しているかのような像がしばしば観察される。このような形態変化は、膵癌の浸潤・転移における上皮間葉移行(epithelial-mesenchymal transition;EMT)の特徴像とされている。膵癌のEMT誘導因子には、さまざまなサイトカインや増殖因子、癌周囲微小環境などが挙げられているが、なかでもTGF-βが中心的な役割を担っていると考えられている。EMT誘導因子はSnail、Slug、ZEB1、SIP1、E2A、Twistなどの転写因子を活性化し、あるいはmicroRNAなどを制御した結果、E-cadherinなどの上皮系マーカーを転写レベルで抑制し、N-cadherinなどの間葉系マーカーの発現を転写レベルで促進させ、癌細胞が細胞間接着を喪失し、高い運動性や浸潤能を獲得し、局所浸潤や他臓器転移をもたらすとされている。膵癌のEMTについての研究は、癌の浸潤・転移のメカニズムの理解につながり、膵癌の新規診断・治療法に寄与するものと思われる。(著者抄録)

    researchmap

  • NK/T-cell lymphoma of bilateral adrenal glands in a patient with pyothorax. 国際誌

    Tomohide Tsukahara, Akira Takasawa, Masaki Murata, Kazuyoshi Okumura, Masato Nakayama, Noriyuki Sato, Tadashi Hasegawa

    Diagnostic pathology   7   114 - 114   2012年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Primary lymphoma of adrenal glands is rare, and non-B-cell lymphoma associated with pyothorax is also very rare. Here we report the first autopsy case of non-B-cell lymphoma in bilateral adrenal glands of a 79-year-old woman with pyothorax who had an aggressive clinical course. Immunohistochemically, tumor cells showed CD3+, CD45RO+, CD5-, CD7-, CD4-, CD8-, CD10-, CD20-, CD30-, CD79a-, CD138-, CD56-, granzyme B-, TIA-1+ and ALK-. In addition, tumor cells were strongly EBER1-positive by in situ hybridization. In genomic DNA of tumor cells, T-cell receptor rearrangements were not detected by southern blotting. We finally diagnosed this case as extranodal NK/T-cell lymphoma (nasal type). Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/8050621197741854.

    DOI: 10.1186/1746-1596-7-114

    PubMed

    researchmap

  • Epidermal growth factor modulates claudins and tight junctional functions in ovarian cancer cell lines. 国際誌

    Marie Ogawa, Takashi Kojima, Masayuki Someya, Kazuaki Nomura, Akira Takasawa, Masaki Murata, Satoshi Tanaka, Tsuyoshi Saito, Norimasa Sawada

    Histochemistry and cell biology   138 ( 2 )   323 - 38   2012年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Ovarian adenocarcinomas, like human ovarian surface epithelial cells, form functional tight junctions. Tight junction molecules claudin-3 and claudin-4, which are the receptors of Clostridium perfringens enterotoxin (CPE), are abnormally upregulated in epithelial ovarian cancers of all subtypes including, mucinous cystadenocarcinoma and serous cystadenocarcinoma. Clostridium perfringens enterotoxin may be a novel tumor-targeted therapy for ovarian cancers. In epithelial ovarian cancers, overexpression of epidermal growth factor receptor has been observed and the exogenous ligand EGF induces epithelial-mesenchymal transition in ovarian surface epithelium. Epidermal growth factor (EGF) signaling modulates expression of claudins with changes of fence and barrier functions in various cell types. However, the regulation of tight junctions by EGF in ovarian cancers remains unclear. In the present study, to investigate the mechanisms of the regulation of tight junctions in ovarian cancers, ovarian cancer cell lines mucinous cystadenocarcinoma (MCAS) and serous cystadenocarcinoma (HUOA) were treated with EGF. Epidermal growth factor downregulated claudin-3 in MCAS and claudin-4 in HUOA by inducing degradation of the proteins with changes in structures and functions of tight junctions via the MEK/ERK or PI3K/Akt signaling pathway. In addition, in HUOA but not MCAS, EGF downregulated the cytotoxic effect of CPE via claudin-4. Thus, there were different mechanisms for regulation of claudins by EGF between subtypes of epithelial ovarian cancer cells in vitro. These results indicate that EGF may affect claudins and tight junctional functions in ovarian cancer cells during cancer progression.

    DOI: 10.1007/s00418-012-0956-x

    PubMed

    researchmap

  • Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer. 国際誌

    Toshihiro Maeda, Masaki Murata, Hideki Chiba, Akira Takasawa, Satoshi Tanaka, Takashi Kojima, Naoya Masumori, Taiji Tsukamoto, Norimasa Sawada

    The Prostate   72 ( 4 )   351 - 60   2012年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Clostridium perfringens enterotoxin (CPE) triggers lysis of epithelial cells through binding to tight-junction proteins claudin-3 (Cldn3) and Cldn4, which are over-expressed in prostate cancer. We investigated the potential of Cldn-targeted therapy using CPE. METHODS: We investigated the expression levels and subcellular localization of Cldn3 and Cldn4 in primary human prostate cancer tissues, human prostate cancer cell lines (22Rv1, DU145, and PC3) and normal human prostate epithelial cells (PrECs). Cytotoxic effects of CPE on these cells were examined by colorimetric assay. We studied whether knockdown of Cldn3 and/or Cldn4 expression using RNA interference influenced CPE-mediated cytotoxicity. The therapeutic effect of CPE was evaluated in PC3 xenografts in athymic mice. RESULTS: Cldn4 and Cldn3 were expressed in primary human prostate cancer tissues, 22Rv1, DU145, and PC3. Cldn4 protein was expressed in PrEC. Cldn4 was distributed along whole cell membranes of the cancer cell lines, whereas it was localized at tight junctions in PrEC. CPE-mediated cytotoxicity was greatly detected in PC3, but was hardly detectable in PrEC. Reduced expression of Cldn4, but not Cldn3, led to remarkable decreases of cytotoxicity in both PC3 and 22Rv1. The injection of CPE around PC3 xenografts significantly suppressed tumor growth. CONCLUSION: CPE-mediated cytotoxicity was observed in human prostate cancer cell lines, but barely detected in normal human PrECs. The cytotoxic effect depended not only on the expression level of Cldn4 protein but also on its subcellular localization. These results suggest that Cldn4-targeted therapy using CPE may be a new treatment for prostate cancer.

    DOI: 10.1002/pros.21436

    PubMed

    researchmap

  • An undifferentiated embryonal sarcoma of the liver containing adipophilin-positive vesicles in an adult with massive sinusoidal invasion. 国際誌

    Satoshi Tanaka, Akira Takasawa, Yuichiro Fukasawa, Tadashi Hasegawa, Norimasa Sawada

    International journal of clinical and experimental pathology   5 ( 8 )   824 - 9   2012年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Undifferentiated embryonal sarcoma of the liver (UESL) is a malignant mesenchymal tumor that occurs typically in children and rarely in adults. Here we describe a case of UESL in a 51-year-old woman who presented with a cystic lesion in the liver. Because it grew slowly, the anterior segment of the liver was resected to check the lesion. Histologically, the lesion looked like a telangiectatic hepatic adenoma. Two years after resection, the tumor recurred, and she died 3 years later due to liver failure. The autopsy revealed that these lesions were UESL with massive sinusoidal invasion, and a review of the case indicated the primary lesion was also UESL. We also confirmed these tumor cells by staining with CD56, alpha-smooth muscle actin (SMA), and adipophilin, suggesting that they have a character similar to that of stellate cells in the space of Disse. The histological result of our patient revealed atypical UESL. Therefore, UESL should be considered when a hepatic lesion with degeneration is seen, even in an adult. In addition, the immunohistochemical appearance of this case implies that UESL is perhaps derived from stellate cells or stellate cells with myofibroblast differentiation in the space of Disse.

    PubMed

    researchmap

  • Protein kinase Cα inhibitor enhances the sensitivity of human pancreatic cancer HPAC cells to Clostridium perfringens enterotoxin via claudin-4. 国際誌

    Daisuke Kyuno, Takashi Kojima, Tatsuya Ito, Hiroshi Yamaguchi, Mitsuhiro Tsujiwaki, Akira Takasawa, Masaki Murata, Satoshi Tanaka, Koichi Hirata, Norimasa Sawada

    Cell and tissue research   346 ( 3 )   369 - 81   2011年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Protein kinase C (PKC) is overexpressed in cancer, including pancreatic cancer, compared with normal tissue. Moreover, PKCα is considered one of the biomarkers for the diagnosis of cancers. In several human cancers, the claudin tight junction molecules are abnormally regulated and are thus promising molecular targets for diagnosis and therapy with Clostridium perfringens enterotoxin (CPE). In order to investigate the changes of tight junction functions of claudins via PKCα activation in pancreatic cancer cells, the well-differentiated human pancreatic cancer cell line HPAC, with its highly expressed tight junction molecules and well-developed barrier function, was treated with the PKC activator 12-O-tetradecanoylphorbol 13-acetate (TPA). Treatment with TPA modified the activity of phosphoPKCα and caused an increase of the Snail family members Snail, Slug and Smad-interacting protein 1 and a decrease of E-cadherin. In HPAC cells treated with TPA, downregulation of claudin-1 and mislocalization of claudin-4 and occludin around the nuclei were observed, together with a decrease in the numbers of tight junction strands and an increase in phosphorylation of claudin-4. The barrier function and the cytotoxicity of CPE were significantly decreased on TPA treatment. All such changes after TPA treatment were prevented by inhibitors of panPKC and PKCα. These findings suggest that, in human pancreatic cancer cells, PKCα activation downregulates tight junction functions as a barrier and as a receptor of CPE via the modification of claudin-1 and -4 during epithelial to mesenchymal transition-like changes. PKCα inhibitors might represent potential therapeutic agents against human pancreatic cancer cells by use of CPE cytotoxicity via claudin-4.

    DOI: 10.1007/s00441-011-1287-2

    PubMed

    researchmap

  • Downregulation of tight junction-associated MARVEL protein marvelD3 during epithelial-mesenchymal transition in human pancreatic cancer cells. 国際誌

    Takashi Kojima, Akira Takasawa, Daisuke Kyuno, Tatsuya Ito, Hiroshi Yamaguchi, Koichi Hirata, Mitsuhiro Tsujiwaki, Masaki Murata, Satoshi Tanaka, Norimasa Sawada

    Experimental cell research   317 ( 16 )   2288 - 98   2011年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The novel tight junction protein marvelD3 contains a conserved MARVEL (MAL and related proteins for vesicle trafficking and membrane link) domain like occludin and tricellulin. However, little is yet known about the detailed role and regulation of marvelD3 in normal epithelial cells and cancer cells, including pancreatic cancer. In the present study, we investigated marvelD3 expression in well and poorly differentiated human pancreatic cancer cell lines and normal pancreatic duct epithelial cells in which the hTERT gene was introduced into human pancreatic duct epithelial cells in primary culture, and the changes of marvelD3 during Snail-induced epithelial-mesenchymal transition (EMT) under hypoxia, TGF-β treatment and knockdown of FOXA2 in well differentiated pancreatic cancer HPAC cells. MarvelD3 was transcriptionally downregulated in poorly differentiated pancreatic cancer cells and during Snail-induced EMT of pancreatic cancer cells in which Snail was highly expressed and the fence function downregulated, whereas it was maintained in well differentiated human pancreatic cancer cells and normal pancreatic duct epithelial cells. Depletion of marvelD3 by siRNAs in HPAC cells resulted in downregulation of barrier functions indicated as a decrease in transepithelial electric resistance and an increase of permeability to fluorescent dextran tracers, whereas it did not affect fence function of tight junctions. In conclusion, marvelD3 is transcriptionally downregulated in Snail-induced EMT during the progression for the pancreatic cancer.

    DOI: 10.1016/j.yexcr.2011.06.020

    PubMed

    researchmap

  • A nuclear factor-κB signaling pathway via protein kinase C δ regulates replication of respiratory syncytial virus in polarized normal human nasal epithelial cells. 国際誌

    Tomoyuki Masaki, Takashi Kojima, Tamaki Okabayashi, Noriko Ogasawara, Tsuyoshi Ohkuni, Kazufumi Obata, Akira Takasawa, Masaki Murata, Satoshi Tanaka, Satoshi Hirakawa, Jun Fuchimoto, Takafumi Ninomiya, Nobuhiro Fujii, Hiroyuki Tsutsumi, Tetsuo Himi, Norimasa Sawada

    Molecular biology of the cell   22 ( 13 )   2144 - 56   2011年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Respiratory syncytial virus (RSV) is the major cause of bronchitis, asthma, and severe lower respiratory tract disease in infants and young children. The airway epithelium, which has a well-developed barrier regulated by tight junctions, is the first line of defense during respiratory virus infection. In upper airway human nasal epithelial cells (HNECs), however, the primary site of RSV infection, the mechanisms of replication and budding of RSV, and the epithelial cell responses, including the tight junctional barrier, remain unknown. To investigate the detailed mechanisms of replication and budding of RSV in HNECs and the epithelial cell responses, we established an RSV-infected model using human telomerase reverse transcriptase--transfected HNECs. We first found that the expression and barrier function of tight junction molecules claudin-4 and occludin were markedly induced together with production of proinflammatory cytokines interleukin 8 and tumor necrosis factor-α in HNECs after RSV infection, and the induction of tight junction molecules possibly contributed to budding of RSV. Furthermore, the replication and budding of RSV and the epithelial cell responses in HNECs were regulated via a protein kinase C δ/hypoxia-inducible factor-1α/nuclear factor-κB pathway. The control of this pathway in HNECs may be useful not only for prevention of replication and budding of RSV, but also in therapy for RSV-induced respiratory pathogenesis.

    DOI: 10.1091/mbc.E10-11-0875

    PubMed

    researchmap

  • Transcriptional regulation of claudin-18 via specific protein kinase C signaling pathways and modification of DNA methylation in human pancreatic cancer cells. 国際誌

    Tatsuya Ito, Takashi Kojima, Hiroshi Yamaguchi, Daisuke Kyuno, Yasutoshi Kimura, Masafumi Imamura, Akira Takasawa, Masaki Murata, Satoshi Tanaka, Koichi Hirata, Norimasa Sawada

    Journal of cellular biochemistry   112 ( 7 )   1761 - 72   2011年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Since claudin-18 (Cldn18) is overexpressed in precursor lesion PanIN and pancreatic duct carcinoma, it serves as a diagnostic marker and a target of immunotherapy. The stomach isoform of Cldn18, Cldn18a2 is regulated via a PKC/MAPK/AP-1-dependent pathway in PKC activator 12-O-tetradecanoylphorbol 13-acetate (TPA)-stimulated gastric cancer cells. However, little is known about how Cldn18 is regulated, not only in pancreatic duct carcinoma but also in normal human pancreatic duct epithelial cells (HPDE cells). In the present study, four pancreatic cancer cell lines, HPAF-II, HPAC, PANC-1 and BXPC3, and hTERT-HPDE cells in which the hTERT gene was introduced into HPDE cells in primary culture, were treated with TPA. In all human pancreatic cancer cell lines and hTERT-HPDE cells, Cldn18 mRNA indicated as Cldn18a2 was markedly induced by TPA and in well- or moderately differentiated human pancreatic cancer cells HPAF-II and HPAC and hTERT-HPDE cells, the protein was also strongly increased. The upregulation of Cldn18 by TPA in human pancreatic cancer cell lines was prevented by inhibitors of PKCδ, PKCε, and PKCα, whereas the upregulation of Cldn18 by TPA in hTERT-HPDE cells was prevented by inhibitors of PKCδ, PKCθ, and PKCα. Furthermore, a CpG island was identified within the coding sequence of the Cldn18 gene and treatment with the demethylating agent 5-azadeoxycytidine enhanced upregulation of Cldn18 by TPA in HPAF-II and HPAC, but not hTERT-HPDE cells. Our findings suggest that in human pancreatic cancer cells, Cldn18 is primarily regulated at the transcriptional level via specific PKC signaling pathways and modified by DNA methylation.

    DOI: 10.1002/jcb.23095

    PubMed

    researchmap

  • c-Jun N-terminal kinase is largely involved in the regulation of tricellular tight junctions via tricellulin in human pancreatic duct epithelial cells. 国際誌

    Takashi Kojima, Jun Fuchimoto, Hiroshi Yamaguchi, Tatsuya Ito, Akira Takasawa, Takafumi Ninomiya, Shin Kikuchi, Noriko Ogasawara, Tsuyoshi Ohkuni, Tomoyuki Masaki, Koichi Hirata, Tetsuo Himi, Norimasa Sawada

    Journal of cellular physiology   225 ( 3 )   720 - 33   2010年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Tricellulin (TRIC) is a tight junction protein at tricellular contacts where three epithelial cells meet, and it is required for the maintenance of the epithelial barrier. To investigate whether TRIC is regulated via a c-Jun N-terminal kinase (JNK) pathway, human pancreatic HPAC cells, highly expressed at tricellular contacts, were exposed to various stimuli such as the JNK activators anisomycin and 12-O-tetradecanoylphorbol 13-acetate (TPA), and the proinflammatory cytokines IL-1β, TNFα, and IL-1α. TRIC expression and the barrier function were moderated by treatment with the JNK activator anisomycin, and suppressed not only by inhibitors of JNK and PKC but also by siRNAs of TRIC. TRIC expression was induced by treatment with the PKC activator TPA and proinflammatory cytokines IL-1β, TNFα, and IL-1α, whereas the changes were inhibited by a JNK inhibitor. Furthermore, in normal human pancreatic duct epithelial cells using hTERT-transfected primary cultured cells, the responses of TRIC expression to the various stimuli were similar to those in HPAC cells. TRIC expression in tricellular tight junctions is strongly regulated together with the barrier function via the JNK transduction pathway. These findings suggest that JNK may be involved in the regulation of tricellular tight junctions including TRIC expression and the barrier function during normal remodeling of epithelial cells, and prevent disruption of the epithelial barrier in inflammation and other disorders in pancreatic duct epithelial cells.

    DOI: 10.1002/jcp.22273

    PubMed

    researchmap

  • 原発性肺癌と胸膜悪性中皮腫の合併症例における遺伝子発現に関する検討(Array-based analysis of a collision tumor composed of malignant pleural mesothelioma and primary lung cancer) 査読

    田畑 佑希子, 高澤 啓, 畑中 豊, 久保田 佳奈子, 羽賀 博典, 樋田 泰浩, 松野 吉宏

    日本癌学会総会記事   69回   453 - 454   2010年8月

     詳細を見る

    記述言語:英語   出版者・発行元:日本癌学会  

    researchmap

  • タクロリムス投与中に間質性肺炎により死の転帰をとった関節リウマチ患者の剖検2症例の検討

    神田 直, 竹田 剛, 栗田 崇史, 菊池 英明, 高澤 啓, 菊地 慶介

    臨床リウマチ   21 ( 4 )   334 - 340   2009年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本臨床リウマチ学会  

    症例1(70歳女性)。35年前に関節リウマチ(RA)発症、他院でステロイド薬が投与されていた。3年前より著者らの施設で種々の抗リウマチ薬を投与するも改善さず、タクロリムス投与を開始したが、約3ヵ月後、労作時呼吸困難の出現で入院となった。諸検査でタクロリムスによる薬剤性間質性肺炎と診断され、ステロイド増量、ステロイドパルス療法を行ったが、第12病日目に死亡となった。症例2(71歳女性)。3年前にRA発症、1年前より間質性肺炎でPSLが投与されていた。今回、タクロリムス投与開始から約3週後に呼吸困難が増悪し、無菌性肺炎の診断で抗生剤にて軽快するも、1週間後に再発、入院となった。諸検査でタクロリムスによる間質性肺炎の増悪と診断され、ステロイドパルス療法が行なわれたが第15病目に死亡となった。尚、両症例とも剖検では通常型間質性肺炎を背景に器質化期のびまん性肺胞障害が確認された。

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2009&ichushi_jid=J02269&link_issn=&doc_id=20100118120007&doc_link_id=10.14961%2Fcra.21.334&url=https%3A%2F%2Fdoi.org%2F10.14961%2Fcra.21.334&type=J-STAGE&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00007_3.gif

  • Mutation-, aging-, and gene dosage-dependent accumulation of neuroserpin (G392E) in endoplasmic reticula and lysosomes of neurons in transgenic mice. 国際誌

    Akira Takasawa, Ichiro Kato, Kumi Takasawa, Yoko Ishii, Toshiko Yoshida, Mohammad H Shehata, Hiroshi Kawaguchi, Omar M M Mohafez, Masakiyo Sasahara, Koichi Hiraga

    The Journal of biological chemistry   283 ( 51 )   35606 - 13   2008年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Mutations in human neuroserpin gene cause an autosomal dementia, familial encephalopathy with neuroserpin inclusion bodies (FENIB). We generated and analyzed transgenic mice expressing high levels of either FENIB-type (G392E) or wild-type human neuroserpin in neurons of the central nervous system. G392E neuroserpin accumulated age-dependently in neurons of the neocortex, thalamus, amygdala, pons, and spinal cord of homozygous transgenic mice. Such accumulations were not observed in hemizygous transgenic mice nor in transgenic mice for wild-type neuroserpin. In differential centrifugation of brain homogenates, G392E neuroserpin recovered in the nucleus-rich fraction dramatically increased along with aging, suggesting that the aggregations gradually increase their densities presumably by their conversion into heavier and more compact configurations. In immunoelectron microscopical analyses, immunopositivities for G392E neuroserpin were found not only in endoplasmic reticulum but also in lysosomes. G392E neuroserpin transgenic mice were much more susceptible to seizures induced by kainate administration than nontransgenic mice. Overall, G392E neuroserpin accumulated in the central nervous system neurons of transgenic mice in mutation-, aging-, and gene dosage-dependent manners. The established transgenic mice will be valuable to elucidate not only mechanisms for the formation of G392E neuroserpin aggregations but also pathways for the degradation and/or clearance of the already formed aggregations in neurons.

    DOI: 10.1074/jbc.M804125200

    PubMed

    researchmap

  • Hepatic iron accumulation is not directly associated with induction of DNA strand breaks in the liver cells of Long-Evans Cinnamon (LEC) rats.

    Masanobu Hayashi, Tomoko Kuge, Daiji Endoh, Kenji Nakayama, Jiro Arikawa, Akira Takazawa, Toyo Okui

    Experimental animals   51 ( 1 )   43 - 8   2002年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Effects of accumulation of copper and iron on induction of DNA strand breaks were investigated in Long-Evans Cinnamon (LEC) rats that spontaneously develop fulminant hepatitis. Copper and iron accumulated in the liver of LEC rats in an age-dependent manner from 4 to 15 weeks. Low-iron diet prevented the accumulation of iron in the liver, but did not prevent accumulation of copper. The amounts of DNA strand breaks that were estimated by comet assay in the liver cells of rats fed standard diet increased with age from 4 to 15 weeks. No significant differences were observed in the proportions of LEC rat liver cells without tail and the average lengths of tail momentum in the comet images between LEC rats that had been fed standard MF diet and low-iron diet. These results support the idea that accumulation of iron is not directly associated with the induction of DNA damage in the liver cells of LEC rats.

    PubMed

    researchmap

  • No significant differences were observed in the amounts of DNA strand breaks produced by copper between male and female liver cells of long-evans cinnamon (LEC) strain rats.

    M Hayashi, T Kuge, D Endoh, K Nakayama, J Arikawa, A Takazawa, T Okui

    The Journal of veterinary medical science   63 ( 10 )   1109 - 13   2001年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The amounts of DNA single strand breaks that are oxidative damage produced by copper were examined by comet assay in the liver cells of an inbred strain of Long-Evans Cinnamon (LEC) rats that spontaneously develops fulminant hepatitis. At 4 weeks of age, copper contents in the liver of LEC rats were approximately 30-fold higher than those of WKAH rats that are control rats used in the present study. Copper accumulated in the liver of LEC rats in an age-dependent manner and no significant differences were observed between copper contents in the livers of males and females at each week of age from 4 to 15 weeks. No significant amounts of DNA strand breaks were found in the liver cells of both male and female WKAH rats from 4 to 15 weeks of age. DNA strand breaks were produced in the substantial population of LEC rat liver cells at 10 weeks of age and induced in an age-dependent manner from 10 to 15 weeks of age. The amounts of DNA strand breaks produced by copper accumulation in the liver cells of female LEC rats are not more abundant than those in the cells of male rats, although it has been reported that hepatitis in female rats is more serious than that in male rats.

    PubMed

    researchmap

  • Cu-metallothioneins (Cu(I)8-MTs) in LEC rat livers 13 weeks after birth still act as antioxidants. 国際誌

    N Shishido, K Nakayama, A Takazawa, T Ohyama, M Nakamura

    Archives of biochemistry and biophysics   387 ( 2 )   216 - 22   2001年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Redox properties of metallothioneins (MTs) and Cu in the cytosol from Long-Evans Cinnamon (LEC) rat livers 13 weeks after birth were investigated. MTs from LEC rat livers contain 8 g atoms of Cu and 1 g atom of Zn per mole of protein (Cu(I)8-MTs). Titration of Cu(I)8-MTs with CuCl2 indicates that Cu(I)8-MTs were able to reduce further 2-g atoms of cupric ions per mole MTs as bound form. Hg2+-induced hydroxyl radical generation from Cu(I)8-MTs was demonstrated by ESR using the spin trap, 5,5-dimethyl-1-pyrroline N-oxide (DMPO). The intensity of DMPO-OH signal from Cu-loaded MTs was increased with the increasing number of Cu in MTs. The used cytosol fraction contained 1.37 mM total Cu and 5 mM DTNB titrable-SH groups has a potential to reduce 2 mM CuCl2. No ESR signal due to Cu2+ was also detected with LEC rat liver cytosol, whereas strong Cu2+ signal appeared by the addition of HgCl2. The rate constants for the reaction of Cu(I)8-MTs with superoxide and hydroxyl radicals were estimated to be 2 x 10(6) and > or = 10(12) M(-1)s(-1), respectively, from competition kinetics. Cu2+-catalyzed oxidation of DNA was strongly inhibited both in the presence of Cu-unsaturated MTs and GSH. The results suggest that Cu(I)8-MTs from LEC rat livers just before hepatitis still act as antioxidants.

    PubMed

    researchmap

  • Hepatic copper accumulation induces DNA strand breaks in the liver cells of Long-Evans Cinnamon strain rats. 国際誌

    M Hayashi, T Kuge, D Endoh, K Nakayama, J Arikawa, A Takazawa, T Okui

    Biochemical and biophysical research communications   276 ( 1 )   174 - 8   2000年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Effects of accumulation of copper and iron on the production of DNA strand breaks were investigated in Long-Evans Cinnamon (LEC) strain rats that spontaneously develop fulminant hepatitis. Copper and iron accumulated in the liver of LEC rats in an age-dependent manner from 4 to 15 weeks. Low-copper food prevented the accumulation of copper in the liver, but did not prevent accumulation of iron. When the amounts of DNA single strand breaks were estimated by comet assay, the number of DNA strand breaks in the liver cells of rats fed standard food increased with age from 4 to 15 weeks. The number of DNA strand breaks in the liver cells from rats fed low-copper food were the same as those of rats at 4 weeks of age. Thus, the copper accumulation in the liver of LEC rats induced DNA strand breaks, but accumulation of iron did not.

    PubMed

    researchmap

  • Spontaneous porphyria of the Long-evans cinnamon rat: an animal model of Wilson's disease. 国際誌

    K Nakayama, A Takasawa, I Terai, T Okui, T Ohyama, M Tamura

    Archives of biochemistry and biophysics   375 ( 2 )   240 - 50   2000年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    To confirm and extend our previous microspectrophotometric observations of 30-week-old male Long-Evans Cinnamon (LEC) rats, an animal model of human Wilson's disease, we analyzed the porphyrin patterns of the organs, urine, and plasma of LEC rats. Abnormal accumulation of porphyrins, especially highly carboxylated porphyrins (uro- and heptaporphyrin), in the kidneys and liver was seen in male and female LEC rats aged 30 weeks and also in 10-week-old rats, before the onset of spontaneous hepatic dysfunction. Accumulation of copper and iron in the kidneys was not observed in the 10-week-old rats. Massive accumulation of porphyrins was observed only in the kidneys of the 30-week-old male LEC rat, indicating that this symptom is related to sex and age. Renal accumulation of porphyrins was reflected in the rate of urinary porphyrin excretion. Hepatic accumulation of porphyrins appeared to be independent of sex and age. These results indicate that neither renal nor hepatic porphyrin accumulation is the result of renal deposition of metals or of spontaneous hepatic dysfunction and that porphyrinuria in the LEC rat is closely related to the renal accumulation of porphyrins. In contrast to these organs, a reduction in the porphyrin levels was observed in the brain of the LEC rat. This was independent of sex and age. The present work stresses the existence of an abnormal heme metabolism in the LEC rat, and thus, the necessity to study the heme metabolism in human Wilson's disease is strongly suggested.

    PubMed

    researchmap

  • 肝炎発症前のLECラット肝でも,銅メタロチオネイン(Cu(I)8-MTs)は抗酸化的に働く 査読

    宍戸 直美, 中山 憲司, 高澤 啓, 大山 徹, 中村 正雄

    磁気共鳴と医学   11   131 - 134   2000年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)日本医学館  

    雑誌掲載版

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2001217161

  • ヒト・ウイルソン病モデル動物におけるポルフィリン代謝異常

    高澤 啓, 中山 憲司, 寺井 格, 奥井 登代, 大山 徹, 田村 守

    ポルフィリン   8 ( 1 )   17 - 22   1999年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:ポルフィリン研究会事務局  

    researchmap

  • Synthesis and redox properties of amino acid-bridged dinuclear iron(III) complexes

    Keisuke Umakoshi, Yasuhiro Tsuruma, Chang Eon Oh, Akira Takasawa, Hana Yasukawa, Yoichi Sasaki

    Bulletin of the Chemical Society of Japan   72 ( 3 )   433 - 440   1999年3月

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    A series of dinuclear iron(III)complexes with μ-O,O'-bridging amino acids (as zwitter ionic forms) have been prepared: [Fe2(μ-O)(μ-amino acid)(tpa)2](ClO4)4 (tpa = tris(2-pyridylmethyl)amine; amino acid = L- valine (1), L-proline (2), L-alanine (3), L-tyrosine (4), L-tryptophan (5), L-phenylalanine (6), L-alanyl-L-alanine (7)). Among them, 1, 2, and 7 were structurally characterized at 163 K. The non-equivalent ligating mode of the two tpa ligands is common to all the three complexes. The amino acid bridged complexes exhibit irreversible one electron reduction waves, with splitting or accompanying shoulders. The bulk electrolysis of these complexes confirmed that the total number of electrons involved in the reduction is one; i.e. Fe2(III, III) → Fe2(II, III). Addition of acid or base leaves positive or negative components, respectively, of the splitting wave. This phenomenon was interpreted as a proton coupled electron transfer where the protonated and deprotonated amino acid bridged species are reduced at different potentials. Magnetic susceptibility measurements in the temperature range, 2-300 K, revealed antiferromagnetic coupling with J = -116, -129, -120, -120, and - 129 cm-1 for 1, 2, 4, 6, and 7, respectively (H = -2JS1·S2; S1 = S2 = 5/2).

    DOI: 10.1246/bcsj.72.433

    Scopus

    researchmap

  • Abnormal accumulation of porphyrin derivatives in the kidneys of Long-Evans Cinnamon rats, as evidenced by microspectrophotometry. 国際誌

    K Nakayama, A Takasawa, T Ohyama, M Tamura

    Biochemical and biophysical research communications   242 ( 1 )   164 - 9   1998年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    In the study described here we have revealed an abnormal accumulation of porphyrin derivatives in the kidneys of Long-Evans Cinnamon (LEC) rats, an animal model for human Wilson's disease. In addition, we have confirmed that the derivatives emitted red-orange light in renal sections under UV excitation. This renal red-orange emission has previously been identified as luminescence from cuprous metallothioneins [Cu(I)-MTs], which also accumulate in both the kidneys and liver of LEC rats. In this study, we measured the emission spectra of the luminescence in the kidneys using microspectrophotometry. The spectra of the renal red-orange emission resembled those of porphyrin derivatives rather than those of Cu(I)-MTs. We then extracted these derivatives from the kidneys. An abundance of porphyrin derivatives was established. A significant increase in the levels of the derivatives in the liver and urine of the LEC rats was also confirmed. These results provide evidence of a heme-metabolism abnormality in LEC rats.

    PubMed

    researchmap

▼全件表示

書籍等出版物

  • WHO血液腫瘍分類 : WHO分類2008をうまく活用するために

    直江, 知樹

    医薬ジャーナル社  2010年2月  ( ISBN:9784753224265

     詳細を見る

    総ページ数:v, viii, 587p   記述言語:日本語  

    CiNii Books

    researchmap

MISC

  • 膵癌患者の予後と癌進展におけるJAM-Aの役割(Junctional Adhesion Molecule-A may play a role in the progression of pancreatic cancer)

    及能 大輔, 高澤 啓, 高澤 久美, 真柄 和史, 小山内 誠

    日本癌学会総会記事   81回   J - 2053   2022年9月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本癌学会  

    researchmap

  • タイト結合分子JAM-Aの異常高発現が乳がんの悪性化に関与する(Elevated expression of JAM-A contributes malignant progression of breast cancer)

    真柄 和史, 高澤 啓, 高澤 久美, 及能 大輔, 小山内 誠

    日本癌学会総会記事   81回   P - 3247   2022年9月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本癌学会  

    researchmap

  • 免疫チェックポイント阻害薬による偽増悪および免疫関連有害事象を併発した肺多形癌の一剖検例

    多田 聡法, 真柄 和史, 高澤 啓, 久保田 雄策, 小野 佑輔, 及能 大輔, 高澤 久美, 廣橋 良彦, 小山内 誠

    日本病理学会会誌   111 ( 1 )   357 - 358   2022年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 両側肺の壊死組織周囲への黒色色素、シュウ酸カルシウム結晶の沈着をともなった深在性真菌症の一剖検例

    久保田 雄策, 小野 佑輔, 高澤 啓, 多田 聡法, 真柄 和史, 青山 智志, 及能 大輔, 高澤 久美, 小山内 誠

    日本病理学会会誌   111 ( 1 )   357 - 357   2022年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 舌扁平上皮癌におけるPVR発現とその意義

    永井 佐和, 高澤 啓, 永井 美佐, 仲盛 優菜, 小野 佑輔, 真柄 和史, 及能 大輔, 高澤 久美, 村田 雅樹, 小山内 誠

    日本病理学会会誌   111 ( 1 )   354 - 354   2022年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • ビタミンD代謝酵素CYP24A1は乳癌に対する新規治療標的である

    紙谷 咲良, 仲盛 優菜, 真柄 和史, 小野 佑輔, 及能 大輔, 高澤 久美, 高澤 啓, 小山内 誠

    日本病理学会会誌   111 ( 1 )   354 - 354   2022年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 膵臓癌におけるALDOA発現とその意義

    永井 美佐, 小野 佑輔, 高澤 啓, 永井 佐和, 真柄 和史, 青山 智志, 及能 大輔, 高澤 久美, 小山内 誠

    日本病理学会会誌   111 ( 1 )   352 - 352   2022年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • レチノイン酸代謝酵素CYP26A1の異常発現は、膵癌細胞の悪性形質の促進に関与する

    井上 彩乃, 小野 佑輔, 高澤 啓, 及能 大輔, 真柄 和史, 青山 智志, 高澤 久美, 小山内 誠

    日本病理学会会誌   111 ( 1 )   351 - 352   2022年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 乳がんにおいてJAM-Aの異常高発現が悪性化に関与する

    真柄 和史, 高澤 啓, 高澤 久美, 小野 佑輔, 及能 大輔, 小山内 誠

    日本病理学会会誌   111 ( 1 )   284 - 284   2022年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • ビタミンD代謝酵素CYP24A1の発現様式は口腔扁平上皮がんにおける予後規定因子である

    仲盛 優菜, 紙谷 咲良, 真柄 和史, 小野 佑輔, 及能 大輔, 高澤 久美, 高澤 啓, 小山内 誠

    日本病理学会会誌   111 ( 1 )   278 - 279   2022年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 子宮頸部腺癌におけるJAM-A高発現はPVR/CD155と関連して癌悪性化に寄与する

    村上 太郎, 高澤 啓, 青山 智志, 小野 佑輔, 高澤 久美, 村田 雅樹, 小山内 誠

    日本病理学会会誌   111 ( 1 )   250 - 250   2022年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • タイト結合蛋白質Claudin-1は細胞接着、微絨毛形成を制御する

    高澤 啓, 高澤 久美, 青山 智志, 村上 太朗, 真柄 和史, 小野 佑輔, 及能 大輔, 小山内 誠

    日本病理学会会誌   111 ( 1 )   249 - 249   2022年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 膵癌におけるJAM-Aの機能

    及能 大輔, 高澤 啓, 高澤 久美, 小野 佑輔, 真柄 和史, 仲盛 優菜, 小山内 誠

    日本病理学会会誌   111 ( 1 )   239 - 239   2022年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 両側肺の壊死組織周囲への黒色色素、シュウ酸カルシウム結晶の沈着をともなった深在性真菌症の一剖検例

    久保田 雄策, 小野 佑輔, 高澤 啓, 多田 聡法, 真柄 和史, 青山 智志, 及能 大輔, 高澤 久美, 小山内 誠

    日本病理学会会誌   111 ( 1 )   357 - 357   2022年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 舌扁平上皮癌におけるPVR発現とその意義

    永井 佐和, 高澤 啓, 永井 美佐, 仲盛 優菜, 小野 佑輔, 真柄 和史, 及能 大輔, 高澤 久美, 村田 雅樹, 小山内 誠

    日本病理学会会誌   111 ( 1 )   354 - 354   2022年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • ビタミンD代謝酵素CYP24A1は乳癌に対する新規治療標的である

    紙谷 咲良, 仲盛 優菜, 真柄 和史, 小野 佑輔, 及能 大輔, 高澤 久美, 高澤 啓, 小山内 誠

    日本病理学会会誌   111 ( 1 )   354 - 354   2022年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 膵臓癌におけるALDOA発現とその意義

    永井 美佐, 小野 佑輔, 高澤 啓, 永井 佐和, 真柄 和史, 青山 智志, 及能 大輔, 高澤 久美, 小山内 誠

    日本病理学会会誌   111 ( 1 )   352 - 352   2022年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • レチノイン酸代謝酵素CYP26A1の異常発現は、膵癌細胞の悪性形質の促進に関与する

    井上 彩乃, 小野 佑輔, 高澤 啓, 及能 大輔, 真柄 和史, 青山 智志, 高澤 久美, 小山内 誠

    日本病理学会会誌   111 ( 1 )   351 - 352   2022年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 乳がんにおいてJAM-Aの異常高発現が悪性化に関与する

    真柄 和史, 高澤 啓, 高澤 久美, 小野 佑輔, 及能 大輔, 小山内 誠

    日本病理学会会誌   111 ( 1 )   284 - 284   2022年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • ビタミンD代謝酵素CYP24A1の発現様式は口腔扁平上皮がんにおける予後規定因子である

    仲盛 優菜, 紙谷 咲良, 真柄 和史, 小野 佑輔, 及能 大輔, 高澤 久美, 高澤 啓, 小山内 誠

    日本病理学会会誌   111 ( 1 )   278 - 279   2022年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • タイト結合蛋白質Claudin-1は細胞接着、微絨毛形成を制御する

    高澤 啓, 高澤 久美, 青山 智志, 村上 太朗, 真柄 和史, 小野 佑輔, 及能 大輔, 小山内 誠

    日本病理学会会誌   111 ( 1 )   249 - 249   2022年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 膵癌におけるJAM-Aの機能

    及能 大輔, 高澤 啓, 高澤 久美, 小野 佑輔, 真柄 和史, 仲盛 優菜, 小山内 誠

    日本病理学会会誌   111 ( 1 )   239 - 239   2022年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 免疫チェックポイント阻害薬による偽増悪および免疫関連有害事象を併発した肺多形癌の一剖検例

    多田 聡法, 真柄 和史, 高澤 啓, 久保田 雄策, 小野 佑輔, 及能 大輔, 高澤 久美, 廣橋 良彦, 小山内 誠

    日本病理学会会誌   111 ( 1 )   357 - 358   2022年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • Analysis of AEBP1 in the microenvironment of head and neck squamous cell carcinoma

    Shohei Sekiguchi, Akira Yorozu, Eiichiro Yamamoto, Takeshi Niinuma, Akira Takasawa, Gota Sudo, Kazushige Koike, Yui Hatanaka, Ayano Yoshido, Hiroshi Kitajima, Masahiro Kai, Makoto Osanai, Kenichi Takano, Akihiro Miyazaki, Hiromu Suzuki

    CANCER SCIENCE   113   1506 - 1506   2022年2月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:WILEY  

    Web of Science

    researchmap

  • 悪性末梢神経鞘腫のFFPE組織標本を用いた新規バイオマーカー探索の試み

    車野 晃大, 高澤 啓, 伊藤 祐衣, 桐澤 くらら, 青山 智志, 小野 祐輔, 高澤 久美, 及能 大輔, 小山内 誠

    日本病理学会会誌   110 ( 2 )   71 - 71   2021年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 活性化マクロファージはIL-1β-SAA1 axisを介して早期大腸がんの浸潤を促進する

    須藤 豪太, 山本 英一郎, 青木 敬則, 高澤 啓, 新沼 猛, 久保 俊之, 萬 顕, 吉戸 文乃, 北嶋 洋志, 甲斐 正広, 小山内 誠, 仲瀬 裕志, 鈴木 拓

    日本癌学会総会記事   80回   [P14 - 3]   2021年9月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本癌学会  

    researchmap

  • 頭頸部扁平上皮がんの腫瘍微小環境におけるAEBP1の解析

    関口 翔平, 萬 顕, 山本 英一郎, 新沼 猛, 高澤 啓, 須藤 豪太, 小池 和茂, 畠中 柚衣, 吉戸 文乃, 北嶋 洋志, 甲斐 正広, 小山内 誠, 高野 賢一, 宮崎 晃亘, 鈴木 拓

    日本癌学会総会記事   80回   [J14 - 5]   2021年9月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本癌学会  

    researchmap

  • 蛍光標識単球を用いた肝区域の可視化技術の開発

    及能 大輔, 高澤 啓, 高澤 久美, 小野 佑輔, 真柄 和史, 仲盛 優菜, 竹政 伊知朗, 小山内 誠

    日本癌学会総会記事   80回   [P14 - 3]   2021年9月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本癌学会  

    researchmap

  • Desmoplastic reactionの子宮頸部腺癌における予後バイオマーカーとしての可能性

    秋元 太志, 高澤 啓, 高澤 久美, 小山内 誠, 斉藤 豪

    日本癌学会総会記事   80回   [P14 - 4]   2021年9月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本癌学会  

    researchmap

  • SMOC1の大腸腫瘍診断マーカーとしての臨床的有用性の検討

    青木 敬則, 山本 英一郎, 高澤 啓, 新沼 猛, 山野 泰穂, 萬 顕, 北嶋 洋志, 甲斐 正広, 小山内 誠, 仲瀬 裕志, 菅井 有, 鈴木 拓

    日本癌学会総会記事   80回   [P14 - 4]   2021年9月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本癌学会  

    researchmap

  • 頭頸部扁平上皮癌の癌微小環境におけるAEBP1の解析

    萬 顕, 山本 圭佑, 小幡 和史, 大國 毅, 黒瀬 誠, 近藤 敦, 高澤 啓, 小島 隆, 鈴木 拓, 高野 賢一

    日本耳鼻咽喉科学会会報   124 ( 4 )   690 - 690   2021年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本耳鼻咽喉科頭頸部外科学会  

    researchmap

  • 卵巣甲状腺乳頭癌の1例

    太田 未咲, 岡村 直樹, 萬 和馬, 鈴木 利理, 田渕 雄大, 坂下 智博, 杉田 真太朗, 高澤 啓

    市立釧路総合病院医学雑誌   33 ( 1 )   59 - 62   2021年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:市立釧路総合病院  

    卵巣粘液性嚢胞癌を疑い、手術加療を行なったところ、術後病理組織検査で卵巣原発の甲状腺乳頭癌の診断となった1例を経験したので報告する。卵巣悪性腫瘍の中で甲状腺乳頭癌は非常に稀であり、臨床症状や画像所見から診断に至るのが困難である。その管理や予後予測に関しては今後さらなる症例の集積が求められる。(著者抄録)

    researchmap

  • 子宮頸部腺癌におけるclaudin-6発現とその意義

    伊藤祐衣, 伊藤祐衣, 高澤啓, 車野晃大, 車野晃大, 桐澤くらら, 桐澤くらら, 高澤久美, 青山智志, 青山智志, 小野祐輔, 及能大輔, 小山内誠

    日本病理学会会誌   110 ( 2 )   82 - 82   2021年

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    J-GLOBAL

    researchmap

  • レチノイン酸代謝酵素CYP26A1の発現は,乳がん組織のホルモンレセプター,HER2発現様式と関連する

    小野佑輔, 山本夏子, 高澤久美, 真柄和史, 青山智志, 及能大輔, 高澤啓, 小山内誠

    日本病理学会会誌   110 ( 1 )   323 - 323   2021年

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    J-GLOBAL

    researchmap

  • 血管内皮細胞のVEGFR2を介した肝蛍光発色技術の開発

    及能大輔, 及能大輔, 高澤啓, 真柄和史, 仲盛優菜, 小野佑輔, 高澤久美, 竹政伊知朗, 小山内誠

    日本病理学会会誌   110 ( 1 )   220 - 220   2021年

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    J-GLOBAL

    researchmap

  • 乳癌におけるJAM-Aの発現とその意義

    真柄和史, 高澤啓, 高澤久美, 青山智志, 小野佑輔, 及能大輔, 小山内誠

    日本病理学会会誌   110 ( 1 )   322 - 322   2021年

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    J-GLOBAL

    researchmap

  • 子宮頸部腺がんで高発現するGPR30/GPER1はがん悪性化に関与する

    高澤啓, 秋元太志, 高澤久美, 及能大輔, 小山内誠

    日本癌学会学術総会抄録集(Web)   80th   [P14 - 3]   2021年

     詳細を見る

    記述言語:英語  

    J-GLOBAL

    researchmap

  • 胆道癌におけるタイト結合分子claudin18の発現状態を利用した病理学的診断および根治切除後の予後予測への有用性

    及能大輔, 木村康利, 高澤啓, 計良淑子, 太田盛道, 永山稔, 今村将史, 西舘敏彦, 沖田憲司, 信岡隆幸, 小山内誠, 竹政伊知朗

    日本外科学会定期学術集会(Web)   121st   SF - 4   2021年

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本外科学会  

    J-GLOBAL

    researchmap

  • 乳癌におけるALDOAの発現とその病理学的意義

    桐澤くらら, 桐澤くらら, 高澤啓, 車野晃大, 車野晃大, 伊藤祐衣, 伊藤祐衣, 高澤久美, 青山智志, 青山智志, 小野祐輔, 及能大輔, 小山内誠

    日本病理学会会誌   110 ( 2 )   86 - 86   2021年

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    J-GLOBAL

    researchmap

  • SMOC1の大腸腫瘍診断マーカーとしての臨床的有用性の検討

    青木 敬則, 山本 英一郎, 高澤 啓, 新沼 猛, 山野 泰穂, 萬 顕, 北嶋 洋志, 甲斐 正広, 小山内 誠, 仲瀬 裕志, 菅井 有, 鈴木 拓

    日本癌学会総会記事   79回   PJ14 - 1   2020年10月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本癌学会  

    researchmap

  • 頭頸部扁平上皮がんの微小環境におけるAEBP1の解析

    萬 顕, 関口 翔平, 山本 英一郎, 新沼 猛, 高澤 啓, 須藤 豪太, 畠中 柚衣, 北嶋 洋志, 甲斐 正広, 小山内 誠, 宮崎 晃亘, 高野 賢一, 鈴木 拓

    日本癌学会総会記事   79回   PJ14 - 6   2020年10月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本癌学会  

    researchmap

  • 早期大腸がん浸潤先進部の分子解析

    須藤 豪太, 山本 英一郎, 青木 敬則, 高澤 啓, 新沼 猛, 久保 俊之, 萬 顕, 北嶋 洋志, 甲斐 正広, 小山内 誠, 仲瀬 裕志, 鈴木 拓

    日本癌学会総会記事   79回   PJ14 - 8   2020年10月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本癌学会  

    researchmap

  • 子宮頸部腺癌におけるタイト結合関連タンパク質JAM-Aの高発現は、癌悪性化に寄与する

    村上 太郎, 高澤 啓, 青山 智志, 小野 佑輔, 高澤 久美, 村田 雅樹, 小山内 誠

    日本病理学会会誌   109 ( 1 )   313 - 314   2020年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 子宮頸部腺がんにおける間質反応の臨床病理学的意義

    高澤 啓, 青山 智志, 小野 佑輔, 高澤 久美, 村田 雅樹, 小山内 誠

    日本病理学会会誌   109 ( 1 )   370 - 370   2020年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 悪性末梢神経鞘腫のFFPE組織標本を用いた新規バイオマーカー探索の試み

    車野 晃大, 伊藤 祐衣, 高澤 啓, 桐澤 くらら, 青山 智志, 小野 佑輔, 高澤 久美, 小山内 誠

    日本病理学会会誌   109 ( 1 )   498 - 498   2020年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 子宮頸部腺癌におけるタイト結合関連タンパク質claudin-6発現とその意義

    伊藤 祐衣, 高澤 啓, 桐澤 くらら, 車野 晃大, 青山 智志, 小野 佑輔, 高澤 久美, 小山内 誠

    日本病理学会会誌   109 ( 1 )   497 - 497   2020年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 乳癌におけるレチノイン酸代謝酵素CYP26A1発現の病理組織学的検討

    山本 夏子, 小野 佑輔, 青山 智志, 大門 史士, 高澤 久美, 高澤 啓, 小山内 誠

    日本病理学会会誌   109 ( 1 )   494 - 494   2020年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 乳癌におけるALDOAの発現とその病理学的意義

    桐澤 くらら, 高澤 啓, 伊藤 祐衣, 車野 晃大, 小野 佑輔, 青山 智志, 高澤 久美, 小山内 誠

    日本病理学会会誌   109 ( 1 )   494 - 494   2020年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 子宮頸部腺がんで高発現するALDOAはがん悪性化に関与する

    高澤啓, 高澤久美, 及能大輔, 小山内誠

    日本癌学会学術総会抄録集(Web)   79th   PJ14 - 5   2020年

     詳細を見る

    記述言語:英語  

    J-GLOBAL

    researchmap

  • 子宮頸部腺癌細胞で高発現するclaudin-1のタイト結合機能に関する役割解析

    高澤久美, 高澤啓, 青山智志, 北嶋洋志, 及能大輔, 小野佑輔, 村田雅樹, 小山内誠

    日本分子生物学会年会プログラム・要旨集(Web)   43rd   2020年

     詳細を見る

  • SMOC1の大腸腫瘍診断マーカーとしての臨床的有用性の検討(Clinical usefulness of SMOC1 as a diagnostic marker of colorectal precancerous lesions)

    青木 敬則, 山本 英一郎, 高澤 啓, 新沼 猛, 山野 泰穂, 萬 顕, 北嶋 洋志, 甲斐 正広, 小山内 誠, 仲瀬 裕志, 菅井 有, 鈴木 拓

    日本癌学会総会記事   78回   P - 1323   2019年9月

     詳細を見る

    記述言語:英語   出版者・発行元:日本癌学会  

    researchmap

  • 次世代につながる疾患診断・治療法の開発〜遺伝子診断法から創薬戦略まで〜 がんにおいて異常発現するタイト結合構成タンパク質の機能解析と治療標的としての可能性

    高澤 啓

    日本組織細胞化学会総会・学術集会講演プログラム・予稿集   60回   50 - 50   2019年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本組織細胞化学会  

    researchmap

  • 子宮頸部腺がんにおけるエストロゲン/GPR30を介したがん悪性化機構(Estrogen/GPR30 contributes to malignant potentials of uterine cervical adenocarcinoma via claudin-1 expression)

    高澤 啓, 高澤 久美, 小山内 誠

    日本癌学会総会記事   78回   P - 1153   2019年9月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本癌学会  

    researchmap

  • FFPE組織を用いたプロテオミクスによる脂肪肉腫診断マーカーの探索

    青山 智志, 高澤 啓, 小野 祐輔, 長谷川 匡, 小山内 誠

    JSBMS Letters   44 ( Suppl. )   106 - 106   2019年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本医用マススペクトル学会  

    researchmap

  • 精巣腫瘍として発症したnon-cutaneous BPDCNの一例

    守田 玲菜, 高澤 啓, 伊藤 夢美香, 辻脇 光洋, 中津川 宗秀, 森田 研, 立野 正敏, 小山内 誠, 松野 吉宏, 平野 博嗣

    日本リンパ網内系学会会誌   59   136 - 136   2019年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本リンパ網内系学会  

    researchmap

  • タイト結合関連タンパク質JAM-Aは子宮頸部腺癌で高発現し、癌悪性化に寄与する

    村上 太郎, 高澤 啓, 青山 智志, 小野 佑輔, 高澤 久美, 村田 雅樹, 小山内 誠

    日本病理学会会誌   108 ( 1 )   460 - 460   2019年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • Vasculogenic mimicryが見られたGIST(gastrointestinal stromal tumor)の一例

    佐藤 みどり, 小山内 誠, 小野 佑輔, 高澤 啓, 村田 雅樹, 三浦 秀元, 秦 史壯

    日本病理学会会誌   108 ( 1 )   451 - 451   2019年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • タイト結合膜蛋白occludinはジスルフィド結合とHIF-1、ユビキチン化により安定性が制御される

    田中 敏, 小野 佑輔, 高澤 啓, 村田 雅樹, 小山内 誠, 澤田 典均

    日本病理学会会誌   108 ( 1 )   331 - 331   2019年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 子宮頸部腺がんにおけるエストロゲン/GPR30/claudin-1を介したがん悪性化機構の解明(Estrogen/GPR30 contributes to malignant potentials of cervical adenocarcinoma via claudin-1)

    高澤 啓, 青山 智志, 高澤 久美, 小野 佑輔, 村田 雅樹, 澤田 典均, 小山内 誠

    日本病理学会会誌   108 ( 1 )   306 - 306   2019年4月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • タイト結合関連分子claudin-18は、レチノイン酸欠乏を原因とする乳がん悪性化に関与する

    小野 佑輔, 小山内 誠, 青山 智志, 高澤 久美, 高澤 啓, 村田 雅樹

    日本病理学会会誌   108 ( 1 )   289 - 289   2019年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 真菌・細菌性髄膜炎の1剖検例

    松浦 洋介, 津田 玲子, 山本 大輔, 松村 晃寛, 松下 隆司, 鈴木 秀一郎, 久原 真, 川又 純, 下濱 俊, 菅原 太郎, 高澤 啓

    臨床神経学   59 ( 1 )   53 - 53   2019年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 腫瘍におけるタイト結合 細胞生物学から臨床まで

    高澤 啓

    日本病理学会会誌   107 ( 2 )   74 - 74   2018年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • FFPE組織を用いた比較プロテオミクスによる高分化型脂肪肉腫のバイオマーカー探索(Identification of potential immunohistochemical markers for liposarcoma based on proteomic analysis using FFPE tissue)

    高澤 啓, 長谷川 匡, 小山内 誠

    日本癌学会総会記事   77回   2257 - 2257   2018年9月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本癌学会  

    researchmap

  • 子宮頸部腺癌におけるJAM-A発現とその意義

    村上 太郎, 高澤 啓, 齋藤 裕己, 青山 智志, 小野 佑輔, 村田 雅樹, 小山内 誠, 澤田 典均

    日本病理学会会誌   107 ( 1 )   526 - 526   2018年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 悪性中皮腫におけるOTUB1の役割

    九笹 めい, 谷野 美智枝, 北崎 アリサ, 杉野 弘和, 石田 雄介, 王 磊, 津田 真寿美, 高澤 啓, 平野 博嗣, 田中 伸哉

    日本病理学会会誌   107 ( 1 )   406 - 406   2018年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • claudin-18はEGFR/ERKシグナル経路と協働して胆道癌の悪性化に関与する(Overexpression of claudin-18 contributes to malignant potentials of bile duct cancer)

    高澤 久美, 高澤 啓, 小山内 誠, 青山 智志, 小野 佑輔, 村田 雅樹, 澤田 典均

    日本病理学会会誌   107 ( 1 )   342 - 342   2018年4月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • レチノイン酸代謝を起点として理解する細胞ががん化する仕組み

    小山内 誠, 小野 佑輔, 高澤 啓, 高澤 久美, 村田 雅樹, 澤田 典均

    日本病理学会会誌   107 ( 1 )   340 - 340   2018年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 子宮頸部腺癌におけるALDOA発現はその悪性形質に関与する

    齋藤 裕己, 高澤 啓, 青山 智志, 高澤 久美, 小野 佑輔, 村田 雅樹, 小山内 誠, 澤田 典均

    日本病理学会会誌   107 ( 1 )   338 - 338   2018年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • タイト結合分子JAM-Aの異常発現が肺腺癌の悪性化に関与する

    真柄 和史, 高澤 啓, 青山 智志, 太田 未咲, 小野 佑輔, 高澤 久美, 村田 雅樹, 小山内 誠, 長谷川 匡, 澤田 典均

    日本病理学会会誌   107 ( 1 )   293 - 293   2018年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • FFPE組織を用いたプロテオミクスによる脂肪肉腫診断マーカーの探索

    青山 智志, 高澤 啓, 村田 雅樹, 小山内 誠, 長谷川 匡, 澤田 典均

    日本病理学会会誌   107 ( 1 )   291 - 291   2018年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 多機能な細胞接着分子が関わるがんの理解 診断・治療への応用をめざして がんにおいて異常発現するタイト結合関連タンパク質の機能解析

    高澤 啓

    日本病理学会会誌   107 ( 1 )   242 - 242   2018年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • タイト結合膜蛋白occludinはジスルフィド結合とユビキチン化を介して安定性が調節され、アポトーシス誘導を制御する

    田中 敏, 高澤 啓, 村田 雅樹, 小山内 誠, 澤田 典均

    生命科学系学会合同年次大会   2017年度   [3P - 0144]   2017年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:生命科学系学会合同年次大会運営事務局  

    researchmap

  • 細胞診が診断の契機となった腎臓原発扁平上皮癌の一例

    田畑 聡美, 小関 孝之, 小笠原 淳, 中野 勝彦, 守田 玲奈, 高澤 啓

    日本臨床細胞学会雑誌   56 ( Suppl.2 )   871 - 871   2017年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本臨床細胞学会  

    researchmap

  • claudin-18はEGFR/ERK経路を介して胆道癌悪性化に関与する

    高澤 啓, 小山内 誠, 澤田 典均

    日本癌学会総会記事   76回   J - 3050   2017年9月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本癌学会  

    researchmap

  • SMOC1のエピジェネティックなサイレンシングは大腸鋸歯状腺腫の発育進展に関連する

    青木 敬則, 山本 英一郎, 高澤 啓, 新沼 猛, 山野 泰穂, 原田 拓, 萬 顕, 北嶋 洋志, 甲斐 正広, 澤田 典均, 仲瀬 裕志, 菅井 有, 鈴木 拓

    日本癌学会総会記事   76回   P - 2227   2017年9月

     詳細を見る

    記述言語:英語   出版者・発行元:日本癌学会  

    researchmap

  • 悪性中皮腫におけるOTUB1の発現

    九笹 めい, 谷野 美智枝, 北崎 アリサ, 杉野 弘和, 石田 雄介, 王 磊, 津田 真寿美, 高澤 啓, 平野 博嗣, 田中 伸哉

    日本癌学会総会記事   76回   P - 3277   2017年9月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本癌学会  

    researchmap

  • 内側楔状開大式高位脛骨骨切り術における内側側副靱帯浅層剥離の影響 定量的膝外反ストレス撮影による検討

    佐藤 大, 薮内 康史, 小野寺 智洋, 亀田 敏明, 岩崎 倫政, 近藤 英司, 小野寺 純, 北村 信人, 安田 和則, 八木 知徳

    北海道整形災害外科学会雑誌   59 ( 1 )   162 - 163   2017年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:北海道整形災害外科学会  

    researchmap

  • 平滑筋肉腫のFFPE組織標本を用いた新規バイオマーカー探索の試み

    青山 智志, 高澤 啓, 伊野 善彦, 小野 佑輔, 村田 雅樹, 小山内 誠, 長谷川 匡, 澤田 典均

    JSBMS Letters   42 ( Suppl. )   49 - 49   2017年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本医用マススペクトル学会  

    researchmap

  • 内側楔状開大式高位脛骨骨切り術における内側側副靱帯浅層剥離の影響 定量的膝外反ストレス撮影による検討

    佐藤 大, 薮内 康史, 小野寺 智洋, 亀田 敏明, 岩崎 倫政, 近藤 英司, 小野寺 純, 北村 信人, 八木 知徳, 坂本 圭太, 高澤 啓, 安田 和則

    日本関節病学会誌   36 ( 2 )   131 - 139   2017年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本関節病学会  

    内側側副靱帯(MCL)浅層の脛骨付着部を剥離して行った内側楔状開大式高位脛骨骨切り術(OWHTO)術後の外反不安定性を検討した。対象は、2009年から2015年にOWHTOを行った84人93膝(男性19人20膝、女性65人73膝、手術時平均60.1歳)とした。疾患は内側変形性膝関節症(OA)74例83膝、突発性膝骨壊死(ON)10例10膝であった。JOAスコアは術前平均69.1点から術後90.3点に有意に改善した。定量的外反ストレス撮影において、内側関節裂隙の開大距離(MJS)は術前から全身麻酔下のMCL浅層剥離直前で有意に増加し、MCL浅層の剥離直後にはさらに有意に増加したが、術後1年以降では術前との間に有意差は認めなかった。術後の開大距離と術中、術後のMJSと術後の開大角と術中、術後のJLCAについての相関関係を検討した結果、いずれの項目についても有意な相関係数を認めなかった。Locking plate抜去部は線維性瘢痕組織で覆われていた。Spot MRIでは、iso-intensityの肥厚したMCL浅層線維を認めた。組織所見では、OWHTO術後に骨とMCL浅層の間に瘢痕組織が介在し、不規則な膠原線維の配列を呈した。以上より、locking plateを用いたOWHTO後の短期成績は良好であった。全症例で、MCL浅層の脛骨付着部を完全に剥離してOWHTOを行ったが、MCL浅層剥離による術後の膝外反不安定性は認めなかった。

    researchmap

  • 乳癌におけるタイト結合関連タンパク質LSRの発現とその意義

    太田 未咲, 高澤 啓, 上田 朝子, 青山 智志, 村田 雅樹, 小山内 誠, 長谷川 匡, 澤田 典均

    日本病理学会会誌   106 ( 1 )   510 - 510   2017年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 子宮頸部腺癌における膜型Estrogen受容体GPR30の発現解析

    伊野 善彦, 高澤 啓, 青山 智志, 村田 雅樹, 小山内 誠, 長谷川 匡, 澤田 典均

    日本病理学会会誌   106 ( 1 )   343 - 343   2017年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 平滑筋肉腫のFFPE組織標本を用いた新規バイオマーカー探索の試み

    高澤 啓, 伊野 善彦, 青山 智志, 秋元 太志, 中西 敬太郎, 村田 雅樹, 小山内 誠, 長谷川 匡, 澤田 典均

    日本病理学会会誌   106 ( 1 )   288 - 288   2017年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 原因蛋白質同定に難渋した心アミロイドーシスの1剖検例

    上田 朝子, 高澤 啓, 太田 未咲, 青山 智志, 村田 雅樹, 小山内 誠, 澤田 典均

    日本病理学会会誌   106 ( 1 )   507 - 507   2017年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 慢性膿胸を背景に発症した両側副腎原発NK/T細胞性リンパ腫の一剖検例

    河田 由香, 高澤 啓, 塚原 智英, 村田 雅樹, 小山内 誠, 長谷川 匡, 澤田 典均

    日本病理学会会誌   106 ( 1 )   516 - 516   2017年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • ランゲルハンス細胞肉腫を含む五重癌の一例

    山本 晃匡, 村田 雅樹, 高澤 啓, 小山内 誠, 長谷川 匡, 澤田 典均

    日本病理学会会誌   106 ( 1 )   514 - 515   2017年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 子宮頸部腺癌におけるALDOAの発現とその臨床病理学的意義

    齋藤 裕己, 高澤 啓, 上田 朝子, 太田 未咲, 伊野 善彦, 青山 智志, 村田 雅樹, 小山内 誠, 澤田 典均

    日本病理学会会誌   106 ( 1 )   511 - 511   2017年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 平滑筋肉腫のFFPE組織標本を用いた新規バイオマーカー探索の試み

    中西 敬太郎, 高澤 啓, 青山 智志, 上田 朝子, 秋元 太志, 村田 雅樹, 田中 敏, 小山内 誠, 長谷川 匡, 澤田 典均

    日本病理学会会誌   105 ( 1 )   602 - 602   2016年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 子宮頸部腺癌における受容体型チロシンキナーゼの発現解析

    上田 朝子, 高澤 啓, 秋元 太志, 中西 敬太郎, 村田 雅樹, 青山 智志, 田中 敏, 小山内 誠, 長谷川 匡, 澤田 典均

    日本病理学会会誌   105 ( 1 )   602 - 602   2016年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 肺腺癌におけるJAM-Aの発現とその意義

    真柄 和史, 高澤 啓, 村田 雅樹, 田上 洋平, 秋元 太志, 田中 敏, 小山内 誠, 長谷川 匡, 澤田 典均

    日本病理学会会誌   105 ( 1 )   588 - 588   2016年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 子宮頸部腺癌におけるタイト結合関連たんぱく質の免疫組織化学的検討

    高澤 啓, 秋元 太志, 村田 雅樹, 青山 智志, 田中 敏, 小山内 誠, 長谷川 匡, 澤田 典均

    日本病理学会会誌   105 ( 1 )   478 - 478   2016年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • レチノイン酸代謝酵素CYP26A1は、fascinの発現増加を介して乳がんの進展に関与する

    小山内 誠, 李 康弘, 高澤 啓, 村田 雅樹, 田中 敏, 澤田 典均

    日本病理学会会誌   105 ( 1 )   471 - 471   2016年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • claudin-1は子宮頸部腺癌細胞の浸潤に関与し、claudin-1の発現はエストロゲンにより調節される

    秋元 太志, 高澤 啓, 村田 雅樹, 上田 朝子, 青山 智志, 田中 敏, 小山内 誠, 澤田 典均

    日本病理学会会誌   105 ( 1 )   349 - 349   2016年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • FFPE組織を用いた比較プロテオミクスによる高分化型脂肪肉腫のバイオマーカー探索

    青山 智志, 高澤 啓, 村田 雅樹, 中西 敬太郎, 田中 敏, 小山内 誠, 長谷川 匡, 澤田 典均

    日本病理学会会誌   105 ( 1 )   338 - 338   2016年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • タイト結合蛋白occludinの低酸素下でのジスルフィド結合とユビキチン化を介した細胞内分布調節

    田中 敏, 小野 佑輔, 高澤 啓, 村田 雅樹, 高澤 久美, 小山内 誠, 澤田 典均

    日本生化学会大会・日本分子生物学会年会合同大会講演要旨集   88回・38回   [2P0424] - [2P0424]   2015年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    researchmap

  • 唾液腺腫瘍におけるタイト結合関連分子の免疫組織化学的検討

    青山 智志, 高澤 啓, 村田 雅樹, 田上 洋平, 長谷川 匡, 澤田 典均

    日本病理学会会誌   104 ( 1 )   401 - 401   2015年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • FISH法によってEWSR1遺伝子再構成を認めた唾液腺の硝子化明細胞癌の一例

    田上 洋平, 高澤 啓, 杉田 真太朗, 村田 雅樹, 田中 敏, 長谷川 匡, 澤田 典均

    日本病理学会会誌   104 ( 1 )   513 - 513   2015年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 低酸素環境でのタイト結合蛋白occludinの細胞内分布調節

    田中 敏, 小野 佑輔, 平塚 佑太郎, 高澤 啓, 村田 雅樹, 高澤 久美, 田上 洋平, 真柄 和史, 澤田 典均

    日本病理学会会誌   104 ( 1 )   448 - 448   2015年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • ランゲルハンス細胞肉腫の一例

    田畑 聡美, 小関 孝之, 小笠原 淳, 中野 勝彦, 高澤 啓, 村田 雅樹, 長谷川 匡

    日本臨床細胞学会雑誌   53 ( Suppl.2 )   731 - 731   2014年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本臨床細胞学会  

    researchmap

  • 低酸素環境でのタイト結合膜蛋白occludinの分解に対するユビキチンの役割

    田中 敏, 小野 佑輔, 平塚 佑太郎, 高澤 啓, 村田 雅樹, 高澤 久美, 澤田 典均

    日本病理学会会誌   103 ( 2 )   41 - 41   2014年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 肝細胞癌および肝内胆管細胞癌におけるタイト結合関連分子の免疫組織化学的検討

    小野 佑輔, 村田 雅樹, 高澤 啓, 平塚 佑太朗, 田中 敏, 澤田 典均

    日本病理学会会誌   103 ( 1 )   393 - 393   2014年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 胆道癌におけるclaudin-18の発現と調節機構および機能解析

    高澤 啓, 村田 雅樹, 計良 淑子, 田中 敏, 澤田 典均

    日本病理学会会誌   103 ( 1 )   270 - 270   2014年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • タイト結合蛋白Occludinのジスルフィド結合を介した酸化センサー機能の解明

    田中 敏, 小野 佑輔, 平塚 佑太郎, 高澤 啓, 村田 雅樹, 高澤 久美, 澤田 典均

    日本病理学会会誌   103 ( 1 )   245 - 245   2014年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 子宮頸部腺癌におけるタイト結合関連分子の免疫組織化学的検討

    秋元 太志, 高澤 啓, 村田 雅樹, 小嶋 結, 田中 敏, 計良 淑子, 荻野 次郎, 長谷川 匡, 澤田 典均

    日本病理学会会誌   103 ( 1 )   245 - 245   2014年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 子宮頸部腺癌におけるタイト結合関連分子の免疫組織化学的検討

    秋元 太志, 高澤 啓, 村田 雅樹, 澤田 典均

    日本産科婦人科学会雑誌   66 ( 2 )   615 - 615   2014年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本産科婦人科学会  

    researchmap

  • 腎不全、肝機能障害、精神発達遅滞を合併した重症MODY5の臨床像

    辻 敦美, 松田 希, 高澤 啓, 田中 絵里子, 竹中 健人, 櫻井 幸, 朝比奈 靖浩, 堀川 幸男, 武田 純, 鹿島田 健一

    日本内分泌学会雑誌   89 ( 3 )   983 - 983   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本内分泌学会  

    researchmap

  • 胆道癌におけるclaudin18、maspin、p53の免疫組織化学的検討

    計良 淑子, 高澤 啓, 村田 雅樹, 荻野 次郎, 及能 大輔, 中西 勝也, 田中 敏, 小島 隆, 長谷川 匡, 澤田 典均

    日本病理学会会誌   102 ( 1 )   471 - 471   2013年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 子宮頸部腺癌におけるタイト結合関連分子の免疫組織化学的検討

    小嶋 結, 平塚 佑太郎, 高澤 啓, 村田 雅樹, 計良 淑子, 荻野 次郎, 田中 敏, 長谷川 匡, 澤田 典均

    日本病理学会会誌   102 ( 1 )   503 - 503   2013年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 膵癌組織および膵癌細胞株におけるタイト結合分子tricellulinの核への局在

    村田 雅樹, 高澤 啓, 田中 敏, 小島 隆, 澤田 典均

    日本病理学会会誌   102 ( 1 )   473 - 473   2013年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • Protein Kinase C-alpha Regulates Claudin-1 via Snail-dependent and -independent Pathways in Pancreatic Cancer

    D. Kyuno, T. Kojima, H. Yamaguchi, T. Ito, M. Imamura, Y. Kimura, A. Takasawa, M. Murata, M. Murata, K. Hirata

    PANCREAS   41 ( 7 )   1150 - 1150   2012年10月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    Web of Science

    researchmap

  • PKCαによるSnailを介した膵癌のタイト結合分子への影響(PKC-alpha regulates claudin-1 via Snail gene in pancreatic cancer)

    及能 大輔, 小島 隆, 山口 洋志, 伊東 竜哉, 今村 将史, 木村 康利, 高澤 啓, 村田 雅樹, 平田 公一, 澤田 典均

    日本癌学会総会記事   71回   295 - 295   2012年8月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本癌学会  

    researchmap

  • タイト結合分子tricellulinの核における発現はヒト膵癌細胞において細胞増殖に関与している(Expression of tricellulin in the nuclei is associated with cell proliferation in human pancreatic cancer cells)

    村田 雅樹, 高澤 啓, 小島 隆, 澤田 典均

    日本癌学会総会記事   71回   525 - 525   2012年8月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本癌学会  

    researchmap

  • 胆道癌におけるclaudin-18、Maspinの免疫組織化学的検討(Immunohistochemical investigation of claudin-18 and Maspin in biliary tract cancer)

    計良 淑子, 高澤 啓, 村田 雅樹, 小島 隆, 長谷川 匡, 澤田 典均

    日本癌学会総会記事   71回   351 - 351   2012年8月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本癌学会  

    researchmap

  • PKCα阻害剤による膵癌細胞株および正常ヒト膵管上皮細胞のタイト結合分子への影響

    及能 大輔, 小島 隆, 伊東 竜哉, 山口 洋志, 高澤 啓, 澤田 典均

    日本病理学会会誌   101 ( 1 )   264 - 264   2012年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • ヒト膵管上皮細胞株におけるJun N-terminal kinase阻害剤によるバリア機能の亢進

    金野 匠, 小島 隆, 及能 大輔, 村田 雅樹, 高澤 啓, 田中 敏, 澤田 典均

    日本病理学会会誌   101 ( 1 )   438 - 438   2012年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 肝炎および肝癌におけるタイト結合分子の発現変化

    辻脇 光洋, 村田 雅樹, 高澤 啓, 平塚 佑太郎, 福田 理英子, 田中 敏, 小島 隆, 澤田 典均

    日本病理学会会誌   101 ( 1 )   360 - 360   2012年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • ヒト鼻粘膜上皮細胞系におけるrespiratory syncytial virus感染によるMatrix Metalloproteinaseの増加

    平川 賢史, 小島 隆, 小幡 和史, 野村 一顕, 正木 智之, 渕本 潤, 高澤 啓, 堤 裕幸, 澤田 典均

    日本病理学会会誌   101 ( 1 )   327 - 327   2012年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 緑膿菌産生エラスターゼによるヒト鼻粘膜上皮バリアへの影響

    野村 一顕, 小島 隆, 小幡 和史, 平川 賢史, 高澤 啓, 氷見 徹夫, 澤田 典均

    日本病理学会会誌   101 ( 1 )   327 - 327   2012年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 胆道癌におけるclaudin-18、maspinの免疫組織化学的検討

    高澤 啓, 計良 淑子, 村田 雅樹, 荻野 次郎, 及能 大輔, 田中 敏, 小島 隆, 長谷川 匡, 澤田 典均

    日本病理学会会誌   101 ( 1 )   288 - 288   2012年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • ヒト鼻粘膜上皮細胞を用いたcurcuminによるRSvirusの複製阻害およびタイト結合発現誘導のメカニズム解析

    小幡 和史, 小島 隆, 正木 智之, 渕本 潤, 平川 賢史, 野村 一顕, 高澤 啓, 小笠原 徳子, 氷見 徹夫, 澤田 典均

    日本病理学会会誌   101 ( 1 )   280 - 280   2012年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 膵癌組織および膵癌細胞株におけるタイト結合分子tricellulinの核への局在

    村田 雅樹, 小野 佑輔, 高澤 啓, 田中 敏, 小島 隆, 澤田 典均

    日本病理学会会誌   101 ( 1 )   264 - 264   2012年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 膵癌におけるタイト結合分子Claudin-18のPKC経路およびDNAメチル化を介した発現調節機構

    伊東 竜哉, 及能 大輔, 山口 洋志, 小島 隆, 目黒 誠, 今村 将史, 木村 康利, 高澤 啓, 村田 雅樹, 澤田 典均, 平田 公一

    日本消化器病学会雑誌   108 ( 臨増大会 )   A902 - A902   2011年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 培養ヒト膵管上皮細胞におけるtricellulin発現調節機構の解明 Caスイッチによる発現・局在変化を中心に

    高澤 啓, 小島 隆, 及能 大輔, 辻脇 光洋, 村田 雅樹, 田中 敏, 澤田 典均

    日本病理学会会誌   100 ( 1 )   318 - 318   2011年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 膵癌細胞株及び正常膵管上皮細胞におけるタイト結合とPKCαとの関係

    及能 大輔, 小島 隆, 伊東 竜哉, 山田 洋志, 辻脇 光洋, 高澤 啓, 村田 雅樹, 田中 敏, 澤田 典均

    日本病理学会会誌   100 ( 1 )   319 - 319   2011年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 卵巣癌細胞株におけるタイト結合分子claudin4に対するCPE作用条件についての検討

    井上 万梨絵, 田中 敏, 染谷 真行, 高澤 啓, 村田 雅樹, 小島 隆, 斎藤 豪, 澤田 典均

    日本病理学会会誌   100 ( 1 )   459 - 459   2011年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 原発性肺癌との衝突が認められた胸膜悪性中皮腫の一例 病理所見および遺伝子発現の解析

    田畑 佑希子, 高澤 啓, 畑中 豊, 谷野 美智枝, 丸川 活司, 羽賀 博典, 樋田 泰浩, 加賀 基知三, 松野 吉宏

    肺癌   50 ( 5 )   588 - 588   2010年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本肺癌学会  

    J-GLOBAL

    researchmap

  • 生体肝移植後のリンパ増殖性疾患に関する臨床病理学的検討 単一施設における38例の解析

    羽賀 博典, 宮川 文, 松野 吉宏, 久保田 佳奈子, 藤田 裕美, 山田 洋介, ヘールナンデス 真子, 高澤 啓, 川上 史, 真鍋 俊明

    日本病理学会会誌   99 ( 1 )   276 - 276   2010年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 6. 嚢胞型胎便性腹膜炎と比較して嚢胞に病理組織学的特徴を有するmeconium pseudocystの1例(一般演題,第81回日本小児外科学会北海道地方会)

    湊 雅嗣, 佐々木 文章, 岡田 忠雄, 水上 尚典, 山田 俊, 長 和俊, 水島 正人, 松野 吉宏, 久保田 佳奈子, 高澤 啓

    日本小児外科学会雑誌   46 ( 1 )   120 - 120   2010年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:特定非営利活動法人日本小児外科学会  

    DOI: 10.11164/jjsps.46.1_120_2

    researchmap

  • 臨床的にHTLV-1関連細気管支肺胞異常症(HABA)を伴ったATLLの1剖検例

    高澤 啓, 菊地 慶介, 松野 吉宏

    日本病理学会会誌   98 ( 1 )   274 - 274   2009年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 腎移植後のリンパ増殖性疾患(posttransplant lymphoproliferative disease:PTLD)4例の臨床病理学的検討

    藤田 裕美, 小川 弥生, 久保田 佳奈子, 山田 洋介, 高澤 啓, ヘールナンデス 真子, 羽賀 博典, 松野 吉宏, 武内 利直

    日本病理学会会誌   98 ( 1 )   275 - 275   2009年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    researchmap

  • 家族性早期発症型認知症FENIBモデルマウスにおいて変異型ニューロセルピン(G392E)は小胞体およびリソソーム内に蓄積する

    加藤 一郎, 石井 陽子, 吉田 淑子, 高澤 久美, 高澤 啓, 近藤 匠, 川口 博, 笹原 正清, 平賀 紘一

    日本生化学会大会・日本分子生物学会年会合同大会講演要旨集   80回・30回   4T21 - 7   2007年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    researchmap

  • 変異G392Eヒトneuroserpinを発現した遺伝子導入マウスはニューロンで凝集形成を伴った神経機能不全を呈する(Transgenic mice expressing mutant G392E human neuroserpin show neuronal dysfunction with aggregate formation in neurons)

    高澤 久美, 高澤 啓, 加藤 一郎, 石井 陽子, 笹原 正清, 平賀 紘一

    神経化学   44 ( 2-3 )   195 - 195   2005年8月

     詳細を見る

    記述言語:英語   出版者・発行元:日本神経化学会  

    researchmap

  • ヒト変異型ニューロセルピンをThy1.2プロモーター制御下で発現するマウスの中枢神経系障害

    高澤 久美, 高澤 啓, 加藤 一郎, 石井 陽子, 笹原 正清, 平賀 紘一

    生化学   77 ( 7 )   678 - 678   2005年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    researchmap

  • ヘム代謝異常を呈するウィルソン病モデル(LEC)ラットについて

    中山 憲司, 高澤 啓, 寺井 格, 奥井 登代, 市原 侃, 大山 徹, 田村 守

    北海道立衛生研究所報 = Report of the Hokkaido Institute of Public Health   52   127 - 127   2002年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:北海道立衛生研究所  

    researchmap

  • LECラットにおけるヘム代謝異常への銅と鉄の関与に関して

    中山 憲司, 高澤 啓, 寺井 格, 奥井 登代, 市原 侃, 大山 徹, 田村 守

    北海道立衛生研究所報 = Report of the Hokkaido Institute of Public Health   52   128 - 128   2002年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:北海道立衛生研究所  

    researchmap

  • LECラットにおけるヘム代謝異常への鉄の影響

    中山 憲司, 高澤 啓, 寺井 格, 奥井 登代, 市原 侃, 大山 徹, 田村 守

    北海道立衛生研究所報 = Report of the Hokkaido Institute of Public Health   52   127 - 127   2002年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:北海道立衛生研究所  

    researchmap

  • LECラット尿中での銅とポルフィリンの関係

    中山 憲司, 高澤 啓, 宍戸 直美, 奥井 登代, 市原 侃, 中村 正雄, 田村 守, 田村 正秀

    生化学   74 ( 8 )   821 - 821   2002年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    J-GLOBAL

    researchmap

  • LECラットにおけるヘム代謝異常への銅と鉄の関与に関して

    中山 憲司, 高澤 啓, 寺井 格, 奥井 登代, 市原 侃, 大山 徹, 田村 守

    生化学   73 ( 8 )   1026 - 1026   2001年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    J-GLOBAL

    researchmap

  • 銅(II)とウロポルフィリンとの複合体に関するスペクトロスコピーおよびクロマトグラフィー研究

    高澤 啓, 中山 憲司, 寺井 格, 奥井 登代, 市原 侃, 大山 徹, 田村 守

    ポルフィリン   10 ( 2 )   42 - 42   2001年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:ポルフィリン研究会事務局  

    researchmap

  • LECラットにおける肝機能障害へのヘム代謝異常の関与について

    中山 憲司, 高澤 啓, 寺井 格, 奥井 登代, 大山 徹, 田村 守

    生化学   72 ( 8 )   943 - 943   2000年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    J-GLOBAL

    researchmap

  • LECラットにおけるヘム代謝異常への銅の影響

    高澤 啓, 中山 憲司, 奥井 登代, 寺井 格, 大山 徹, 田村 守

    生化学   72 ( 8 )   943 - 943   2000年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    J-GLOBAL

    researchmap

  • ウイルソン病患者尿中のヘム代謝産物の動態に関して

    中山 憲司, 高澤 啓, 市原 侃, 寺井 格, 長坂 博範, 小川 恵美, 山本 重則, 鈴木 健, 青木 継稔, 田村 守

    ポルフィリン   9 ( 1 )   28 - 28   2000年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:ポルフィリン研究会事務局  

    researchmap

  • ヒト・ウィルソン病モデル動物におけるポルフィリン代謝異常(II)

    高澤 啓, 中山 憲司, 寺井 格, 奥井 登代, 大山 徹, 田村 守

    生化学   71 ( 8 )   986 - 986   1999年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    researchmap

  • LECラット肝サイトゾルにおける銅の反応性

    宍戸 直美, 中山 憲司, 高澤 啓, 大山 徹, 中村 正雄

    生化学   71 ( 8 )   1022 - 1022   1999年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    researchmap

  • ヒト・ウイルソン病モデル動物におけるポルフィリン代謝異常

    中山 憲司, 高澤 啓, 寺井 格, 奥井 登代, 大山 徹, 田村 守

    ポルフィリン   8 ( 1 )   47 - 47   1999年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:ポルフィリン研究会事務局  

    researchmap

  • ヒト・ウイルソン病モデル動物におけるポルフィリン代謝異常(I)

    中山 憲司, 高澤 啓, 寺井 格, 奥井 登代, 大山 徹, 田村 守

    生化学   71 ( 8 )   985 - 985   1999年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    researchmap

  • 銅によるDNA切断はGSH又はMTsの存在で抑制される

    宍戸 直美, 中山 憲司, 高沢 啓, 大山 徹, 中村 正雄

    生化学   70 ( 8 )   861 - 861   1998年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    researchmap

▼全件表示

受賞

  • 最優秀演題賞

    2022年11月   第54回 日本臨床分子形態学会   細胞接着と微絨毛形成におけるタイト結合蛋白質 claudin 1 の役割

     詳細を見る

  • 学術研究賞

    2018年11月   日本病理学会  

     詳細を見る

共同研究・競争的資金等の研究課題

  • 脱分化型軟骨肉腫に対する新規治療法開発

    研究課題/領域番号:24K12334  2024年4月 - 2027年3月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    清水 淳也, 高澤 啓, 江森 誠人, 房川 祐頼, 佐藤 達也, 高田 弘一, 中橋 尚也

      詳細を見る

    配分額:4,550,000円 ( 直接経費:3,500,000円 、 間接経費:1,050,000円 )

    researchmap

  • 膵癌の予後不良群に過剰発現するタイト結合分子が促進する癌進展機構の解明

    研究課題/領域番号:24K11826  2024年4月 - 2027年3月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    及能 大輔, 今村 将史, 高澤 啓, 木村 康利

      詳細を見る

    配分額:4,680,000円 ( 直接経費:3,600,000円 、 間接経費:1,080,000円 )

    researchmap

  • 非コードRNAがコードする大腸がん関連マイクロプロテインの同定

    研究課題/領域番号:24K10335  2024年4月 - 2027年3月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    北嶋 洋志, 高澤 啓, 新沼 猛

      詳細を見る

    配分額:4,550,000円 ( 直接経費:3,500,000円 、 間接経費:1,050,000円 )

    researchmap

  • 胎盤FFPE組織のプロテオーム解析による早発型妊娠高血圧腎症の病態解明と臨床応用

    研究課題/領域番号:24K12536  2024年4月 - 2027年3月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    染谷 真行, 高澤 啓, 秋元 太志

      詳細を見る

    配分額:4,550,000円 ( 直接経費:3,500,000円 、 間接経費:1,050,000円 )

    researchmap

  • 尿路上皮癌の免疫チェックポイント分子をターゲットとした新規治療戦略

    研究課題/領域番号:24K12504  2024年4月 - 2027年3月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    八重樫 洋, 高澤 啓, 岩本 大旭

      詳細を見る

    配分額:4,680,000円 ( 直接経費:3,600,000円 、 間接経費:1,080,000円 )

    researchmap

  • 高深度プロテオーム解析を用いたがんにおけるタイト結合タンパク質局在制御因子の探索

    研究課題/領域番号:23K06426  2023年4月 - 2027年3月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    高澤 久美, 高澤 啓

      詳細を見る

    配分額:4,680,000円 ( 直接経費:3,600,000円 、 間接経費:1,080,000円 )

    researchmap

  • プロテオーム解析による骨肉腫の肺転移機序解明と新規治療開発

    研究課題/領域番号:23K08657  2023年4月 - 2026年3月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    江森 誠人, 高澤 啓, 高田 弘一, 中橋 尚也

      詳細を見る

    配分額:4,680,000円 ( 直接経費:3,600,000円 、 間接経費:1,080,000円 )

    researchmap

  • 大腸低分化腺がんにおけるSAA1の分子機能解明と診断・治療への応用

    研究課題/領域番号:22K07964  2022年4月 - 2025年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    青木 敬則, 高澤 啓, 山本 英一郎, 新沼 猛

      詳細を見る

    配分額:4,160,000円 ( 直接経費:3,200,000円 、 間接経費:960,000円 )

    researchmap

  • レチノイン酸特異的代謝酵素CYP26のレチノイン酸非依存性がん悪性化機構の解明

    研究課題/領域番号:22K06983  2022年4月 - 2025年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    小野 佑輔, 高澤 啓, 小山内 誠

      詳細を見る

    配分額:4,160,000円 ( 直接経費:3,200,000円 、 間接経費:960,000円 )

    researchmap

  • 深在性真菌症のFFPE組織を用いた分子形態学的な同定および解析方法の確立

    研究課題/領域番号:22K06944  2022年4月 - 2025年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    青山 智志, 高澤 啓, 山本 聡

      詳細を見る

    配分額:4,160,000円 ( 直接経費:3,200,000円 、 間接経費:960,000円 )

    researchmap

  • RSウイルス感染症の宿主標的治療の構築に向けた感染規定宿主因子の同定と基盤研究

    研究課題/領域番号:22K06726  2022年4月 - 2025年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    山本 聡, 小笠原 徳子, 高澤 啓

      詳細を見る

    配分額:4,160,000円 ( 直接経費:3,200,000円 、 間接経費:960,000円 )

    researchmap

  • FFPE組織を用いた比較プロテオーム解析を基盤とした難治性希少がんの新規治療標的探索

    2022年4月 - 2023年3月

    公益財団法人 寿原記念財団  研究助成金 

      詳細を見る

    担当区分:研究代表者 

    researchmap

  • 希少がんのFFPE組織を用いたプロテオーム解析による治療標的探索技術の構築

    2022年4月 - 2023年3月

    公益財団法人 秋山記念生命科学振興財団  研究助成 

      詳細を見る

    担当区分:研究代表者 

    researchmap

  • PVRが担う細胞接着機能と癌免疫逃避機能の統合的理解

    研究課題/領域番号:21K06890  2021年4月 - 2024年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    村田 雅樹, 高澤 啓, 廣橋 良彦

      詳細を見る

    配分額:4,160,000円 ( 直接経費:3,200,000円 、 間接経費:960,000円 )

    Poliovirus receptor (PVR/NECL5)は、ポリオウイルスの感染を成立させる受容体として発見された後、上皮細胞では、細胞間接着分子Nectinファミリー NECL5 として再同定された。一方、免疫細胞において、PVRは抗原提示細胞に発現し、活性化T細胞やNK細胞が発現するT-cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT) がその受容体となり、免疫反応を抑制するTIGIT-PVR免疫チェックポイントを形成していた。つまり、PVRは、細胞間接着、免疫チェックポイントの2つの機能を有するユニークなタンパク質であることが明らかとなった。本研究では、がん細胞で異常発現し、2つの細胞機能を併せ持つユニークな分子PVRの、細胞接着とがん免疫チェックポイントの関連、クロストークの解明を目指す。
    TCGAのRNA-seqデータセットで、PVRのmRNA高発現が予後不良になることが予測された頭頚部がんの切除材料を対象に、PVRの免疫組織化学を行い、陽性強度・面積、発現態度を評価しスコア化した。その結果、PVRの染色態度に特徴的な違いを見出し、その違いに着目した解析の結果、病理組織学的因子との有意な関連が明らかとなった。また、Kaplan-Meier法による予後解析では、PVRの発現態度により顕著な予後不良を示すことが明らかとなった。頭頚部がん細胞株に対して、CRSPR-Cas9を用いてPVR発現欠損株を作製した。欠損株を用いた解析では、がん悪性化に関わる機能が欠損株で減じていることを確認した。現在は、発現欠損株にPVR発現を回復させた株の樹立を進めている。更に、別の頭頚部癌細胞株でPVR発現欠損株を作製中である。

    researchmap

  • 近赤外蛍光標識抗体によるclaudin18.2を標的とした胆管癌可視化技術の開発

    研究課題/領域番号:21K08715  2021年4月 - 2024年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    及能 大輔, 高澤 啓, 木村 康利

      詳細を見る

    配分額:4,030,000円 ( 直接経費:3,100,000円 、 間接経費:930,000円 )

    researchmap

  • 悪性末梢神経鞘腫瘍のFFPE組織を用いたプロテオーム解析により同定した新規治療標的候補の臨床利用を目指した基盤研究

    2021年4月 - 2022年3月

    日本医療研究開発機構  橋渡し研究戦略的推進プログラム シーズA 

      詳細を見る

  • 治療応用を目指した胃癌におけるタイト結合分子CL-18.2発現調節機構の解析

    研究課題/領域番号:20K07640  2020年4月 - 2024年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    伊東 竜哉, 高澤 啓, 竹政 伊知朗, 信岡 隆幸

      詳細を見る

    配分額:4,290,000円 ( 直接経費:3,300,000円 、 間接経費:990,000円 )

    researchmap

  • ショットガンプロテオミクスを用いた神経線維腫の悪性化機序解明と治療への応用

    研究課題/領域番号:20K09506  2020年4月 - 2023年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    江森 誠人, 高澤 啓, 高田 弘一, 村橋 靖崇

      詳細を見る

    配分額:4,290,000円 ( 直接経費:3,300,000円 、 間接経費:990,000円 )

    神経線維腫1型患者で悪性末梢神経鞘腫瘍(MPNST)を3回外科的に切除したFFPE組織から、神経線維腫とMPNSTのレーザーマイクロダイセクションにより腫瘍切片を切り出し、タンパク質を抽出した。これら3病変に共通でMPNSTに有意に増加していたタンパク質は321種、神経線維腫に有意に増加していたタンパク質は18種であった。増加したタンパク質群のKEGG pathway解析で、MPNSTではタンパク質合成・プロセッシング・分解過程の全てが活性化され、特にプロテアソーム関連タンパクが多く増加(Fold Enrichment:7.93)していた。抗体入手が可能なプロテアソームサブユニット20S proteasome β2、PSMD2は免疫組織染色にてMPNSTで発現が亢進していた。このことからプロテアソーム選択的阻害剤がMPNSTに対する治療効果を示す可能性が示唆された。そこでMPNST細胞株sNF96.2,SCC94,SCC24で、プロテアソーム選択的阻害剤の暴露を行い、細胞株での増殖抑制を確認した。

    researchmap

  • 子宮頸部腺がんのエストロゲン依存性がんとしての再定義を目指して

    研究課題/領域番号:20K07409  2020年4月 - 2023年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    高澤 啓, 秋元 太志, 青山 智志

      詳細を見る

    配分額:4,290,000円 ( 直接経費:3,300,000円 、 間接経費:990,000円 )

    子宮頸部腺がん(以下、頸部腺がん)は核内エストロゲン受容体(ER)が陰性であることから、エストロゲン非依存性がんとして理解されてきた。我々は、頸部腺がんの手術材料および細胞株で膜型エストロゲン受容体GPR30が高発現し、エストロゲン依存性にタイト結合蛋白質 claudin-1発現を調節して悪性化に関与していることなどを明らかにした(Akimoto et al. Neoplasia, 2018)。本研究では、GPR30を軸にエストロゲンが寄与する悪性化メカニズムを明らかにし、頸部腺がんをエストロゲン依存性がんとして再定義し、新たな治療戦略策定へつなげることを目的とする。その達成のため、頸部腺がんにおいて①エストロゲン関連刺激が腫瘍に及ぼす効果、②多層オミクス解析によりエストロゲン関連刺激の分子メカニズム、③ヒトパピローマウイルス(HPV)感染とGPR30の関連、を明らかにする
    これまでに、頸部腺癌手術材料を用いた免疫組織化学的検討を行った。頸部腺癌の手術症例に対し、GPR30、ER、p16、EPV E6、HPV E7の免疫染色を行い、陽性強度・面積を評価しスコア化した。HPV E7については、良好な染色性が得られなかったため、以降の検討は行っていない。病理組織学的因子との関連を解析したところ、T因子や病期とGPR30発現との間に有意な関連があった。ERの発現と予後との有意な相関は得られなかった。P16, HPV E6の染色態度とT因子や病期との間に有意な関連は見られなかった。頸部腺がん細胞株にエストロゲン、GPR30作動薬を暴露し、比較プロテオーム解析を行った。エストロゲン、GPR30作動薬で共通して増加するタンパク質を複数同定した。昨年度から、CRSPR-Cas9を用いてGPR30の欠損株作成を複数回、複数細胞株で試みているが、現在まで、欠損株の樹立には至っていない。

    researchmap

  • ヒストンメチル化酵素DOT1L阻害による新たな抗腫瘍メカニズムの解明

    研究課題/領域番号:19H03518  2019年4月 - 2022年3月

    日本学術振興会  科学研究費助成事業 基盤研究(B)  基盤研究(B)

    鈴木 拓, 高澤 啓, 仲瀬 裕志

      詳細を見る

    配分額:16,380,000円 ( 直接経費:12,600,000円 、 間接経費:3,780,000円 )

    researchmap

  • NIP-SNAPsを介したマクロライド系抗菌薬の抗炎症機構の解明

    研究課題/領域番号:19K07168  2019年4月 - 2022年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    山本 聡, 小笠原 徳子, 高澤 啓

      詳細を見る

    配分額:4,420,000円 ( 直接経費:3,400,000円 、 間接経費:1,020,000円 )

    申請者がマクロライド系抗菌薬 (以下マクロライド)の結合タンパク質として同定したNIPSNAP1および2 (以下NIPSNAPs) は、マクロライドが持つ抗炎症作用の詳細を明らかとする上で重要なミトコンドリアタンパク質である。本研究では「NIPSNAPsの生体における根本的な機能は何であるか?」という問いを掲げ、NIPSNAPsの生理機能とマクロライドの抗炎症作用の分子機構を明らかにすることで、耐性菌出現・常在細菌叢撹乱といったマクロライド療法における臨床上の問題点を解決し、かつ慢性気道炎症に対する新規薬剤の創出に資する基盤研究を行う。本研究課題ではミトコンドリアタンパク質NIP-SNAPsによる(1) autophagyを介したミトコンドリアの品質管理機構 (2) 炎症性サイトカイン産生に関わるシグナル伝達経路の同定 (3) マクロライドとの結合様式の詳細を細胞生物、生化学、構造学的に明らかにし、ミトコンドリアーNIP-SNAPsーマクロライドの3者間の関連性を統合することで、マクロライドの抗炎症作用の全貌を解明する。
    本研究課題を達成するために、申請者はNIPSNAPsのdouble knock out (DKO)を樹立し、炎症性サイトカインの産生能、RNA seq.など網羅的な解析をおこなった。その結果、DKO細胞の表現系とsiRNAによるknock down(KD)で見られる表現系に大きな乖離があることを見出した。NIPSNAPのKD細胞においてミトコンドリアの量が減少することや、ミトコンドリア量の減少は炎症性サイトカインの産生に関与することを見出している。

    researchmap

  • プロテオーム解析を用いて発見した平滑筋肉腫の新規バイオマーカーを標的とする診断・治療法開発

    2019年 - 2020年

    日本医療研究開発機構  橋渡し研究戦略的推進プログラム シーズA 

      詳細を見る

  • 子宮頸部腺がんにおける膜型エストロゲン受容体GPR30の発現-エストロゲン感受性がんとしての再定義と治療戦略の再構築を目指して―

    2018年 - 2019年

    寿原記念財団  研究助成金 

      詳細を見る

  • 子宮頸部腺癌治療のパラダイムシフト―膜型エストロゲン受容体を介した新たな治療戦略―

    2018年 - 2019年

    小野がん研究助成基金  研究助成 

      詳細を見る

  • 子宮頸部腺癌における膜型エストロゲン受容体GPR30の機能解析と治療標的の可能性

    研究課題/領域番号:17K08698  2017年4月 - 2020年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    高澤 啓, 村田 雅樹

      詳細を見る

    配分額:4,680,000円 ( 直接経費:3,600,000円 、 間接経費:1,080,000円 )

    近年、子宮頸部(以下、頸部)腺癌の患者数は増加し、子宮頸癌の25%を占めている。頸部扁平上皮癌と比較して頸部腺癌では早期から浸潤・転移し、治療抵抗性が高いため、その予後は悪い。予後改善のため、治療標的として設定可能な分子の同定や新たな治療戦略の確立が求められる。本研究では、申請者がこれまでの研究で確認した頸部腺癌における膜型エストロゲン受容体であるG protein-coupled receptor 30 (以下、GPR30)の発現とその悪性化への関与に焦点をしぼり、その役割を明らかにすることを目的としている。
    これまでに、頸部腺癌手術材料を用いた免疫組織化学的検討を行った。頸部腺癌の手術症例に対し、GPR30の免疫染色を行い、陽性強度・面積を評価しスコア化した。また、ER、ERαの免疫染色と評価も同時に行った。非腫瘍頸部腺上皮では、ER、ERα陽性、GPR30陰性であった。一方、頸部腺癌ではER、ERαは過半で陰性、GPR30は過半で陽性となった。病理組織学的因子との関連を解析したところ、T因子や病期とGPR30発現との間に有意な関連があった。これらの結果は現在投稿中である。
    並行して、頸部腺癌細胞株でのGPR30欠損株および安定発現抑制株の作製を試みた。二年間の間にCRISPR-Cas9を用い、GPR30に対する複数のgRNAを設定し、複数の細胞株を用いてGPR30欠損株の樹立を試みたが、現在までに有望な結果は得られていない。そこで、レンチウイルスを用いたshRNAによるGPR30の安定的な発現抑制株の樹立を試みたが、こちらについても有望な結果は得られていない。GPR30アゴニストの曝露により細胞株の増殖能が亢進すること、claudin-1の発現をGPR30が調整していることを明らかとし、それらの結果については論文として報告した。

    researchmap

  • 質量分析イメージング法によるFFPE組織からのアミロイドーシスの新規同定技術の開発

    2017年 - 2018年

    黒住医学研究振興財団  研究助成金 

      詳細を見る

  • 子宮頸部腺癌のタイト結合に着目した発癌機構解析及び臨床応用を目的とする橋渡し研究

    研究課題/領域番号:26460421  2014年4月 - 2017年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    高澤 啓, 澤田 典均, 田中 敏, 村田 雅樹

      詳細を見る

    配分額:5,070,000円 ( 直接経費:3,900,000円 、 間接経費:1,170,000円 )

    子宮頸部腺癌手術材料でタイト結合関連タンパク質の発現解析を行ったところ、claudin-1, JAM-Aが腺癌組織で高発現していた。その局在は非腫瘍部ではタイト結合領域に見られ、癌細胞では細胞膜全周性に変化していた。発現強度と局在変化を合わせて解析することで、高い判別能が得られた。CRISPR-Cas9システムを用いてclaudin-1欠損株を作成し解析したところclaudin-1の発現が癌悪性化に関与していることが明らかとなった。更にその発現はERK1/2経路を介して調節されていた。以上の結果から、頸部腺癌におけるclaudin-1は診断マーカー、治療標的となりうることが示唆された。

    researchmap

  • タイト結合の機能病理学-ヒト正常上皮を中心に

    研究課題/領域番号:24390089  2012年4月 - 2015年3月

    日本学術振興会  科学研究費助成事業 基盤研究(B)  基盤研究(B)

    澤田 典均, 小島 隆, 田中 敏, 村田 雅樹, 髙澤 啓, 郷 充, 今村 将史

      詳細を見る

    配分額:18,460,000円 ( 直接経費:14,200,000円 、 間接経費:4,260,000円 )

    タイト結合は、体の内外を境し、外界刺激に対するバリアで、細胞にとっては極性を維持する細胞接着装置である。本研究ではヒト正常上皮細胞を用いて、以下を明らかにした。タイト結合機能の可逆的な変化は、あたらしい薬物投与法の開発につながることが示唆された。タイト結合タンパクががん治療の標的分子となる可能性が示唆された。タイト結合タンパクの免疫組織染色は、病理発生学や病理診断学に有用であることが示唆された。

    researchmap

  • 胆道癌の予後改善に向けた新規診断マーカー候補クローディンとマスピンの発現解析

    研究課題/領域番号:24790355  2012年4月 - 2014年3月

    日本学術振興会  科学研究費助成事業 若手研究(B)  若手研究(B)

    高澤 啓

      詳細を見る

    配分額:4,550,000円 ( 直接経費:3,500,000円 、 間接経費:1,050,000円 )

    胆道癌材料を用いたclaudin-18, mapsin, p53の免疫染色を行い、その評価を行った。その結果、いずれの交代も腫瘍部での良好な染色性を示した。3抗体の組み合わせで腫瘍・非腫瘍を判別可能であることが確認された。胆道癌細胞株を用いた実験では、claudin-18が増殖・浸潤に関与するシグナル伝達系で調節を受けている事、その発現が細胞株の増殖能、浸潤能に関与している可能性を見出した。

    researchmap

  • 新規培養ヒト正常膵管上皮細胞を用いた膵癌タイト結合分子標的治療の基礎的研究

    研究課題/領域番号:23590404  2011年 - 2013年

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    小島 隆, 村田 雅樹, 高澤 啓

      詳細を見る

    配分額:5,200,000円 ( 直接経費:4,000,000円 、 間接経費:1,200,000円 )

    本研究は、我々が確立した新規培養ヒト正常膵管上皮細胞と膵癌細胞株を用いて、膵癌において高発現しているタイト結合蛋白claudin(CL)-4、CL-18およびPKCを標的とした膵癌分子標的治療の基礎的研究を実施した。結果、ヒト正常膵管上皮細胞と膵癌細胞株のCL-4およびCL-18ともにPKC特にPKCαシグナル伝達経路により調節されていることが分かった。膵癌分子標的治療の候補であるCL-4を介した細菌毒素CPEは、膵癌細胞株においては用量依存性に細胞毒性効果がみられたが、ヒト正常膵管上皮細胞には毒性を示さなかった。そして、膵癌細胞へのCPEの効果は、PKCα阻害剤により調節可能であった。

    researchmap

▼全件表示